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List of abbreviations  
 
AEC    3-amino-9-ethyl carbazole 
Ah-receptor aryl hydrocarbon receptor 
ALA   aminolevulinate 
ALN   auricular lymph node 
ANOVA  analysis of variance 
AP    alkaline phosphatase 
APC   antigen presenting cell 
APP    acute phase protein 
APR    acute phase response  
ASC    antibody-secreting cells 
BCIP   5-bromo-4-chloro-3-indolylphosphate toluidine salt  
BN   Brown Norway 
BSA   bovine serum albumin 
CIS    cytokine-inducible SH2 containing proteins 
CsA   cyclosporin A 
CYP    cytochrome P450 
CYP450  cytochrome P450 
DC   dendritic cell 
ELISA  enzyme-linked immunosorbent assay 
EST    expressed sequence tag 
FBS   fetal bovine serum  
FITC   fluorescein-isothiocyanate 
GC   germinal center 
GlyCAM  glycosylation-dependent cell adhesion molecule 
GST    glutathione-S-transferase 
HCB   hexachlorobenzene 
HEV    high endothelial venule 
HE   hematoxylin eosin  
HgCl2  mercuric chloride  
HSP    heat shock protein 
IFN-γ   interferon−γ 
Ig    immunoglobulin   
IL   interleukin 
LIX    lipopolysaccharide-induced CXC chemokine  
LMWC  low molecular weight compound  
LN   lymph node 
LPS   lipopolysaccharide  
MAPK   mitogen-activated protein kinase 
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MHC   major histocompatibility complex 
MLN   mesenteric lymph node 
MMP   matrix metalloproteinase 
MPO    myeloperoxidase 
MZ   marginal zone  
NBT    nitroblue tetrazolium 
NO   nitric oxide  
NOAEL   no observed adverse effect level 
MTT    3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide 
PAMP  pathogen-associated molecular patterns  
PCA    principal component analysis 
PCB   pentachlorobenzene 
PCDD   polychlorinated dibenzodioxins  
PCDF   polychlorinated dibenzofurans 
PCP    pentachlorophenol 
PCP-NAC  n-acetyl-S-(pentachlorophenyl)-cysteine 
PBS   phosphate buffered saline  
PE    phycoerythrin 
PLN   popliteal lymph node 
PO   peroxidase 
PRR   pattern recognition receptors  
RA-PLNA  reporter antigen-popliteal lymph node assay 
ROS   reactive oxygen species 
SI    stimulation index 
STAT   signal transducer and activator of transcription 
TCBQ  tetrachlorobenzoquinone 
TCDD   2,3,7,8-tetrachlorodibenzo-p-dioxin 
TCHQ  tetrachlorohydroquinone 
TIMP   tissue inhibitor of metalloproteinase 
TNF-α  tumour necrosis factor-α  
TNP    2,4,6-trinitrophenyl 
TLR   Toll-like receptor 
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General Introduction 
 
 
 
 
 
 
 
 
 
 
 
Hexachlorobenzene 
 
Occurrence in the environment  
Hexachlorobenzene (HCB; C6Cl6) is a low molecular weight compound (LMWC; 
molecular weight: 285) that has been used in the past as a fungicide for seed grains. In the 
1970s such a use was prohibited in most countries, but HCB is still generated as a by-
product of several industrial processes, for instance during the manufacturing of 
chlorinated solvents, aluminium and rubber. Furthermore, trace amounts of HCB are 
present as contaminants in several chlorine-containing pesticides. Global emission of 
HCB is estimated to be in the range of 14,000-73,000 kg per year (3). Although emission 
of HCB has decreased substantially compared to 1970s, residues can still be found 
throughout the environment due to its chemical stability, high persistence and re-
emissions of HCB accumulated in soil and water (41,71). HCB can be detected in water 
(7), soil, and sediment (71), but also in tissues of farm animals (34), fish (91) and in 
human milk, serum and adipose tissue (37,79,92).  
 
General Introduction 
 8 
Accidental poisoning in Turkey 
The toxic effects of HCB on humans were first noted in the eastern part of Turkey in the 
period of 1950-1959. Seed grain treated with HCB was unfortunately used as food, 
resulting in a poisoning of approximately 3000-5000 people. Victims developed a 
syndrome that has been called Porphyria Turcica, characterized by hepatic porphyria (10). 
Other clinical features were skin lesions in sun-exposed areas, caused by photochemically 
activation of accumulated porphyrins (6), hyperpigmentation, hirsutism, painless arthritis, 
small hands, enlarged liver, spleen, lymph nodes and thyroid and neurological symptoms 
(27,57). Breast-fed infants born from mothers exposed to HCB developed a syndrome that 
was different from Porphyria Turcica. Since these children developed skin lesions on arms 
and legs that were rose-red this disease was called Pembe Yara (pink sore). Histology of 
skin biopsies showed hyperkeratosis and infiltrations of lymphocytes and macrophages. 
Other clinical symptoms were fever, diarrhea, and hepatomegaly. Thorax radiography 
revealed the presence of pulmonary infiltrates of unknown etiology. These infants did not 
develop porphyria and most victims (>95%) died due to heart-lung failure (11). Follow-up 
studies among 204 victims, 20-30 years after the poisoning have shown that arthritis, 
enlarged thyroid, neurological and dermatological symptoms still persisted (15). 
 
Toxic effects in laboratory animals  
Experiments in laboratory animals confirmed several of the toxic effects observed in 
humans (Table 1). HCB-induced toxicity has been extensively reviewed (14,38,52,78,86). 
 
Table 1: Main toxic effects induced by HCB in laboratory animals 
Toxic effect Reference  
• Hepatic porphyria  17,22,24  
• Cytochrome P450 induction 24,42,77 
• Immunotoxicity  52,88 
• Neurotoxic effects 12,14,35,38 
• Effects on reproductive system 1,23,63 
• Liver cell and thyroid tumors  
(group 2B: possible carcinogenic to humans) 
8,9,31,76 
 
Absorption, distribution and biotransformation 
After oral exposure most of the ingested HCB is excreted unchanged in the faeces (14), 
but a small amount is also absorbed via the small intestines and further taken up via the 
cisterna chyli, entering the lymphatic system (32). In this way HCB is quickly absorbed 
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into the systemic circulation and distributed throughout the body. HCB passively diffuses 
from blood to tissues and accumulates in highly perfused and lipid-rich tissues, for 
instance adipose tissue, lung and liver (33,43).  
 Metabolism of absorbed HCB occurs via two metabolic pathways. The first involves 
cytochrome P450-catalyzed oxidative dehalogenation. Van Ommen et al. (84) have shown 
that in rat liver microsomes HCB is metabolized into pentachlorophenol (PCP), which is 
further converted into tetrachlorohydroquinone (TCHQ) that is in redox equilibrium with 
tetrachlorobenzoquinone (TCBQ). HCB is also metabolized via the mercapturic acid 
pathway resulting in sulphur-containing metabolites. Glutathione-S-transferase catalyzes 
conjugation to glutathione yielding s-(pentachlorophenyl)-glutathione. This conjugate is 
transported to the kidney where it is further metabolized into s-(pentachlorophenyl)-
cysteine and into n-acetyl-S-(pentachlorophenyl)-cysteine, which is excreted via the urine 
(64).  
 
Adverse immune effects of HCB 
 
HCB induces adverse immune effects in different species. In humans immunotoxic effects 
are seen among the victims of the poisoning in Turkey and also in workers exposed 
occupationally to HCB in a chemical plant in Brazil. In these workers impaired functions 
of neutrophilic granulocytes and increased serum IgM and IgG levels are observed 
(61,62).  
 Studies in laboratory animals revealed that HCB has opposite immunotoxic effects 
in mice and rats. HCB exposure in mice suppresses the immune system (5,40), whereas in 
rats stimulation is observed (53,68,87,89,90). Oral exposure of Wistar rats to HCB results 
in a dose-dependent increase of the number of peripheral neutrophilic and basophilic 
granulocytes and monocytes and of spleen and lymph node (LN) weights. Histopathology 
shows increased marginal zones and follicles and extramedullary hemopoiesis in the 
spleen and increased numbers of high endothelial venules (HEVs) in mesenteric lymph 
nodes (MLN) and popliteal lymph nodes (PLN). The primary and secondary IgM and IgG 
responses to tetanus toxoid, a thymus-dependent antigen, are elevated in HCB-exposed 
rats (89). Schielen et al. (68) have shown that HCB increases the number of ED3+ 
macrophages in the spleens of Wistar rats. These macrophages are associated with 
experimentally induced autoimmune diseases such as rheumatoid arthritis (18,19) and are 
thought to be capable of activating B-1 cells (16). B-1 cells are known to produce natural 
antibodies, such as anti-DNA antibodies and both serum IgM levels against such 
autoantigens as the number of splenic B-1 cells are increased after HCB exposure (68,69). 
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These results may be indicatory of an autoimmune component in HCB-induced 
immunostimulation.  
 A study comparing three different rat strains (Wistar, Brown Norway (BN) and 
Lewis) has shown that the BN rat appears to be the most susceptible strain for HCB-
induced immunotoxicity (53). BN rats are known to be more prone to develop type-2 
dependent autoimmunity whereas Lewis rats are more susceptible to develop type-1 
mediated autoimmune diseases (20). Drugs known to induce adverse immune effects such 
as D-penicillamine (20) and nevirapine (72) induce autoimmunity in BN rats and 
tolerance in Lewis rats. Effects induced by HCB are less polarized, since adverse immune 
effects are induced in both strains (53). Table 2 summarizes the immunotoxic effects of 
HCB in the BN rat.  
 
Table 2: Summary of immunotoxic effects of HCB in the Brown Norway rata 
Parameter Doseb References  
• Increased spleen weight 150, 450 53 
• Increased popliteal, axillary and mandibular LN weight  450 50,53 
• Increased number of HEVs in PLN 150, 450 53 
• Granuloma formation in the mesenteric LN 450 53 
• Inflammatory skin lesions: hyperplasia epidermis, 
activated dermal vessels, infiltrates of neutrophils, 
macrophages and eosinophils  
150, 450 51,53 
• Inflammatory lung lesions: focal accumulations of 
macrophages, granuloma formation, perivascular 
eosinophilic infiltrates, HEV-like venules 
150, 450 53 
• Increased total serum IgM and IgE levels 450 53 
• Increased total serum IgG levels 150, 450 53 
• Increased serum IgM levels against ssDNA 150, 450 53 
• Increased in vitro and in vivo airway hyperresponsiveness  450  50,54 
• Decreased IL-2 mRNA expression  150 85c 
• Increased IL-10 mRNA expression 50 85c 
aBN rats were exposed to HCB via the diet for 3 or 4 weeks. The table contains only significant  
changes. bDietary HCB concentration in mg/kg diet. cIn this study rats were exposed to HCB for 6  
weeks.  
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Mechanisms of HCB-induced adverse immune effects 
 
Many LMWCs, such as drugs, metals and environmental pollutants, are able to induce 
systemic allergy or autoimmune-like phenomena. A lot of research has been done to 
elucidate the mechanisms of LMWC-induced adverse immune effects (for reviews on this 
topic see refs.: 26,30,58,59,70). In the remainder of this chapter possible mechanisms of 
LMWC-induced autoimmunity or allergy are discussed in context of HCB-induced 
immunostimulation.  
 
Neoantigen formation and T cell activation   
Since LMWC themselves are too small to be recognized by T cells, one possible way in 
which a LMWC can activate the immune system is by generating neoantigens. T cells can 
only recognize peptides that are presented in a major histocompatibility (MHC)-restricted 
manner. Thus, when chemicals are capable of binding to a protein, a hapten-carrier 
complex is formed. After degradation in the antigen presenting cell (APC) parts of this 
neoantigen are presented by the MHCII and can be recognized by the T cell receptor 
(TCR). This is called signal 1, but T cells need a second signal for complete activation. 
Signal 2 comprises a broad range of factors like costimulatory molecules and pro-
inflammatory cytokines (44). Hence, chemicals that are capable of forming neoantigens 
and simultaneously generate costimulatory signals can cause specific T cell sensitization.               
 HCB itself is not able to bind to proteins, but its oxidative metabolite TCBQ is 
protein-reactive (83,84). The CYP450 catalyzed conversion of HCB seems not to be 
involved in the observed immunostimulation. Schielen et al. (67) have shown that after 
inhibition of cytochrome P450IIIA adverse immune effects still occurred. Furthermore, 
pentachlorobenzene, a compound that is metabolized into the same oxidative 
intermediates as HCB, failed to induce any immunostimulating effects in Wistar rats. 
Involvement of reactive intermediates formed in the mercapturic acid pathway are also not 
implicated, since pentachloronitrobenzene, a compound that is converted into the same 
mercapturic acid metabolites as HCB, did not induce any inflammatory effects in BN rats 
(49).  
 In the last decade it has become evident that chemicals implicated in adverse 
immune reactions can be converted in their reactive intermediates by enzymes present in 
granulocytes (for reviews see refs.: 80,82). Neutrophils and monocytes contain enzymes, 
such as myeloperoxidase (MPO) that can oxidize chemicals. MPO has been shown to 
convert several chemicals into reactive and potential immunogenic intermediates, for 
instance gold salts (28), diclofenac (55), procainamide (81) and aniline (93). After oral 
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exposure to HCB phagocytes are attracted to spleen, skin and lung and may be involved in 
oxidation of HCB into reactive oxidative metabolites that eventually may sensitize 
hapten-specific T cells.  
 
Adaptive versus innate immunity  
The presence of macrophages and granulocytes in skin, lung and spleen of HCB-exposed 
rats (53,68) indicates that the innate immune system may play an important role in the 
observed immunostimulation. For a long time immunotoxicological research has focused 
on adaptive immunity and its role in recognition of (neo)antigens. The two main 
characteristics of the adaptive immune system are clonal specificity and memory, features 
mediated by T and B cells. In contrast, innate immune recognition is mediated by 
germline encoded non-clonal receptors, pattern recognition receptors (PRRs), that 
recognize conserved molecular patterns associated with pathogens, the so-called 
pathogen-associated molecular patterns (PAMPs). PRRs, for example Toll-like receptors 
(TLRs) (48) and CD14 (60), are present on the surface of innate immune cells such as 
macrophages, dendritic cells and granulocytes (47). After engagement of the PRR innate 
immune cells are activated and a cascade of reactions is initiated to induce an optimal 
immune response. These include increased expression of pro-inflammatory and effector 
cytokines and chemokines, recruitment of leukocytes, induction of costimulatory 
molecules on APCs and regulation of T cell differentiation (46).  
 Some inert chemicals are known to specifically activate innate immune cells, for 
instance silica. In rats, inhalation of silica dust can lead to granulomatous inflammation 
and fibrosis in the lung. After deposition in the lung, silica chronically attracts and 
activates alveolar macrophages leading to the release of pro-inflammatory cytokines, such 
as tumour necrosis factor (TNF)-α and interleukin (IL)-1 and reactive oxygen species 
(ROS) (21,29). Release of these pro-inflammatory mediators can elicit a cascade of 
events, such as expression of cell adhesion molecules and release of chemokines leading 
to the recruitment of inflammatory cells. Thus, silica can be considered as an adjuvant and 
exposure can eventually lead to autoimmune-like effects. In workers occupationally 
exposed to silica dust the incidence of scleroderma (36) and systemic lupus erythematosus 
(13) was higher. Thus, adjuvant signals can lead to autoimmune-like effects, a 
phenomenon that can be explained by the so-called danger hypothesis, proposed by 
Matzinger (44).  
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The danger model  
The danger hypothesis is based on the assumption that the immune system does not 
discriminate between self and non-self, but rather between harmless and dangerous. 
According to this hypothesis, danger signals can activate APCs that subsequently can 
deliver costimulatory signals to T cells and danger signals can be derived from damaged 
cells, but also heat shock proteins or cytokines are considered as inducible danger signals 
(2).  
 Evidence for this theory has been provided by several studies. In vitro experiments 
have shown that immature dendritic cells (DCs) can both phagocytose apoptotic and 
necrotic cells. Necrotic cells provided maturation signals to the DC, resulting in 
upregulation of costimulatory molecules. On the contrary, apoptotic cells were not able to 
activate DCs (25,66). Uptake of necrotic cells, but not apoptotic cells, by macrophages 
increased CD40 expression and enhanced T cell proliferation (4). Macrophages play an 
essential role in the clearance of cellular debris and might be responsible for 
discriminating between danger signals, e.g. necrosis, or harmless signals, e.g. apoptosis. 
Other in vitro studies showed that necrotic cells induced NF-κB and chemokine gene 
expression in DCs, macrophages and fibroblasts. Notably, activation of NF-κB required 
TLR2 signaling. This could mean that besides exogenous (microbial) signals for TLR 
activation, endogenous signals also mediate immune responses via TLR activation (39). 
This links Janeway’s model of pattern recognition of exogenous non-self to Matzinger’s 
danger hypothesis.  
 Research done by Shi and colleagues suggests that cells contain molecules with 
adjuvant properties that are released when the cell membrane integrity is lost. In contrast 
to the above mentioned studies, these adjuvant signals are released either during necrosis 
or apoptosis (74,75). Recently, evidence for the existence of endogenous adjuvants has 
been found, i.e. uric acid, a degradation product of nucleotides. Uric acid is produced by 
injured cells and was capable of DC activation and enhancement of cytotoxic T cell 
priming (73).  
 T cell responses can also be augmented by pro-inflammatory cytokines, a feature 
explained by the ability of cytokines to upregulate costimulatory molecules on APCs and 
in this way delivering a signal 2 (45). Furthermore, pro-inflammatory cytokines promote 
clonal expansion and differentiation of helper T cells in an antigen-dependent manner, 
probably by providing growth and survival signals (56).  
 A consequence of the generation of danger signals could be that a signal 2 is 
delivered to autoreactive T cells. These T cells are present in healthy individuals and are 
controlled by regulatory T cell populations to prevent immune responses to self (65). 
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Endogenous danger signals may break this peripheral tolerance and in this way induce an 
adverse immune response against self. All together these studies show that innate and 
adaptive immunity are not two separate entities. Innate immune cells are important 
effector cells in the sense that they detect danger signals during pathological situations 
and are activated to mount an efficient adaptive immune response (46,48).  
 The role of innate immunity in HCB-induced immunotoxicity is not completely 
clear. The presence of granulocytes and macrophages could indicate that innate immunity 
plays an important role in the induction of an immune response. Figure 1 summarizes 
schematically our hypotheses on how HCB can stimulate the immune system. We 
hypothesize that HCB, after storage in tissues, causes cell stress or necrosis, leading to 
attraction and activation of macrophages. Subsequently a non-specific inflammatory 
response is induced. Furthermore necrosis or inflammatory cytokines can be sensed as 
danger signals by innate immune cells, leading to upregulation of costimulatory molecules 
and enhancement of T cell responses. Our second hypothesis involves biotransformation 
of HCB in reactive metabolites, by for instance myeloperoxidase. After covalent binding 
of the metabolites to proteins neoantigens are formed that are presented to T cells leading 
to signal 1. T cell activation and maturation occurs when a signal 2 is present. Together, 
this induces an adaptive immune response against the formed neoantigens, leading to 
sensitization and formation of memory T cells. 
 
Scope of this thesis  
 
The aim of this thesis was to investigate the above proposed hypotheses. We assessed the 
sensitizing potential of two oxidative metabolites of HCB, TCHQ and TCBQ. Therefore, 
these reactive metabolites were tested in the mouse reporter-antigen popliteal lymph node 
assay using TNP-Ficoll as a reporter-antigen (Chapter 2). To obtain more insight in the 
effects of HCB on a molecular level, a toxicogenomics experiment was performed after 
subchronic exposure of BN rats to HCB (Chapter 3). Microarrays containing thousands 
of genes were used to assess gene expression profiles. In Chapter 4 the role of T cells 
was investigated. For this purpose BN rats were exposed orally to HCB and treated 
simultaneously with Cyclosporin A (CsA) a compound known to reduce peripheral T cell 
numbers and inhibit antigen-induced T cell activation. In Chapter 5 experiments were 
performed to investigate if oral exposure to HCB leads to sensitization and formation of 
memory T cells. This chapter also describes data from a kinetic study, performed to obtain 
information on the initiation phase of HCB-induced immunostimulation. Because 
macrophages are already present in an early stage, their involvement was also investigated 
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in this chapter. For these experiments the macrophage ‘suicide’ technique with clodronate 
liposomes was used. Treatment with clodronate liposomes depletes macrophages in spleen 
and liver after intraperitoneal injection. Finally, Chapter 6 summarizes and discusses data 
described in this thesis.  
HCB
Macrophage
activation
Biotransformation in 
reactive metabolites
T cell activation and 
maturation
Inflammatory response
APC
MHCII
     
      Signal 1
Th cell 
TCR
Cell stress/ Necrosis 
Binding to self proteins Æ
neoantigen formation
Danger / Signal 2
Figure 1: Simplified scheme of the hypothetical pathways of HCB-induced immune stimulation  
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Abstract 
 
Hexachlorobenzene (HCB) is an environmental pollutant that causes autoimmune-like 
effects in humans and rats. It is not completely clear whether T cells are involved and, if 
so, how they are stimulated after oral exposure to HCB. HCB as a rather inert chemical is 
not likely to bind covalently to macromolecules. The oxidative metabolite of HCB, 
tetrachlorobenzoquinone (TCBQ) which is in redox equilibrium with tetrachloro-
hydroquinone (TCHQ) can bind to macromolecules, hence may form hapten-carrier 
complexes in vivo. We have assessed in the reporter antigen-popliteal lymph node assay 
(RA-PLNA) whether HCB or TCHQ and TCBQ are able to induce a TNP-specific IgG1 
response to the T cell independent antigen 2,4,6-trinitrophenyl (TNP)-Ficoll, which is 
indicative of neoantigen specific T cell help. To this end, these compounds and silica were 
injected into the footpad of Balb/c mice. Silica was included as an inert model compound, 
which causes autoimmune-like effects by activating macrophages. Seven days later cell 
number and TNP-specific antibody secreting cells (ASC) in the popliteal lymph node 
(PLN) were determined. Furthermore, a secondary PLNA was performed to find out if 
TCHQ was capable of eliciting a memory response. Silica, TCHQ and TCBQ, but not 
HCB, increased PLN cellularity and the number of IgM producing ASC by ELISPOT. 
Both oxidative metabolites were able to induce the formation of germinal centers as 
assessed by immunohistochemistry and an IgG1 response to TNP-Ficoll. In the secondary 
PLNA only mice primed with TCHQ and challenged with TCHQ together with TNP-Ficoll 
showed a significant increase in TNP-specific IgG1 ASC. Present data show that TCHQ 
and TCBQ are capable of inducing neoantigen specific T cell help and that TCHQ can 
induce a compound specific memory response.  
 
Introduction 
 
Hexachlorobenzene (HCB) is a highly persistent environmental pollutant with pronounced 
toxic and immunotoxic effects. Humans involved in the intoxication incident with HCB in 
Turkey in the 1950s suffered from a syndrome characterized by hepatic porphyria, skin 
lesions caused by porphyrins, splenomegaly, enlarged lymph nodes and arthritis (4). 
Breast-fed infants born to mothers exposed to HCB did not develop porphyria but a 
syndrome characterized by high mortality, hepatomegaly and inflammatory skin infiltrates 
predominantly consisting of lymphocytes and macrophages. Also in the lungs infiltrates 
were present (5). 
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 In several rat studies, oral exposure to HCB induced similar adverse (immune) 
effects as observed in man (16,36,37). Remarkably, porphyrins appeared not to be 
involved in the development of skin lesions in the rat (26) and several studies have shown 
that these skin effects could have an (auto)immune-like etiology (19,27). The mechanism 
of HCB-induced immunopathology is still unclear. HCB is a rather inert, highly 
hydrophobic low molecular weight compound (LMWC) and only a small portion of 
ingested HCB is metabolized whereas the remainder is stored in tissues with a high lipid 
content or excreted in unchanged form via the faeces (14,15). HCB is metabolized via two 
different pathways. Conjugation to glutathione by glutathion-s-transferase eventually 
leads to the formation of N-acetyl-S-(pentachlorophenyl)-cysteine (PCP-NAC), which is 
excreted via the urine (23). HCB can also be degraded by P450-catalyzed oxidative 
dehalogenation to pentachlorophenol (PCP), tetrachlorohydroquinone (TCHQ) and 
tetrachlorobenzoquinone (TCBQ) (33). Under physiological conditions TCHQ autoxidizes 
into its semiquinone radical and further into TCBQ (41). Neither of these two metabolic 
pathways seem involved in the observed immunopathology (18,26). However, conversion 
of HCB into oxidative metabolites might occur in a non-P450 catalyzed reaction. 
 It has been shown that autoimmunogenic xenobiotics such as procainamide (10), 
gold (I) disodium thiomalate (9) and propylthiouracil (35) (reviewed in 30) can be 
metabolized also extrahepatically by mononuclear phagocytes in a non-P450 dependent 
manner. These reactive metabolites might conjugate to macromolecules and thus act as 
haptens and be recognized by T cells. The same may apply to benzoquinones and 
semiquinones, which are highly electrophilic compounds. Notably, van Ommen et al. 
(31,32,34) have shown that TCBQ can bind to macromolecules like proteins and DNA. 
Recently it has been shown that the oxidative metabolite of benzene, p-benzoquinone is 
able to induce T-cell dependent immune reactions in mice (8). From this we hypothesize 
that following HCB exposure metabolic enzymes, like for instance myeloperoxidase 
present in granulocytes, convert HCB into reactive oxidative metabolites that eventually 
may sensitize hapten-specific T cells. HCB as an inert chemical might also directly 
activate phagocytes and consequently act as an adjuvant like for instance silica. Silica is a 
chemical known as a non haptenizing inert compound with intrinsic adjuvant activity that 
is able to activate macrophages, but has previously been shown not to induce specific T 
cell activation. Silica-induced macrophage activation can lead to a non-specific 
stimulation of the immune system and chronic inflammation (39).  
 To investigate this, we have studied these chemicals in the reporter antigen-popliteal 
lymph node assay (RA-PLNA) using the T cell-independent antigen TNP-Ficoll (3,21). 
Important to note is that TNP-Ficoll as a sugar molecule is not recognized by T cells, but 
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can activate B cells to produce IgM antibodies. For switching to other isotypes, e.g. IgG1, 
B cells require additional help such as from T cells. Since these T cells cannot be 
activated by TNP-Ficoll, the help can only come from T cells activated by the injected 
chemical. In this model an isotype switch to IgG1 indicates that the chemical injected is 
able to form neoantigens that can stimulate T cells (1). The aim of the present experiments 
was to assess whether HCB and its metabolites TCHQ and TCBQ can induce hapten 
specific T cell help. Silica is also included in this assay to serve as a inert model 
compound. Furthermore, to assess whether help for the TNP-specific isotype switch to 
IgG1 was TCHQ specific and thus possibly dependent on TCHQ-specific T cells we 
performed a secondary RA-PLNA protocol with challenge doses of TCHQ together with 
TNP-Ficoll in mice presensitized to TCHQ.  
 
Materials and Methods 
 
Animals  
Female specific pathogen-free BALB/c mice (6-8 weeks of age) (Harlan, Netherlands BV, 
Zeist, The Netherlands) were housed under hygienic barrier conditions in filter-topped 
macrolon cages with bedding of wood chips, a temperature of 23±2°C, 50-55% relative 
humidity and a 12 h light/dark cycle. Mice were assigned randomly to specific treatment 
groups and were allowed to settle for a week before the start of the experiment. They 
received standard lab chow and acidified tap water ad libitum. All experiments were 
approved by an ethical committee and conducted in accordance with the Guiding 
Principles in the Use of Animals in Toxicology.  
 
Chemicals and reagents  
HCB (purity>99%) was obtained from Fluka Chemika (Buchs, Switzerland), TCBQ (p-
chloranil; purity>98%) from Merck-Schuchardt (Hohenbrunn, Germany), silica (SiO2) 
and TCHQ (purity>99%) were obtained from Sigma Chemical Co. (St. Louis, MO).  The 
antigen TNP-Ficoll was prepared as described by Albers et al. (1). Immobilon-P 
membranes were purchased from Millipore (Etten-Leur, The Netherlands) and alkaline 
phosphatase (AP)-conjugated goat-anti-mouse human adsorbed IgM and IgG1 from 
Southern Biotechnology Associates (Birmingham, AL). Nitroblue tetrazolium (NBT) and 
5-bromo-4-chloro-3-indolylphosphate toluidine salt (BCIP) were both from Sigma 
Chemical Co. (St. Louis, MO) and as solvent for stock solutions of NBT and BCIP we 
used dimethylformamide (BDH Laboratory Supplies, Poole, UK). For 
immunohistochemistry, acetone and H2O2 were acquired from Merck (Darmstadt, 
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Germany), 3-amino-9-ethyl carbazole (AEC) from Janssen (Beerse, Belgium) and rabbit-
anti-rat-peroxidase (PO) from DAKO (Glostrup, Denmark). Rat anti-mouse B220 (RA3-
6B2) was used for detection of B cells. Monoclonal antibodies for staining of surface 
molecules for flow cytometry were obtained from BD Pharmingen (San Diego, CA): CD4 
fluorescein-isothiocyanate (FITC) (RM4-5), CD8α phycoerythrin (PE) (53-6.7), CD19 PE 
(1D3). Chemicals not specifically mentioned here were from Sigma Chemical Co.  
 Caution: HCB, TCHQ, TCBQ and silica are hazardous agents and should be 
handled accordingly. HCB is very persistent in the environment and possibly a 
carcinogen, TCHQ and TCBQ are genotoxic compounds. Silica can be harmful by 
inhalation.  
 
Treatment of mice  
The RA-PLNA was essentially performed as described previously (1). Briefly, all 
chemicals used in the RA-PLNA were ground to a fine suspension (20 mg/ml) in a glass 
potter in a solution of 10% (w/v) dextrose and 2% (v/v) Tween-80 in saline. This solution 
was used to facilitate the suspension of these hydrophobic chemicals (28). All suspensions 
were placed in an ultrasonic bath for at least one hour. For the primary RA-PLNA a total 
volume of 50 µl of each suspension together with 10 µg of the reporter antigen TNP-
Ficoll was injected sc into the right hind footpad of naive BALB/c mice, hence the dose 
per animal was 1 mg/mouse. Control mice received the vehicle plus 10 µg TNP-Ficoll. 
Seven days later, mice were killed by cervical dislocation, and draining PLNs were 
isolated. For the kinetic study with HCB and silica, mice were killed 21 days after the 
injection. In the secondary PLNA, mice were primed with either 50 µl solvent or with 1 
mg TCHQ in 50 µl solvent. After 4 weeks, mice were challenged sc in the same footpad 
with a suboptimal dose of 20 µg TCHQ together with 10 µg TNP-Ficoll in 50 µl. This 
suboptimal dose was predetermined as a dose that is too low to induce a primary PLN 
response in unprimed mice. Five days after injection of the challenge dose, mice were 
killed by cervical dislocation and draining PLNs were isolated. For both the primary and 
the secondary RA-PLNA single cell suspensions were prepared in phosphate buffered 
saline (PBS) containing 1% bovine serum albumin (BSA), washed once by centrifugation, 
resuspended in PBS/1%BSA, counted using a Coulter Counter (Coulter Electronics, 
Luton, UK) and then adjusted to 1 x 106 cells per ml.  
 
ELISPOT assay  
This assay was essentially performed as described previously by Schielen et al. (29). 
Briefly, from each lymph node 0.5 x 106 cells in 500 µl PBS/1%BSA were incubated 
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(37°C, 4 h) in wells containing TNP-BSA-coated (overnight 4°C) Immobilon-P 
membranes as bottom. Thereafter, membranes were washed and incubated with optimal 
dilutions of isotype specific AP-conjugated anti-mouse Ig antibodies in PBS/1% BSA 
(o.n. 4°C). After they were washed, spots were developed by using a freshly prepared 
solution containing BCIP and NBT in Tris buffer (100 mM Trizma base, 100 mM NaCl, 5 
mM MgCl2·6H2O, pH 9.5). Specific ASCs per 106 cells were calculated from spot 
numbers counted with the aid of a stereomicroscope by two observers.   
 
Flow cytometry  
For analysis of surface markers single cell suspensions (1 x 105 cells) in PBS/1%BSA 
were centrifuged, resuspended and incubated with combinations of optimal dilutions of 
FITC- and PE-conjugated mAbs in 96-wells plates (30 min, in the dark, 4°C).  Samples 
were analyzed on a FACScan flow cytometer with standard FACSflow using CellQuest 
software (BD Biosciences, Franklin Lakes, NJ, USA).  
 
Immunohistochemistry  
For the visualization of germinal centers acetone-fixed cryostat sections (7 µm) of PLN 
were incubated with predetermined optimal dilutions of the B cell monoclonal B220 in 
PBS/1%BSA (overnight 4°C). After three washes in PBS/0.05%Tween, sections were 
incubated with polyclonal PO-conjugated rabbit-anti-rat-Ig diluted in PBS/5% normal 
mouse serum (1 h, room temperature). After final washes peroxidase activity was 
visualized with AEC and sections were counterstained with Mayer’s hematoxylin. 
Acetone-fixed cryostat sections (7 µm) of paws were stained with acid phosphatase to 
visualize macrophages. Sections were incubated with a solution of 4 mg Naphthol AS-BI 
phosphate in 0.25 ml dimethyl formamide and 25 ml acetate buffer. To this solution 35 
mg diazonium salt was added at 37°C for 45 min. After washing in running water sections 
were counterstained with Mayer’s hematoxylin.  
 
Statistics  
Values deviating more than 2 standard deviations from group means were considered as 
outliers and not included in statistical analyses. Preceding statistical analysis, all data were 
transformed to log 10 values to homogenize variance. Differences between group means 
were analyzed using one-way ANOVA with Bonferroni's post hoc test for contrasts 
(p<0.05, p< 0.01 and p<0.001).  
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Results 
 
Primary RA-PLNA 
 Cell number  
Female BALB/c mice received a sc injection of 1 mg of the different chemicals together 
with 10 µg TNP-Ficoll into the right hind footpad. After 7 days, PLNs were removed and 
cell number and TNP-specific IgM and IgG1 ASC were assessed. TCHQ and TCBQ, but 
also silica, induced a significant increase in PLN cell number. HCB, however, caused only 
a slight but not significant (p<0.077) increase of cell number (Figure 1). The PLN 
stimulation indices (SI) from each group were calculated by dividing cell number of the 
treatment group by the cell number of the control group (1.3 ± 0.1 x 106 cells), resulting in 
the following SI: 1.9 for HCB (2.4 ± 0.6 x 106 cells), 3.5 for silica (4.5 ± 1.6 x 106 cells), 
4.1 for TCBQ (5.2 ± 2.2 x 106 cells) and 5.7 for TCHQ (7.2 ± 3.2 x106 cells). 
Figure 1: PLN cell number 7 days after injection of different compounds 
together with TNP-Ficoll. Data are obtained from 2 individual 
experiments. Bars represent mean ± SE of 5-10 mice per group. ** 
Significantly different from control group with p<0.01. All data were 
determined by ANOVA followed by Bonferroni’s post hoc-test.  
 
 TNP-specific antibody-secreting cells  
Results of the ELISPOT are presented in Figure 2 as the number of ASC per 106 cells. 
HCB was not able to increase either IgM or IgG1 ASC. TCHQ and TCBQ significantly 
enhanced the number of IgM ASC as well as of IgG1 ASC. Results show a 6-fold increase 
in IgM ASC for both metabolites, whereas IgG1 ASC were increased 20-fold and 30-fold 
for TCHQ and TCBQ, respectively. In case of silica the number of IgM ASC, but not of 
IgG1 ASC was significantly enhanced.   
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Figure 2: Number of TNP-specific antibody-secreting cells (ASC) per 106 
cells as determined by ELISPOT at day 7 after injection of the different 
compounds together with TNP-Ficoll. Data are obtained from 2 individual 
experiments. Bars represent mean ± SE of 6-9 mice. Significantly different 
from the control group * p<0.05; ** p<0.01, *** p<0.001.  
 
 Immunohistochemistry  
To establish whether the different chemicals were capable of inducing germinal center 
formation all compounds were injected in the footpad without TNP-Ficoll. Seven days 
later PLNs were removed and immunohistochemistry was performed. B cell staining 
clearly showed that both TCHQ and TCBQ were capable of inducing germinal center 
formation (Figure 3), whereas HCB and silica did not induce the development of germinal 
centers.  
 
 Flow cytometry  
Table 1 shows relative and absolute amount of B (CD19+) cells, helper T cells (CD4+, Th 
cells) and cytotoxic T cells (CD8+, Tc cells) in the PLN. Silica induced a significant 
increase of the absolute number of Th and Tc cells. Injection of HCB caused a significant 
increase of the absolute number of Tc cells. In the case of TCHQ and TCBQ, the absolute 
numbers of B, Th and Tc cells were all significantly increased. The relative numbers of 
lymphocyte subsets give an indication of which cells contribute the most to the PLN 
enlargement. Data show that the PLN enlargement that is seen after injection of TCHQ 
and TCBQ is predominantly due to an increase in B cells, since relative B cell numbers  
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Figure 3: B220 (B cell monoclonal) stained sections of PLN isolated on day 7 from mice injected 
with 50 µl vehicle (A), 1 mg HCB (B), 1 mg silica (C), 1 mg TCHQ (D) and 1 mg TCBQ (E). 
TCHQ and TCBQ show germinal centers (arrows).  
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Table 1: Absolute and relative lymphocyte subsets per PLN1 
 B cells 
 
Th cells Tc cells 
Control   30 ± 2.3 
 (24 ± 2.4) 
  76 ± 5.8 
 (59 ± 1.5) 
 26 ± 2.2 
(20 ± 0.5) 
Silica 117 ± 19 
 (34 ± 2.2) 
183 ± 42** 
 (52 ± 2.4) 
 60 ± 11** 
(18 ± 0.8) 
 HCB   62 ± 7.5 
 (26 ± 2.2) 
129 ± 15 
 (54 ± 2.0) 
 50 ± 6.5* 
(20 ± 1.5) 
TCHQ 243 ± 40*** 
 (39 ± 3.4*) 
256 ± 20*** 
 (45 ± 3.9**) 
 90 ± 6.8*** 
(16 ± 3.4) 
TCBQ 259 ± 61*** 
 (45 ± 2.9**) 
229 ± 45*** 
 (42 ± 2.2***) 
 77 ± 14*** 
(15 ± 1.2*) 
1Absolute (x 105) and relative (%; between brackets) numbers of Th cells (CD4+), Tc cells (CD8+), 
and B cells (CD19+) cells at day 7 after injection of the different chemicals and TNP-Ficoll as 
determined by flow cytometry. Data are expressed as mean ± SE (4-6 mice per group). Cells were 
triple stained for combinations of CD4, CD8 and CD19. Significantly different from the control 
group *р<0.05; **р<0.01, ***p<0.001 determined by ANOVA followed by Bonferroni’s post-hoc 
test. 
  
were significantly elevated from 24% in controls to 39% and 45% for TCHQ and TCBQ, 
respectively, whereas the relative numbers of T cells were decreased.  
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Figure 4: Number of TNP-specific ASC per 106 cells. Mice were primed with a sc injection of 1 mg 
TCHQ or the solvent. After 4 weeks mice were challenged by a sc injection in the same footpad 
with 20 µg TCHQ or the solvent together with 10 µg TNP-Ficoll. Five days later ASC were 
assessed. Bars represent mean ± SE of 4 mice. Significantly different from the control group 
(priming and challenge with solvent) *p<0.05; **p<0.01.     
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Secondary RA-PLNA with TCHQ  
Mice were primed with a sc injection of 1 mg TCHQ or treated with the vehicle. After 4 
weeks mice were challenged in the same footpad with 20 µg TCHQ together with 10 µg 
TNP-Ficoll. Appropriate control groups receiving TCHQ only at priming or only as 
challenge and a control group only treated with solvent were included. Cell number of all 
TCHQ-treated groups was significantly increased compared to the mice that were injected 
with solvent during priming and challenge and there was no significant difference 
between the groups (data not shown).  
 
A      B      C  
     
D        E 
  
Figure 5: Sections of paws injected with vehicle (A), 1 mg HCB (B), or 1 mg silica (C) stained for 
acid phosphatase, staining macrophages (in black). With a higher magnification large particles 
(arrows) can be seen in HCB treated animals (D) and a large number of smaller particles (arrows) in 
the silica treated mice (E). Both HCB and silica attract macrophages to the paw (B-E).    
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 ASC against TNP-Ficoll were measured in the secondary response (Figure 4). Mice 
treated with vehicle at priming and challenge had no ASC. Also, mice that were only 
primed with TCHQ had hardly detectable IgM and IgG1 ASC. Challenging naive mice 
with 20 µg TCHQ resulted in an increase of predominantly IgM ASC to 23 ± 8 per 106 
cells (not significant) and no increase in IgG1 ASC. A recall with TCHQ in primed mice 
resulted in an increase of IgM ASC to 36 ± 14 per 106 cells (not significant) and a 
significant enhancement of IgG1 ASC to 20 ± 6 per 106 cells.   
  
Deposit formation and clearance 
Because we did not measure an elevation in cell number 7 days after HCB injection, a 
kinetic study was performed. Deposits were visible after injection of both silica and HCB. 
HCB deposits were macroscopically completely cleared after 21 days whereas silica 
deposits were still visible at that time point. Figure 5 shows histology of the paw at day 7 
after injection of HCB and silica showing clearly the presence of HCB and silica particles. 
Staining the paw sections with acid phosphatase revealed an infiltration of macrophages, 
surrounding the silica and HCB particles. Figure 6 shows the primary PLN response 21 
days after injection of 1 mg of HCB or silica. Control animals were injected with the 
vehicle only. Silica induced a chronic PLN response that was even higher 21 days after 
injection than after 7 days (Figure 1). The slight increase in PLN cell number 7 days after 
HCB injection (Figure 1) had disappeared after three weeks. 
Figure 6: Cell number of PLN 21 days after injection of 1 mg HCB or 1 
mg silica. Bars represent mean ± SE of 3 mice per group. ** Significantly 
different from control group with p<0.01. All data were determined by 
ANOVA followed by Bonferroni’s post hoc test.  
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Discussion 
 
The aim of the present study was to assess whether metabolites of HCB can activate T 
cells. To this end, we used the RA-PLNA with TNP-Ficoll as a RA and the secondary 
RA-PLNA to measure a memory response against TCHQ. Silica was included in the 
primary RA-PLNA as an inert model compound.  
 We show that silica as well as TCHQ and TCBQ caused a significant increase in 
PLN cellularity whereas HCB caused only a slight but not significant increase. Both 
metabolites induced the formation of germinal centers and also an IgG1 response to TNP-
Ficoll. A switch to IgG1 in the RA-PLNA with TNP-Ficoll is indicatory for neoantigen 
specific T cell help, since TNP-Ficoll as a sugar moiety cannot be recognized by T cells 
(1). So, accordingly, both TCHQ and TCBQ are likely to form neoantigens and stimulate 
T cells. Silica and HCB were unable to do so and only silica treatment caused an 
enhancement of the IgM response to TNP-Ficoll. To confirm that the results of the 
primary response were compound specific, we primed mice with TCHQ and challenged 
them 4 weeks later with a suboptimal dose of TCHQ together with TNP-Ficoll. A 
significant increase in TNP-specific IgG1 ASC was only found in mice that were primed 
and challenged with TCHQ. 
 Together, we show here that TCHQ and TCBQ, but not HCB itself, are capable of 
inducing neoantigen specific T cell help and that TCHQ can induce a compound specific 
memory response. TCBQ is a quinone that can react with macromolecules to form 
adducts. Importantly, studies on the microsomal oxidation of HCB showed that the major 
metabolites formed were PCP and TCHQ and revealed covalent binding to protein and 
DNA (34). Since ascorbic acid prevented covalent binding, it was assumed that TCHQ 
needs to be oxidized in its semiquinone form or in TCBQ and that the latter two are the 
ultimate covalent binding compounds (32). TCHQ readily autoxidizes at physiological pH 
into its semiquinone form and further into TCBQ (22) implicating that the ultimate 
haptenating metabolites can be formed spontaneously in the paw.  
 By using a secondary RA-PLNA, we show that injection of a suboptimal dose (20 
µg) of TCHQ in primed mice resulted in a significant increase of TNP-specific IgG1 
ASC. Remarkably, all treatment groups showed an increase in cell number (data not 
shown). In preliminary experiments, a suboptimal dose was determined as the dose that 
does not induce a PLN reaction. However, in the memory study mice were injected twice 
in the same paw, which could lead to irritation and subsequently to an increase in PLN 
cell number, but not to isotype switching. Nevertheless, in primed mice challenged with 
the vehicle, no ASC cells were detected, but naive mice challenged with TCHQ showed 
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only increased IgM but no IgG1 ASC. So, besides eliciting an isotype switch to TNP-
Ficoll in the primary RA-PLNA, TCHQ was also able to induce a secondary PLN 
response. This response follows the pattern of a memory response since it is induced by a 
much lower dose and in a shorter time period than the primary response. Previously p-
benzoquinone, a metabolite of benzene, has also been shown to elicit a secondary 
response in the PLNA (8).  
 Both HCB and silica were not able to elicit an isotype switch in the RA-PLNA with 
TNP-Ficoll, as was expected based on their chemical structure. After injection of both 
chemicals deposits were visible in the footpad, but HCB deposits disappeared completely 
after 21 days, whereas silica deposits were still present at that time point. The PLN 
response to silica increased in time, as has already been shown before (39), but HCB was 
not able to induce an increase in PLN cellularity at any of the assessed time points. 
Present data showing that HCB induced only moderate PLN responses seem to contradict 
with our previous work (28) in which we showed that different doses of HCB caused a 
clear and significant elevation of PLN cellularity in the primary PLNA in Balb/c mice. 
We performed a series of additional unpublished studies to compare different sources of 
HCB (Fluka vs. BDH derived) as they had a different crystalline appearance. The only 
difference that seems to remain is the source of BALB/c mice as the previous experiments 
were done with mice bred in former in-house facilities, whereas the present BALB/c mice 
were from Harlan.  
 Data shown here on silica, however, were similar to those observed previously (1). 
Silica is known to induce a nonspecific immunostimulation, because the undegradable 
particles cannot be cleared by macrophages. This causes a continuously activation of 
macrophages which leads to the production of pro-inflammatory cytokines as TNF-α and 
IL-1β (7) and the formation of reactive oxygen species (11) leading to immunostimulation 
and secondary cell damage. Injection of silica into the footpad induced an even higher 
response 21 days after injection than after 7 days, and previous work revealed that this 
reaction could last even up to 180 days (39). Apparently, our data show a clear difference 
between the effects of silica and HCB in the PLNA although they are both insoluble and 
injected as suspension. Silica and HCB particles are visible as particles and attract 
macrophages into the paw. The slight elevation in PLN cell number after injection of 
HCB is probably caused by the presence of immunostimulating macrophages in the paw. 
The reason for the difference in magnitude of the PLN response may be that in contrast to 
silica HCB can be processed by macrophages, since HCB deposits eventually disappear. It 
is known that in the setting of the PLNA, metabolism in the paw is not sufficient to 
convert chemicals that need biotransformation to form reactive intermediates (13,20). 
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Upon oral treatment of BN rats as the most susceptible strain of rats for HCB induced 
immunopathology HCB will probably reach the organs (spleen, skin, lungs) where 
extrahepatic metabolic conversion can take place and reactive intermediates, like TCBQ 
can be formed.  
 Both TCBQ and p-benzoquinone (8) display typical characteristics of haptens, 
namely, a low molecular weight and the ability to react with protein. Benzene and HCB 
can be considered as prohaptens. As already noted, P450 metabolism is not involved in 
HCB-induced immunopathology (26). Possibly, HCB is metabolized extrahepatically by 
peroxidases in leukocytes, including granulocytes. Whether peroxidase-rich cell types are 
capable of converting HCB is as of yet unknown. PCP, however, can be converted by a 
H2O2-dependent horseradish peroxidase-catalyzed oxidation yielding TCBQ as a major 
product (25). Besides the reported genotoxic activity, that is caused by its reactive 
metabolite TCBQ (6,12,40), PCP induced immunological aberrations in man and rats. 
Human exposure to PCP induced T cell activation and autoimmunity, immunosuppression 
and B cell dysregulation (17). A study in rats showed suppressed antibody responses and 
enhanced lymphocyte blastogenesis after PCP exposure (2). In vivo administration of PCP 
to rats showed the ability of TCBQ to bind covalently to albumin and hemoglobin and the 
formation of adducts (38) supporting the protein reactivity of this metabolite in vivo. So, 
PCP induced adverse immune effects as well but those are not comparable to the HCB 
induced immunopathology. Notably, distribution patterns and excretion of HCB and PCP 
after oral exposure differ, since HCB is a more lipophilic and persistent chemical than 
PCP and more likely to accumulate in the body. The same might be true for another 
chemical, pentachlorobenzene (PCB) that has the same oxidative metabolites as HCB, but 
a shorter half-life. Feeding studies in rats showed that PCB, besides a slight elevation in 
IgA, does not cause the same immunopathology as HCB (26). To our knowledge, PCB 
does not induce infiltration of inflammatory cells after oral exposure to rats. Since 
inflammatory cells like macrophages and granulocytes probably play an important role in 
HCB-induced immunopathology, either by inducing inflammation or by extrahepatic 
formation of reactive metabolites, it is quite logical that PCB does not induce the same 
immunopathology. Another important difference between the metabolic pathways of PCB 
and HCB is the primary oxidation step. Conversion of PCB into PCP is a simple 
hydroxylation where no reactive intermediate is formed. The first step in the HCB 
oxidation is an oxidative dehalogenation that generates a highly reactive intermediate 
(“benzohaloquinone”) (24). This intermediate might also contribute to the observed 
immunopathology. Difference in kinetics as well as intermediates formed could explain 
the discrepancy between these compounds that generate the same metabolites, but do not 
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induce the same immunopathology. Since oral exposure of rats to HCB resulted in 
infiltrations of peroxidase-rich cell types like granulocytes in spleen, skin and lungs (19) 
these cells may be involved in the conversion of HCB into its haptenating metabolites. 
Human data from Turkey revealed infiltrations of lymphocytes and macrophages in the 
skin of the breast-fed infants born to mothers exposed to HCB (5).  
 So, present data seem to support our hypothesis that both T cells as well as 
macrophages and granulocytes play an important role in HCB-induced immunopathology. 
We are currently investigating whether TCBQ-specific T cells are present in BN rats 
exposed to HCB and if HCB can be metabolized extrahepatically into reactive metabolites 
by myeloperoxidase or phagocytes. In that case, HCB can be considered as a prohapten 
that needs to be metabolized first to create haptens which could attribute to the observed 
immunopathology.  
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Abstract 
 
Hexachlorobenzene (HCB) is a persistent environmental pollutant with toxic effects in 
man and rat. Reported adverse effects are hepatic porphyria, neurotoxicity, and adverse 
effects on the reproductive and immune system. To obtain more insight into HCB-induced 
mechanisms of toxicity, we studied gene expression levels by using DNA microarrays. For 
4 weeks Brown Norway rats were fed a diet supplemented with 0, 150 or 450 mg HCB/kg. 
Spleen, mesenteric lymph nodes (MLN), thymus, blood, liver, and kidney were collected 
and analyzed using the Affymetrix rat RGU-34A GeneChip microarray. Most significant 
(p<0.001) changes as compared to the control group occurred in spleen, followed by 
liver, kidney, blood and MLN, but only a few genes were affected in thymus. This was to 
be expected as the thymus is not a target organ of HCB. Transcriptome profiles confirmed 
known effects of HCB such as stimulatory effects on the immune system and induction of 
enzymes involved in drug metabolism, porphyria and the reproductive system. In line with 
previous histopathological findings were the increased transcript levels of markers for 
granulocytes and macrophages. New findings include the upregulation of genes encoding 
pro-inflammatory cytokines, antioxidants, acute phase proteins, mast cell markers, 
complement, chemokines, and cell adhesion molecules. Generally, gene expression data 
provide evidence that HCB induces a systemic inflammatory response, accompanied by 
oxidative stress and an acute phase response. In conclusion, this study confirms 
previously observed (immuno)toxicological effects of HCB but also reveals several new 
and mechanistically relevant gene products. Thus, transcriptome profiles can be used as 
markers for several of the processes that occur after HCB exposure. 
 
 Introduction 
 
Hexachlorobenzene (HCB) was used as a fungicide until the 1970s, when such use was 
prohibited. Considerable amounts are still generated as waste-byproducts of industrial 
processes and emitted into the environment. Because of its chemical stability, persistence 
and long-range transport HCB can be found throughout the environment and is detectable 
in human milk, blood and adipose tissue.   
 In the 1950s an accidental poisoning in Turkey revealed several toxic effects of 
HCB in humans. Approximately 3000-5000 people ingested HCB-treated seed grain and 
developed a disease called Porphyria Turcica (14), characterized by hepatic porphyria and 
cutaneous skin lesions caused by a disturbed porphyrin metabolism (2). Other clinical 
symptoms included enlarged liver, spleen, lymph nodes (LN) and thyroid, neurological 
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symptoms and arthritis. Infants born to mothers exposed to HCB developed a different 
syndrome called Pembe Yara, characterized by high mortality, diarrhea, fever, 
hepatomegaly, and skin lesions in the absence of porphyria, but with infiltrations of 
macrophages and lymphocytes and infiltrates in the lung (5). Immunotoxic effects were 
reported in the Turkish poisoning victims, but also in occupationally exposed workers in 
Brazil. Increased levels of IgM and IgG were observed, as well as impaired function of 
neutrophil granulocytes (34,35). 
 In rats, HCB induces hepatic porphyria, neurotoxic effects (8) and toxic effects on 
the reproductive system (19), thyroid function (22) and immune system (30,46). Because 
HCB is a lipophilic xenobiotic, exposure leads to accumulation in adipose tissue whereas 
only a small part of ingested HCB is metabolized. HCB can be converted in a cytochrome 
P450 (CYP)-dependent manner (45), but also via the mercapturic acid pathway (36).  
 Brown Norway (BN) rats are very susceptible to HCB-induced adverse immune 
effects. Exposure causes a dose-dependent immunostimulation characterized by enlarged 
spleen and LNs and increased serum levels of total IgM, IgG, IgE, and IgM against single-
stranded (ss) DNA. Furthermore, rats developed inflammatory skin and lung effects 
characterized by infiltrates of eosinophilic granulocytes and macrophages (30,31). 
Although both T cells and macrophages seem to play an important role in HCB-induced 
immunotoxicity in BN rats (11), exact mechanisms are unknown.  
 In this study we used DNA microarray analysis to assess changes associated with 
HCB exposure at the gene expression level. Transcript levels were measured by using the 
Affymetrix RG U34A GeneChip. BN rats were exposed to 0, 150 or 450 mg HCB per kg 
diet, doses used also in earlier studies (11,31), and gene expression levels were assessed in 
spleen, mesenteric lymph node (MLN), thymus, blood, liver, and kidney. This approach 
revealed several changes in line with the known toxic effects but also revealed novel ones, 
which may suggest additional (immuno)toxic effects of HCB exposure and/or provide 
more insight into the mechanisms of HCB-induced adverse effects.  
  
Materials and Methods 
 
Rats and maintenance 
Three-week old SPF female inbred Brown Norway (BN/SsNOlaHsD, termed BN) rats 
were purchased from Harlan (Blackthorn, UK). Rats were acclimatized for 1 week before 
starting the experiment. They were kept two by two under standard conditions with food 
and acidified drinking water ad libitum. The diet consisted of a semisynthetic diet 
(SSP/TOX, Hope Farms, Woerden, The Netherlands) with or without crystalline HCB 
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(99% purity, Aldrich Chemie, Bornem, Belgium) by mixing of homogeneity. The 
experiments were approved by the animal experiments committee of the Faculty of 
Veterinary Medicine of the Utrecht University.  
 
Experimental protocol 
Rats were randomly assigned to different experimental groups (n=6), receiving either 
control diet or the diet supplemented with 150 mg (low dose) or 450 mg (high dose) HCB 
per kg. Body weight (bwt) and skin lesions were recorded twice per week. After 28 days 
rats were killed by CO2/O2, blood was collected in tubes containing EDTA to prevent 
clotting, and transferred into Fastubes (Endotell, Allschwill, Switzerland) containing 
guanidinium isothiocyanate in 0.9% NaCl solution. Tubes were snap-frozen in liquid 
nitrogen. Spleen, MLN, thymus (freed from adjacent LN), liver and kidney were 
collected, weighed and snap-frozen in liquid nitrogen.  
In additional experiments for pathology, blood and serum analysis, rats were exposed to 
the same dosing regimes. Rats were killed by a lethal dose of pentobarbital (Euthesate® 
Ceva Sante Animale B.V. Maassluis, The Netherlands, 0.3 g/kg bwt, i.p.). One part of the 
blood was collected in EDTA-tubes for total and differential leukocyte counts the other 
part was used for serum analysis. Spleen, MLN, thymus, liver, and kidney were fixed in 
phosphate-buffered 4% formaldehyde and after embedding in Paraplast, 5 µm sections 
were stained with hematoxylin and eosin.  
 
DNA microarray experiment 
Total RNA was obtained by acid guanidinium isothiocyanate-phenol-chloroform 
extraction (Trizol, Invitrogen Life Technologies, San Diego, CA, USA; ref. 7) and 
purified on an affinity resin (RNeasy, Qiagen, Hilden, Germany) according to 
manufacturer’s instructions. DNA microarray experiments were conducted as 
recommended by the manufacturer of the GeneChip system (GeneChip Expression 
Analysis Technical Manual) and as previously described (25). Rat specific RG U34A 
gene expression probe arrays (Affymetrix, Santa Clara, CA, USA) were used containing 
8799 probe sets interrogating primarily annotated genes. Per tissue and per animal one 
chip was used. The resulting image files (.dat files) were processed using the Microarray 
Analysis Suite 5 (MAS5) software (Affymetrix). Tab-delimited files were obtained 
containing data regarding signal intensity (Signal) and categorical expression level 
measurement (Absolute Call). 
 
Chapter 3 
 43 
Data analysis 
To determine which genes were diffentially expressed between the three treatment groups, 
a one-way analysis of variance (ANOVA) was applied to genes that had a present call in 
at least one of the samples. Genes with a p-value < 0.001 were considered statistically 
significant. Group average fold changes were calculated by using the average of the low 
or high dose group, compared with the control group. The annotation of the genes was 
determined by using NetAffx (http://www.affymetrix.com; ref. 24). Further information 
on probe sets was found in literature or in the KEGG database 
(http://www.genome.ad.jp/kegg/kegg2.html). Additional data analysis by Principal 
Component Analysis (PCA) was performed using GeneMaths (Applied Maths, Sint-
Martens-Latem, Belgium). Averages of gene expression levels in control, low and high 
dose groups were calculated and low values were cut off using a lower threshold of 10 and 
the values were log transformed before PCA.  
 
GC/MS analysis of contamination in the HCB sample 
To analyze HCB for contaminating polychlorinated dibenzodioxins and polychlorinated 
dibenzofurans (PCDDs/PCDFs) a solution of acetone containing 13C12-labeled internal 
quantitation standards (Cambridge Isotope Laboratories, Woburn, MA, USA) of the 
PCDDs and PCDFs was added to dichloromethane. The solution was brought on a 
Carbosphere column, then purified on Al2O3, evaporated to dryness and redissolved in 
toluene. GC/MS analyses were performed on a double focusing mass spectrometer 
coupled to a gas chromatograph. GC separations were carried out on a nonpolar capillary 
column (60 m DB-5MS; J&W Scientific, Folsom, CA, USA; 0.25 mm ID, 0.10 µm film 
thickness). Ionisation of the sample was performed in the electron impact mode. Detection 
was performed by selected ion recording. 
  
Results and discussion 
 
Body weight gain, macroscopic skin lesions and organ weights  
During treatment with the low dose diet body weight increased significantly from day 10 
onward, whereas rats exposed to the high dose diet had a significantly higher body weight 
on days 10 and 20 (not shown). One of the rats in the high dose group died after 25 days 
of exposure to HCB. Time of onset, severity and size of the skin lesions were similar as 
described previously (31). Increased liver and spleen weights in both dosing groups were 
also in accordance with previous work, as were the observed histopathological changes in 
these organs (31). In the high dose group kidney weight was increased significantly as 
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were observed before in Wistar rats treated with HCB for 25 days (21), but not in BN rats 
treated with HCB for 21 days (28). Histopathological changes were not observed. Thymus 
weight decreased significantly in the high dose group. It is likely that this thymus atrophy 
is caused by stress, as typical stress-induced alterations (23) were observed. No significant 
differences in MLN weight were found, but histopathology of MLN of the high dose 
group showed comparable morphology as reported previously (31). 
 
Figure 1: Principal component analysis (PCA) plot of the ratios of low 
dose versus control (white dots) or high dose versus control (black dots).  
 
DNA microarray analysis 
The PCA plot (Figure 1) of the ratios of the low and high dose group over the control 
group shows that gene expression in spleen, blood, and liver is dose-dependently changed, 
whereas this is less clear for MLN, thymus and kidney. Spleen and blood cluster close 
together, as do kidney and thymus, but liver and MLN are more distant from those tissues. 
Most significant changes (p<0.001) in gene expression occurred in spleen (679 probe 
sets), followed by liver (346), kidney (232), blood (144), MLN (104), and thymus (28). 
The low number of changes in thymus is not surprising as the thymus is not a target organ 
of HCB. Remarkably, in kidney many genes were affected, although this organ has rarely 
been described to be affected by HCB. Furthermore, although organ weights were 
liver kidney
MLN
blood
thymus
spleen
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increased, no histopathological changes were detected in the present study. Because not 
all significantly changed genes can be included in this paper, we present only genes 
associated with immunology (Tables 1-6), acute phase responses (APRs) and oxidative 
stress (Table 7) and enzymes involved in drug metabolism, porphyria and estrogen 
metabolism (Table 8).  
 Figure 2 shows a deduced scheme of immune cells and mediators involved in the 
inflammatory response. This scheme is used to simplify the cascade of reactions that 
occur during inflammation and to discuss the results in a logical order. The complete list 
of significantly changed probe sets can be found on http://www.ebi.ac.uk/arrayexpress. 
Figure 2: Hypothetical overview of cells and factors involved in the inflammatory response 
initiated by HCB. Assuming that HCB attracts and activates macrophages this would lead to a 
cascade of reactions, activating immune cells and pro- and anti-inflammatory (in grey) mediators, 
eventually leading to inflammation.  
Complement 
activation Mast cell degranulation 
Vascular permeability and 
tissue recruitment of leukocytes 
Expression of cell adhesion 
molecules on leukocytes
Acute phase response 
Influx of leukocytes 
Macrophage activation 
Chemokines 
TNFα
IL-6
IL-1β
p38 MAPKOxidative 
stress 
STAT-1
Production of chemokines, 
cytokines and oxidative stress
INFLAMMATORY RESPONSE
HCB
Suppressors 
of cytokine 
signaling 
Cell damage
Annexin-1
Toxicogenomics of subchronic hexachlorobenzene exposure in Brown Norway rats 
 46 
Table 1: Spleen: representative genes that changed significantly (p<0.001) after HCB 
treatment: immune system1 
Accession 
number 
Gene name Fold change 
low dose 
Fold change 
high dose 
Granulocytes and macrophages  
AA957003 S100 calcium binding protein A8    2.8  34 
U50353 Defensin 3a    2.5  32 
AA946503 Lipocalin 2   1.7  24 
L18948 S100 calcium binding protein A9   3.2  19 
L06040 12-lipoxygenase   1.9    5.7 
M32062 Fc receptor, IgG, low affinity III   1.4    2.0 
AA894004 ESTs, Highly similar to Capg mouse 
macrophage capping protein  
  1.2     1.4 
X73579 Fc receptor, IgE, low affinity II (CD23)  -1.1   -2.3 
Mast cells    
U67913 Mast cell protease 10 12  42 
U67888 Mast cell protease 3   3.4  20 
U67907 Mast cell protease 4 precursor   1.5    8.7 
M21622 High-affinity IgE receptor    3.2    7.0 
U67914 Mast cell carboxypeptidase A3 precursor   1.8    6.8 
U67908 Mast cell protease 5 precursor    1.2    6.0 
M38759 Histidine decarboxylase   3.7    4.3 
Pattern Recognition molecules   
AF087943 CD14 antigen   1.1    1.7 
Complement    
AF036548 Response genes to complement-32  -1.3  20 
AA818025 CD59 antigen   1.1    1.7 
Cell adhesion molecules  
X05834 Fibronectin 1   1.8    3.5 
AJ009698 Embigin   1.4    3.3 
Chemokines     
U90448 CXC chemokine LIX   1.0    1.9 
U17035 Chemokine (CXC-motif) ligand 10   1.0   -2.3 
Cytokines and cytokine-associated genes 
M63122 Tumor necrosis factor receptor   1.3     1.3 
AF075382 Suppressor of cytokine signaling-2    1.3    -1.3 
M98820 Interleukin 1 beta   1.5   -1.2 
M55050 Interleukin 2 receptor beta chain    1.2   -1.4 
L00981 Lymphotoxin, tumor necrosis factor-alpha  -1.1   -1.4 
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M34253 Interferon regulatory factor 1 -1.1 -1.6 
U14647 Interleukin 1 beta converting enzyme  1.1 -1.6 
U69272 Interleukin 15 -1.1 -1.7 
U48596 
mitogen activated protein kinase kinase 
kinase 1 
 1.0 -1.8 
U17035 Transforming growth factor, beta 3 -2.9 -3.0  
Genes associated with T and B cells and MHCII expression  
U39609 
Anti-nerve growth factor 30 antibody light-
chain  
 1.3  3.8 
L22654 Anti-acetylcholine receptor antibody 
rearranged immunoglobulin gamma-2a 
chain, VDJC region 
 1.6  3.2 
L07398 
Immunoglobulin rearranged gamma-chain 
V region 
 1.0  2.4 
M18526 Immunoglobulin germline ҏkappa-chain    1.2  1.6 
X13016 MRC OX-45 surface antigen  1.1 -1.3 
U11681 Rapamycin and FKBP12 target-1 protein -1.0 -1.3 
D13555 T cell receptor CD3, subunit zeta -1.1 -1.4 
U31599 MHC class II-like beta chain RT1.Mb  -1.0 -1.4 
L14004 Polymeric immunoglobulin receptor  1.0 -1.4 
D10728 Lymphocyte antigen CD5 -1.2 -1.6 
M85193 RT6.2 -1.3 -1.6 
U24652 Linker of T-cell receptor pathways -1.0 -1.7 
X14319 T-cell receptor active beta-chain, V region -1.2 -2.1 
1Table contains the GenBank accession numbers (http://www.ncbi.nih.gov/entrez/query.fcgi?db=nucleotide) of 
cDNA fragments present on Affymetrix RG U34A gene chips, gene name and average fold change in expression 
of both low dose and high dose vs control. Fold changes are calculated with data from 5-6 rats per group. One-
way ANOVA was used to determine significance; only probe sets that changed significantly with p<0.001 are 
shown.   
  
Inflammatory response  
 Macrophages 
In HCB-exposed rats macrophage infiltrations were observed in skin, lung (31), spleen 
(11,31) and liver (8). As expected, HCB increased gene expression of macrophage 
markers in spleen and MLN and Kupffer cell markers in liver, supporting the significance 
of macrophages in HCB-induced immunotoxicity.  
 
 Pro-inflammatory cytokines 
Gene expression of the receptor for tumor necrosis factor (TNF)-α and TNF-β (TNF 
receptor superfamily, member 1) in MLN, spleen and kidney was increased. In addition, 
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IL-6 gene expression was affected in MLN, just as the IL-6 signal transducer in kidney. 
IL-6 is a pleiotropic cytokine that plays an important role in B cell differentiation, growth 
of T cells and differentiation of macrophages (32). HCB also induced gene expression of 
IL-1β in spleen (low dose group) and IL-1β converting enzyme in kidney, an enzyme that 
converts IL-1β and IL-18 to their active form. Gene expression of IL-18 was elevated in 
liver, a cytokine produced mainly by Kupffer cells.  
  
 p38 MAPK signaling pathway 
The mitogen-activated protein kinase (MAPK) family consists of signal transduction 
molecules important during inflammation. HCB induced expression of p38 MAPK and 
other MAPKs in kidney. Activation of p38 MAPK leads to phosphorylation of several 
transcription factors, such as signal transducer and activator of transcription-1 (STAT-1). 
Gene expression of STAT-1 was increased in liver. Both MAPK and STAT-1 are 
important in cytokine production, and negative regulation of cytokine signaling occurs at 
the level of transcription of these molecules. Proteins involved in suppression of cytokine 
production are the so-called suppressors of cytokine signaling (SOCS). HCB exposure 
increased gene expression of several of these proteins, probably to counteract the high 
cytokine levels. In spleen SOCS-2 was upregulated in the low dose group, but 
downregulated in the high dose group and SOCS-3 was upregulated in MLN. In the 
thymus cytokine inducible SH2-containing protein was upregulated, a protein that plays a 
critical role in controlling T cell activation (6). 
 
 Oxidative stress and antioxidants  
Previous studies have shown that HCB exposure induced oxidative stress (4) and 
increased expression of antioxidants in the liver (41). The present work confirms these 
findings, as several antioxidants were induced in liver. Transcriptome profiles show that 
antioxidants are also increased in spleen, MLN, blood and kidney. The infiltrated 
macrophages and granulocytes probably generate these reactive oxygen species (ROS). 
Additional experiments showed that serum hydroperoxides were significantly increased in 
HCB-exposed BN rats (not shown). Excessive presence of ROS can activate NFκB, an 
important factor in regulating the inflammatory response (39). In addition, ROS can cause 
cell damage, providing danger signals that can attract inflammatory cells. Therefore, 
increased oxidative stress induced by HCB may play a pivotal role in the observed 
immunostimulation. 
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Table 2: MLN: representative genes that changed significantly (p<0.001) after HCB 
treatment: immune system2 
Accession 
number 
Gene name Fold change 
low dose 
Fold change 
high dose 
Granulocytes and macrophages   
L18948 S100 calcium binding protein A9 2.2 22 
AA957003 S100 calcium binding protein A8 2.6 19 
M32062 Fc γ receptor 2.0  2.8 
AJ223184 DORA protein (immunoglobulin superfamily, 
member 6)  
1.1  2.6 
Pattern recognition molecules 
U44129 Mannose-binding lectin-1 1.5  2.6 
AF087943 CD14 antigen 1.8  2.5 
Cell adhesion  molecules 
L08100 Glycam 1 3.1  2.5 
Chemokines 
U92803 CC-chemokine-binding receptor JAB61 1.9  2.6 
AF053312 CC chemokine ST38 precursor  2.4 16 
Cytokines  
M26744 Interleukin 6 2.3  4.3 
AF075383 Suppressor of cytokine signaling-3 1.9  2.5 
M63122 Tumor necrosis factor receptor 1.2  1.8 
AA891209 ESTs, highly similar to interleukin 25 1.2  1.5 
Genes associated with T and B cells and MHCII expression 
M28671 Rearranged IgG-2b  1.5  3.2 
X07189 Immunoglobulin heavy chain constant region 2.5  3.1 
M18526 Immunoglobulin germline kappa-chain  1.4  1.8 
2Table contains the GenBank accession numbers (http://www.ncbi.nih.gov/entrez/query.fcgi?db=nucleotide) of 
cDNA fragments present on Affymetrix RG U34A gene chips, gene name and average fold change in expression 
of both low dose and high dose vs control. Fold changes are calculated with data from 5-6 rats per group. One-
way ANOVA was used to determine significance; only probe sets that changed significantly with p<0.001 are 
shown.   
 
 Acute phase response 
Acute phase proteins (APPs) are important in inflammatory responses. HCB increased 
gene expression of several APPs, such as heat shock proteins (HSPs) in spleen and MLN. 
HSPs protect cells against cellular stress. HCB also increased expression of matrix 
metalloproteinase-9 (MMP-9) in spleen and of the natural inhibitors of MMPs, tissue 
inhibitor of metalloproteinase 1 (TIMP-1) in liver and TIMP-2 in MLN. MMPs play an 
important role in the cleavage of membrane components enabling leukocytes to 
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extravasate the blood. HCB also affected transcript levels of other APPs, such as 
haptoglobin (a hemoglobin scavenger), lipopolysaccharide-binding protein, orosomucoid 
(important in immunomodulation), and metallothionein and ceruloplasmin (antioxidants). 
Negative APPs (transferrin and its receptor) were also induced, these proteins are 
normally downregulated during an APR. Synthesis of these APPs, however, is also 
dependent on iron metabolism. HCB induces iron accumulation in the liver (41). The 
upregulation of transferrin gene expression in spleen and kidney suggests that this is also 
the case in these organs. 
 
Table 3: Thymus: representative genes that changed significantly (p<0.001) after HCB 
treatment: immune system3 
Accession 
number 
Gene name Fold change 
low dose 
Fold change 
high dose 
Granulocytes and macrophages   
L18948 S100 calcium binding protein A9 1.1 2.0 
X14323 IgG receptor FcRn  1.2 1.2 
Mast cells    
U67911 Mast cell protease 8 precursor 1.5 2.0 
Chemokines and cytokines 
AF075383 Cytokine inducible SH2-containing protein  1.2 1.7 
Genes associated with B cells 
L22654 
Anti-acetylcholine receptor antibody 
rearranged Ig gamma-2a chain, VDJC region 
1.6 3.7 
M18526 Ig germline kappa-chain  2.0 3.2 
3Table contains the GenBank accession numbers (http://www.ncbi.nih.gov/entrez/query.fcgi?db=nucleotide) of 
cDNA fragments present on Affymetrix RG U34A gene chips, gene name and average fold change in expression 
of both low dose and high dose vs control. Fold changes are calculated with data from 5-6 rats per group. One-
way ANOVA was used to determine significance; only probe sets that changed significantly with p<0.001 are 
shown.   
 
 Complement system 
Complement components are also important in inflammatory responses. HCB increased 
gene expression of several components of the complement pathway in spleen, blood, 
kidney and liver. 
 
 Mast cells 
HCB enhanced gene expression of mast cell enzymes, probably a consequence of 
complement activation. This finding may also be explained by a characteristic of the BN 
rat, a strain that tends to respond in a more T helper 2-skewed fashion. Basal levels of 
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serum IgE are high and HCB increases IgE levels even more (31). Loading of mast cells 
with IgE may result in degranulation and release of inflammatory mediators. 
 
 Chemokines and chemokine receptors 
In all analyzed organs, HCB increased gene expression of chemokines, important 
mediators in the recruitment of leukocytes from the circulation. HCB induced gene 
expression of several CXC chemokines and their receptors: lipopolysaccharide-induced 
CXC chemokine LIX, chemokine (CXC motif) ligand 10, growth-related oncogene (Gro) 
and the CXC chemokine receptor 2 (CXCR2). LIX is a potent neutrophil chemoattractant, 
whereas chemokine (CXC motif) ligand 10 plays an important role in chemotaxis of 
activated T cells and monocytes. Gro is a ligand that binds to CXCR2, a receptor that is 
present on neutrophils. HCB induced gene expression of two CC chemokine receptors: 
CC-chemokine-binding receptor JAB61, a receptor that binds monocyte chemoattractant 
protein-1 and -3 and the receptor for macrophage inflammatory protein-1α that is present 
on neutrophils and eosinophils (27).  
 
 Cell adhesion molecules  
Chemokines induce expression of cell adhesion molecules on both endothelial cells and 
leukocytes. HCB affected gene expression of cell adhesion molecules in all organs except 
the thymus. Intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and 
selectin are endothelial cell adhesion molecules that recognize receptors on hemopoietic 
cells. Other cell adhesion molecules in which gene expression was induced by HCB were 
fibronectin-1, embigin, CD36 and glycosylation-dependent cell adhesion molecule-1 
(GlyCAM-1). The latter is expressed only on high endothelial venules (HEVs) in LNs. 
Previous reports have shown that HCB increased the development of HEVs in LN (31), 
which probably results in increased GlyCAM-1 mRNA expression.  
 
 Granulocytes 
Upregulation of chemokines and cell adhesion molecules leads to influx of leukocytes. 
Data obtained in this study confirm increased numbers of monocytes and neutrophilic 
granulocytes in blood (unpublished data) and cellular infiltrations in spleen of BN rats 
(29). In all analyzed organs and blood gene expressions for S100 calcium binding protein 
A8 and A9 were upregulated. These proteins are abundantly present in the cytoplasm of 
neutrophils, monocytes and macrophages (37). Other markers associated with 
granulocytes and macrophages that were affected by HCB were defensin (neutrophils and 
macrophages), lipocalin (granulocytes) and CD24 (granulocytes, monocytes and  
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Table 4: Blood: representative genes that changed significantly (p<0.001) after HCB 
treatment: immune system4 
Accession 
number 
Gene name Fold change 
low dose 
Fold change 
high dose 
Granulocytes and macrophages  
AA957003 S100 calcium binding protein A8   4.7 34 
L18948 S100 calcium binding protein A9   4.7 19 
L06040 12-lipoxygenase   1.6  3.6 
U49062 Heat stable antigen CD24  -1.2 -3.0 
Mast cells  
Y67913 Mast cell protease 10  17 16 
U67911 Mast cell protease 8 precursor   3.9  4.6 
X61654 AD1 (mast cell antigen; CD63)   1.7  2.0 
Pattern recognition molecule 
AA875213 Peptidoglycan recognition protein   4.3  7.7 
Complement  
AA818025 CD59 protein precursor   1.6  2.6 
Cell adhesion  molecules 
AF074211 Acid translocase/CD36 antigen   2.4  3.6 
AJ009698 Embigin   1.9  2.0 
D00913 Intercellular adhesion molecule 1    2.2  1.8 
Chemokines 
E13732 CC chemokine receptor    1.3  2.4 
U90610 CXC chemokine receptor (CXCR4)   2.2  1.1 
Anti-inflammatory response 
AI171962 Annexin 1 (p35) (Lipocortin 1)   2.1  4.1 
Genes associated with T and B cells and MHCII expression 
X76697 CD52/B7 antigen   1.6  2.1 
X53517  CD37 antigen  -1.2 -1.8 
Z49761 RT1.Ma  -1.4 -1.8 
D13555 T cell receptor CD3, subunit zeta  -1.6 -2.0 
X53430 CD3d antigen (T3 delta)  -1.5 -2.0 
X53054 RT1.D beta chain  -1.4 -2.1 
X13044 MHCII associated invariant chain gamma  -1.5 -2.3 
M15562 MHC class II RT1.u-D-alpha chain   -1.3 -2.5 
U39609 
Anti-nerve growth factor 30 antibody light-
chain, variable and constant regions 
 -1.5 -2.7 
4Table contains the GenBank accession numbers (http://www.ncbi.nih.gov/entrez/query.fcgi?db=nucleotide) of 
cDNA fragments present on Affymetrix RG U34A gene chips, gene name and average fold change in expression 
of both low dose and high dose vs control. Fold changes are calculated with data from 5-6 rats per group. One-
way ANOVA was used to determine significance; only probe sets that changed significantly with p<0.001 are 
shown.   
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Table 5: Liver: representative genes that changed significantly (p<0.001) after HCB 
treatment: immune system5 
Accession 
number 
Gene name Fold change 
low dose 
Fold change 
high dose 
Granulocytes and macrophages 
AA946503 Lipocalin 2  4.3 210 
L18948 S100 calcium binding protein A9  3.4   28 
AA957003 S100 calcium binding protein A8  1.1    8.5 
X76489 CD9 for cell surface glycoprotein  1.4    3.6 
AI104781 Arachidonate 5-lipoxygenase activating protein -1.1    2.3 
AA893191 ESTs: phosphatidic acid phosphatase type 2c  1.2    2.0 
M55532 Carbohydrate binding receptor (Kupffer cell 
receptor)  
 1.1     1.6 
S79263 Interleukin-3 receptor beta subunit (colony 
stimulating factor 2 receptor beta 1 low affinity 
(granulocyte-macrophage) 
 1.7    1.3 
Mast cells  
M18335 Mast cell protease 8 precursor  2.2    2.8 
Complement    
Z50051 Complement component 4 binding protein, alpha  1.3    2.3 
Cell adhesion  molecules   
D00913 Intercellular adhesion molecule 1  1.2    2.3 
Chemokines 
D11445 Gro  1.6  11.5 
Cytokines    
AA892553 Signal transducer and activator of transcription 1   1.1    3.3 
U77777 Interleukin 18  1.3    1.9 
L25785 
Transforming growth factor betaҏ stimulated 
clone  
-1.5   -1.5 
Genes associated with T and B cells and MHCII expression 
L22654 Anti-acetylcholine receptor antibody, rearranged 
immunoglobulin gamma-2a chain, VDJC region 
-1.0    8.8 
U39609 Anti-nerve growth factor-30 antibody light-chain 
mRNA, variable and constant regions 
 1.9    8.7 
X68782 Immunoglobulin heavy chain VDJ-region CH1-
CH2 
 1.4    4.6 
X53054 RT1.D beta chain  1.5    2.0 
5Table contains the GenBank accession numbers of cDNA fragments present on Affymetrix RG U34A gene 
chips, gene name and average fold change in expression of both low dose and high dose vs control. Fold changes 
are calculated with data from 5-6 rats per group. One-way ANOVA was used to determine significance; only 
probe sets that changed significantly with p<0.001 are shown.   
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lymphocytes). HCB also induced gene expression of 12-lipoxygenase and arachidonate 5-
lipoxygenase activating protein, both involved in leukotriene activation, which takes place 
in myeloid cells (3). Gene expression of Fc receptors was also elevated by HCB, probably 
because of the increase in the number of cells bearing this receptor. The same is true for 
the upregulation of gene expression of several pattern recognition molecules, such as 
CD14, mannose-binding lectin and peptidoglycan recognition molecules, present on 
monocytes, macrophages and neutrophils. 
 This work indicates that HCB exposure results in a systemic inflammatory response. 
To counterbalance this response, the immune system produces anti-inflammatory 
mediators. HCB exposure induced gene expression of one of these mediators, annexin-1, 
which blocks leukocyte migration and induces apoptosis in inflammatory cells (33).  
 
T and B cells and MHCII expression  
Gene expression of T cell markers, such as CD3 a subunit of the T cell receptor, was 
decreased in spleen, whereas in blood, HCB decreased gene expression for CD3 and  
CD37, the latter being a B cell-marker. Furthermore, HCB increased gene expression of 
CD52 or B7 antigen, a marker present on antigen presenting cells, such as B cells and 
monocytes. This is in line with previous studies that have shown a stronger increase of 
monocytes and granulocytes in blood after HCB exposure resulting in relatively fewer 
lymphocytes (40,48). In kidney, we observed an increased expression of OX-45, a 
membrane protein involved in the binding to LFA-3, important in adhesion of T cells to 
other cell types and in T cell activation. HCB enhanced gene expression of 
immunoglobulins in spleen, MLN, liver and kidney. This is in line with the observed 
increase of serum levels of IgM, IgG and IgE in BN rats (31). MHCII gene expression 
was decreased in spleen and blood and increased in liver and kidney. 
 
Autoantibodies  
The anti-acetylcholine receptor antibody gene (rearranged Ig γ-2a chain) was upregulated 
in spleen, thymus, liver and kidney. These autoantibodies are associated with the 
autoimmune disease myasthenia gravis (MG), a neurological disease characterized by 
degeneration of the acetylcholine receptor and resulting in muscle weakness (9). HCB-
induced neurological effects, however, are not the same as symptoms described for MG. 
Additional experiments performed to detect anti-acetylcholine receptors antibodies (total 
Ig) in serum did not confirm gene expression data. HCB exposure also increased gene 
expression of anti-nerve growth factor-30 antibodies in spleen and liver and 
downregulated expression in blood. These antibodies belong to the naturally occurring  
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Table 6: Kidney: representative genes that changed significantly (p<0.001) after HCB 
treatment: immune system6 
Accession 
number 
Gene name Fold change 
low dose 
Fold change 
high dose 
Granulocytes and macrophages  
L18948 S100 calcium binding protein A9  1.2  9.6 
AA957003 S100 calcium binding protein A8 -1.7  3.8 
M32062 Fc gamma receptor  1.2  2.7 
U10894 Allograft inflammatory factor -1.1  2.5 
AA946503 Lipocalin 2  1.1  2.0 
U49062 Heat stable antigen CD24  1.1  1.8 
Complement 
X71127 Complement protein C1q beta chain  1.3  4.0 
D88250 Complement component 1, subcomponent  1.1  2.9 
Cell adhesion  molecules 
M84488 Vascular cell adhesion molecule 1  1.0  3.0 
D00913 Intercellular adhesion molecule 1  1.0  2.0 
U82612 Fibronectin 1  1.0  1.6 
AI17646 Selectin, endothelial cell, ligand  1.3 -1.5 
Chemokines 
U17035 Chemokine (CXC motif) ligand 10   1.2  2.0 
Cytokines and cytokine-associated genes  
M63122 Tumor necrosis factor receptor  1.1  1.9 
U48596 Mitogen-activated protein kinase kinase kinase 1  1.2  1.9 
M92340 Interleukin 6 signal transducer  1.0  1.5 
S79676 Interleukin 1beta converting enzyme -1.2  1.4 
U73142 p38 mitogen activated protein kinase -1.1  1.3 
Genes associated with T and B cells and MHCII expression 
L22654 
Anti-acetylcholine receptor antibody, rearranged 
Ig gamma-2a chain, VDJC region 
 2.6  5.3 
AJ223184 
DORA protein (immunoglobulin superfamily 
member 6) 
-1.4  2.6 
U75411 Anti-idiotype immunoglobulin M light chain -1.0  2.0 
X13016 MRC OX-45 surface antigen  1.1  1.6 
AF029240 MHC class Ib RT1.S3  1.0  1.4 
S59893 La=autoantigen SS-B/La  1.0  1.4 
X56596 MHC class II antigen RT1.B-1 beta-chain  1.3  1.3 
X53054 RT1.D beta chain  1.5  1.2 
M15562 MHC class II RT1.u-D-alpha chain   -1.3 -2.5 
6Table contains the GenBank accession numbers (http://www.ncbi.nih.gov/entrez/query.fcgi?db=nucleotide) of 
cDNA fragments present on Affymetrix RG U34A gene chips, gene name and average fold change in expression 
of both low dose and high dose vs control. Fold changes are calculated with data from 5-6 rats per group. One-
way ANOVA was used to determine significance; only probe sets that changed significantly with p<0.001 are 
shown.   
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Table 7: Representative genes that changed significantly (p<0.001) after HCB treatment 
were functionally grouped: acute phase response and oxidative stress7 
Accession 
number 
Gene name Fold change 
low dose 
Fold change 
high dose 
SPLEEN 
U24441 Matrix metalloproteinase 9 (gelatinase B)  1.1  7.4 
M58040 Transferrin receptor -1.1  7.1 
AI233261 Glutamate-cysteine ligase  1.2  5.0 
K01933 Haptoglobin  1.3  4.2 
U06099 Thiol-specific antioxidant (peroxiredoxin 2)  1.2  3.0 
D38380 Transferrin  1.0  2.1 
M11794 Metallothionein-1 and -2  1.1  2.0 
L33869 Ceruloplasmin   1.0  1.9 
AA944397 Heat shock protein 86  1.2  1.8 
X07365 Glutathione peroxidase  1.4  1.7 
Y00497 Manganese-containing superoxide dismutase -1.0  1.6 
AI170613 Heat shock 10 kD protein 1  1.1  1.3 
M21060 Copper-zinc containing superoxide dismutase  1.0  1.3 
D00680 Plasma glutathione peroxidase precursor -1.2 -3.5 
MLN 
D00680 Plasma glutathione peroxidase precursor  2.0  4.3 
Y00497 Manganese-containing superoxide dismutase  1.8  2.6 
AA817854 Ceruloplasmin   1.0  2.2 
S72594 Tissue inhibitor of metalloproteinase 2  1.5  2.0 
BLOOD  
AA926149 Catalase  1.7  2.8 
AI236795 ESTs, similar to mouse heat shock protein 84 -1.1 -1.4 
M11942 70 kD heat-shock-like protein -1.1 -1.9 
LIVER 
L32132 Lipopolysaccharide binding protein  1.7  8.3 
AI169327 Tissue inhibitor of metalloproteinase 1  1.0  6.9 
V01216 Orosomucoid 1  3.1  6.1 
J02722 Heme oxygenase   1.8  5.2 
L33869 Ceruloplasmin   1.4  2.0 
Y00497 Manganese-containing superoxide dismutase  1.4  1.6 
X12367 Glutathione peroxidase 1 -1.3 -1.8 
KIDNEY 
L33869 Ceruloplasmin  1.3  4.2 
D38380 Transferrin  1.3  2.7 
X68041 Epididymal secretory superoxide dismutase   1.4 -1.6 
5Table contains the GenBank accession numbers of cDNA fragments present on Affymetrix RG U34A gene 
chips, gene name and average fold change in expression of both low dose and high dose vs control. Fold changes 
are calculated with data from 5-6 rats per group. One-way ANOVA was used to determine significance; only 
probe sets that changed significantly with p<0.001 are shown.   
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autoantibodies and are elevated in inflammatory diseases (10). The exact role of these 
autoantibodies is not yet known. Previously it was shown that HCB increased IgM 
antibodies against autoantigens, such as ssDNA (31,38). Expression of La (= autoantigen 
SS-B/La) was induced in kidney. This protein plays a role in RNA polymerization and is 
often a target of autoantibodies found in several autoimmune diseases (18).  
 
Drug metabolizing enzymes   
 Cytochrome P450 
CYP enzymes are involved in the oxidative dehalogenation of HCB (45) HCB exposure 
increased gene expression of several CYPs and of epoxide hydrolase, an enzyme involved 
in detoxification of epoxides in liver (Table 8).  In spleen, MLN and kidney expression of 
CYP enzymes was also induced but to a lesser extent than in liver.  
 
 Role of dioxin-like contamination of HCB 
Surprisingly, gene expression of CYP1A1 was strongly upregulated in liver. This was an 
unexpected finding as previous work showed that HCB induced much more CYP2B than 
CYP1A1 (13). CYP1A1 upregulation is associated with 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD) or related compounds that activate the aryl hydrocarbon (Ah)-receptor. It 
is still the subject of debate if HCB is a dioxin-like compound. Van Birgelen (43) 
suggested that HCB should be considered as one, as HCB meets the criteria for dioxin-
like compounds: the ability to bind to the Ah-receptor, induction of dioxin-like effects and 
bioaccumulation. Vos (47) commented, however, that although TCDD and HCB share 
some target organs, the toxic effects in these systems are quite different. Furthermore the  
affinity for the Ah receptor is 10,000 times less for HCB than for TCDD (15). HCB was 
analyzed to investigate whether contamination with dioxin-like compounds was 
responsible for the observed effects. Indeed, HCB was contaminated with PCDDs and 
PCDFs and the toxic equivalent was 187 pg/mg HCB. The calculated no observed adverse 
effect level (NOAEL) of CYP1A1 induction was 0.7 to 4 ng TCDD/kg bwt/day (44). In 
our study rats were exposed to approximately 2 ng/kg bwt/day (low dose) and 6 ng/kg 
bwt/day (high dose). So, exposure to dioxins and furans is of the same order of magnitude 
than the calculated NOAEL and therefore not likely to be responsible for the observed 
strong increase in gene expression for CYP1A1. This is not in accordance with previous 
work showing that HCB could only moderately or not at all induce CYP1A1 by HCB 
(13,26). This discrepancy may be explained by strain differences or by the difference in 
detection of CYP1A1 (7-ethoxyresorufin-O-deethylase induction versus gene expression).  
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Table 8: Representative genes that changed significantly (p<0.001) after HCB treatment 
were functionally grouped: enzymes involved in drug metabolism, porphyria and estrogen 
metabolism8 
Accession 
number 
Gene name Fold change 
low dose 
Fold change 
high dose 
SPLEEN    
AA800745 Aminolevulinate, delta-, dehydratase -1.4  10.7 
X06827 Porphobilinogen deaminase   1.2    8.9 
Y00350 Uroporphyrinogen decarboxylase -1.0    4.0 
D50564 Mercaptopyruvate sulfurtransferase  1.1    2.8 
AA859700 ESTs, highly similar to ppox, mouse 
protoporphyrinogen oxidase 
-1.1    2.5 
AI176856 Cytochrome P450 1b1  1.5    1.9 
M10068 NADPH-cytochrome-P450 oxidoreductase -1.0   -1.3 
X04229 Glutathione-S-transferase, Y(b) subunit -1.1   -1.5 
D00680 Glutathione-S-transferase, Yc2 subunit -1.0   -1.7 
MLN    
U36992 Cytochrome P450 7b1  1.4    2.6 
BLOOD     
AI228110 UDP-glucuronosyltransferase 8  1.8    3.8 
D50564 Mercaptopyruvate sulfurtransferase  1.7    2.4 
LIVER    
E00778 Cytochrome P450, family 1, subfamily a, 
polypeptide 1 
65 125 
J02852 Cytochrome P450, IIA3  6.4  46 
S76489 Estrogen sulfotransferase isoform 3 20  43 
K00996 Cytochrome P450e (phenobarbital-induced) 11  13 
M13646 Pregnenolone 16-alpha-carbonitrile-inducible 
cytochrome P450 
 3.2  12 
L24207 Testosterone 6-β-hydroxylase (CYP3A1)  5.9    6.9 
J02722 Heme oxygenase  1.8    5.2 
E01184 P450 MC substituted the C terminal region 
containing HR2 region for the same region of 
cytochrome P450d 
 3.0    5.1 
D86297 Aminolevulinate synthase 2, delta   2.1    4.4 
S82820 Glutathione-S-transferase, Yc2 subunit  3.5    3.4 
M26125 Epoxide hydrolase 1  2.7    2.8 
M13506 Liver UDP-glucuronosyltransferase, phenobarbital-
inducible form 
 2.8    2.7 
S72505 Glutathione-S-transferase, Yc1 subunit  1.7    1.6 
J03914 Glutathione-S-transferase, Yb subunit  1.9    1.8 
X60328 Cytosolic epoxide hydrolase -1.7   -3.1 
X91234 17-beta hydroxysteroid dehydrogenase type 2 -1.9 -18 
Chapter 3 
 59 
KIDNEY    
AI176856 Cytochrome P450, subfamily 1B, polypeptide 1 
(P4501b1) 
 1.1  2.9 
M37828 Cytochrome P450 (P4504a10)  1.2  2.7  
L19998 Minoxidil sulfotransferase  1.1  2.3 
M20131 Cytochrome P450IIE1 -1.4 -1.9 
8Table contains the GenBank accession numbers (http://www.ncbi.nih.gov/entrez/query.fcgi?db=nucleotide) of 
cDNA fragments present on Affymetrix RG U34A gene chips, gene name and average fold change in expression 
of both low dose and high dose vs control. Fold changes are calculated with data from 5-6 rats per group. One-
way ANOVA was used to determine significance; only probe sets that changed significantly with p<0.001 are 
shown.   
 
 Mercapturic acid pathway  
The BN rat degrades HCB also via the mercapturic acid pathway that involves 
glutathione-conjugation catalyzed by glutathione-S-transferase (GST) (36). As expected, 
gene expression of several GSTs was upregulated in liver. Other phase II enzymes that 
were induced were mercaptopyruvate sulfurtransferase, uridine diphophate (UDP)-
glucuronosyltransferase, and the sulfotransferase family.  
 
Porphyria  
One of the main toxic characteristics of HCB is the induction of porphyria in humans (14) 
and experimental animals (8), caused by a disturbance in heme biosynthesis. In the 
present study gene expression of enzymes involved in heme synthesis were induced, such 
as aminolevulinate (ALA) dehydratase, porphobilinogen deaminase and uroporphyrinogen 
decarboxylase in spleen and ALA synthase in liver.  
 
Estrogen/androgen metabolism  
Several reports have shown that HCB exposure induces effects on the reproductive 
system. In humans serum HCB levels from women exposed during the accident in Turkey 
correlated with spontaneous abortion (19) and the proportion of male births was reduced 
in the group of women that had HCB-induced porphyria (20). In monkeys HCB decreased 
estrogen levels (12) and in Wistar rats HCB exposure reduced serum levels of estrogen 
and decreased levels of uterine estrogen receptors (1). Gene expression of estrogen 
sulfotransferase was upregulated in liver. This enzyme is important in the sulfation of 
estrogen, a pathway that inactivates estrogen. The enzyme 17−β hydroxysteroid 
dehydrogenase was downregulated in the liver. This enzyme catalyzes the interconversion 
of testosterone and androstenedione as well as estradiol and estrone. Both can lead to 
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lower estrogen levels. Together these results indicate that HCB interferes with estrogen 
metabolism. 
Conclusions 
 
Gene expression profiles confirmed known effects of HCB such as stimulatory effects on 
the immune system and induction of enzymes involved in drug metabolism, porphyria, 
and the reproductive system. New findings include upregulation of genes encoding pro-
inflammatory cytokines, antioxidants, APPs, complement, mast cell markers, chemokines 
and cell adhesion molecules. Thus, most transcriptome profiles are consistent with and 
complementary to previous pathological findings and can be used as markers for several 
processes that occur after HCB exposure.   
 Presumably, after oral exposure to HCB macrophages are attracted to organs like 
spleen, lung and skin and become activated by HCB. This leads to a cascade of reactions, 
involving innate immune cells as depicted in Figure 2. The gene expression profiles 
provide evidence for the importance of macrophages and granulocytes and mediators 
released by these cells in the adverse inflammatory response against HCB. In this way 
costimulatory or danger signals are generated that can polyclonally activate T cells. Thus, 
DNA microarray analysis revealed the complexity of cells and mediators involved in the 
immune response elicited by HCB and confirms previous work showing the importance of 
macrophages and granulocytes (11,30).  
 Data obtained in an extensive study like this can be used to create a database with 
gene expression profiles of known toxicants, as has been suggested previously (42). 
Chemicals can be screened by establishing their gene expression profiles and comparing 
them with profiles of known toxic chemicals. In this way classes of toxic compounds can 
be recognized as has previously been shown for hepatotoxicants (16,17) and genomics 
may be an additional tool in hazard identification. 
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Abstract 
 
Hexachlorobenzene (HCB) is a persistent environmental pollutant with (auto)immune 
effects in man and rat. The Brown Norway (BN) rat is very susceptible to HCB-induced 
immunopathology, and oral exposure causes inflammatory skin and lung lesions, 
splenomegaly, lymph node (LN) enlargement and increased serum levels of IgE and anti-
ssDNA IgM. The role of T cells in HCB-induced immunopathology is unclear and to 
elucidate this Cyclosporin A (CsA) was used. BN rats were exposed to either a control 
diet or a diet supplemented with 450 mg/kg HCB for 21 days. CsA treatment started 2 
days prior to HCB exposure and rats were injected daily with 20 mg/kg body weight CsA. 
Treatment with CsA prevented the HCB-induced immunopathology significantly. The 
onset of skin lesions was delayed and the severity was also strongly decreased. 
Furthermore, CsA prevented the HCB-induced increase in spleen weight partly and the 
increase in auricular LN weight completely. The increase in serum IgE and IgM against 
ssDNA levels was prevented completely. Macrophage infiltrations into the spleen and 
lung still occurred but infiltrations of eosinophilic granulocytes into the lung were 
prevented. Restimulation of spleen cells with the T cell mitogen ConA and the 
macrophage activator LPS clearly showed that CsA inhibited T cell activation, but not 
macrophage activation. Together, our results show that both T cells and macrophages 
play a prominent role in HCB-induced immunopathology.   
 
Introduction 
 
Hexachlorobenzene (HCB) is an environmental pollutant with pronounced adverse effects 
on the immune system of humans and rats (14). An accidental poisoning in Turkey in the 
1950’s revealed several immunopathological effects of HCB in humans, like 
splenomegaly, enlarged lymph nodes (LN) and painless arthritis (1,18). Breast-fed infants 
born to mothers exposed to HCB developed inflammatory lung and skin lesions, the latter 
characterized by infiltrations of lymphocytes and macrophages (2). Data of humans 
exposed occupationally to HCB indicated that HCB induced significant elevated levels of 
IgM and IgG, as well as reduced neutrophil functions  (19,20). 
 HCB induced comparable immunostimulatory effects in rats (24,28). The BN rat is a 
very susceptible strain and oral exposure to HCB caused splenomegaly, enlarged LN, 
inflammatory skin lesions characterized by an infiltration of eosinophilic granulocytes, 
inflammatory lung lesions characterized by macrophage infiltration, granuloma formation 
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and perivascular eosinophilic infiltrates and increased levels of total serum IgM, IgG, IgE 
and IgM against ssDNA (15).  
 The mechanism of HCB-induced immunopathology in humans and rats is poorly 
understood. The involvement of T cells is still controversial and if T cells are involved it 
is not known how they become activated. Studies in Wistar rats have shown that HCB 
treatment enhanced thymus-dependent parameters like primary and secondary IgM and 
IgG against tetanus toxoid and mitogenic responses to T cell mitogens PHA and ConA 
(29). To investigate the role of thymus-dependent T cells Michielsen et al. (13) exposed 
BN rats depleted of T cells by adult thymectomy, lethal irradiation, and bone marrow 
reconstitution to HCB and found that skin lesions appeared later in HCB-exposed T cell-
depleted-rats than in T cell-competent BN rats. The development of spleen and lung 
effects by HCB was not influenced by this T cell depletion, so it seemed that HCB-
induced inflammatory effects were not thymus-dependent, except for the skin lesions. A 
drawback of this study was that there were still functional T cells present in the spleen as 
demonstrated by flow cytometry. In thymectomized rats 4 % T cells were present in the 
spleen as compared to 15 % in control rats. Since Sado et al. (21) have shown that T cells 
present in the spleen of thymectomized mice were able to proliferate after stimulation 
with ConA, these residual T cells may be responsible for the observed immune effects 
elicited by HCB in these thymectomized rats.    
 Since our previous work did not elucidate the precise role of T cells in HCB-induced 
immunopathology, we decided to investigate this more thoroughly by using Cyclosporin 
A (CsA) as CsA not only decreases peripheral T cell number but also inhibits antigen-
induced T cell activation (9,11).  
 
Materials and methods 
 
Rats and maintenance 
Three-week old specific pathogen-free female inbred Brown Norway (BN/SsNOlaHsD, 
termed BN) rats were purchased from Harlan (Blackthorn, UK). Rats were allowed to 
acclimatize one week before starting the experiment. All rats were housed at the animal 
facilities of the Utrecht University. They were kept two by two in filter-topped macrolon 
cages on bedding of chips and wood, under standard conditions (50-60% relative 
humidity, 12-hr dark/12-hr light cycle) with food and acidified drinking water ad libitum. 
The diet consisted of a semisynthetic diet (SSP/TOX, Hope Farms, Woerden, The 
Netherlands) either or not supplemented with crystalline HCB (99% purity, Aldrich 
Chemie, Bornem, Belgium) by mixing of homogeneity. The experiments were conducted 
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according to the guidelines of the animal experiments committee of the Faculty of 
Veterinary Medicine of the Utrecht University.  
 
Experimental protocol 
Rats were randomly assigned to the different experimental groups, either receiving control 
diet or the diet supplemented with 450 mg HCB per kg. One of the control groups and one 
of the HCB-fed groups received a daily injection of CsA (a gift from Novartis Pharma Inc, 
Basel, Switzerland). CsA was dissolved in olive oil in a concentration of 20 mg/ml. Rats 
treated with CsA received a daily injection of 20 mg/kg/day (=1 ml/kg) via a sc injection 
in the flank, untreated rats received a daily injection of 1 ml olive oil per kg also in the 
flank. CsA treatment started 2 days prior to the beginning of HCB exposure. Rats were 
weighed three times per week and the development of skin lesions was evaluated daily. 
The severity of the lesional sites was rated as described before (15), irrespective of size, as 
1 = minimal (some redness), 2 = moderate (redness), 3 = marked (dry desquamation and 
crusts) and 4 = severe (exudative lesions). A semiquantitative group score of the 
macroscopic skin lesions on day 21 was calculated by multiplying the fraction of rats 
showing skin lesions, the average severity of the skin lesions and the relative lesional area. 
 After 21 days of exposure to HCB rats were killed by a lethal dose of sodium 
pentobarbital (Euthesate, 0.3 g/kg bodyweight, intraperitoneally). Blood was drawn from 
the vena cava and serum was collected after clotting and centrifugation. Liver, spleen, 
thymus (freed from adjacent lymph nodes), mesenteric LN (MLN) and auricular LN 
(ALN) were collected and weighed. LN and parts of the liver and spleen were fixed in 
phosphate-buffered 4% paraformaldehyde and lung was inflated and fixed with 
phosphate-buffered 4% paraformaldehyde to optimize morphology. Formaldehyde-fixed 
tissues were embedded in Paraplast and sections (5 µm) were stained with hematoxylin 
and eosin (HE). Part of the spleen was snap-frozen in liquid nitrogen and used for cryostat 
sections. To avoid bias at examination, sections were scored under code.   
 Single cell suspensions were prepared from part of spleen, part of thymus, ALN and 
MLN in phosphate buffered saline (PBS) containing 1% bovine serum albumin (BSA). 
LN and thymus were minced between two slides and spleens were cut and gently pressed 
through a 70 µm pore sieve to prepare single cell suspensions. Suspensions were washed, 
resuspended in PBS/1%BSA, counted using a Coulter Counter (Coulter Electronics, 
Luton, UK) and then adjusted to 1 or 2.5 x 106 cells per ml.  
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IgE ELISA  
Total serum IgE levels were determined by an isotype-specific sandwich ELISA as 
described before (15). Individual test serum samples were measured in duplicate. The 
concentration of IgE in test serum samples was calculated using a standard curve with 
known amounts of monoclonal rat IgE (Serotec, Oxford, UK) and results were expressed 
in total serum IgE concentrations (ng/ml).  
 
ssDNA ELISA 
ELISA procedures to determine IgM levels against ssDNA were performed essentially as 
described previously with some modifications (24). In short, serial dilutions of the 
individual test sera were added in duplicate to wells coated with ssDNA (50 µg/ml; 
Sigma, St. Louis, MO, USA). Each plate contained serial dilutions of NRS to obtain a 
reference curve. After incubation alkaline phosphatase labeled goat-anti-rat IgM (µ) 
(Brunswich, Amsterdam, The Netherlands) was added to the wells. For the color reaction 
wells were incubated with a solution of 0.01% 4-nitrophenylphospate in 
diethanolaminobuffer (pH 9.8). The reaction was stopped by adding 50 µl 10% (w/v) 
EDTA in distilled water. Absorbance was measured at 405 nm. To calculate IgM serum 
levels against ssDNA calibration curves of the reference serum (NRS) were used. 
Therefore, absorbance values of serial dilutions of the reference serum were plotted 
against the 2log of the dilution. The dilution of the test serum that would result in the 
same absorbance as NRS was calculated by linear regression and was used to obtain the 
ELISA index, which is the ratio of the test dilution used and the calculated dilution of 
NRS at the same absorbance. Mean ELISA index of the control group was transformed to 
1 and data of the treatment groups was expressed relative to the index of the control 
group. 
 
Immunohistology 
Cryostat sections (6 µm) of spleen were stained with ED3 (monoclonal antibody that 
recognizes a subpopulation of macrophages). ED3 was a kind gift from Dr. C. Dijkstra 
(Free University, Amsterdam, The Netherlands). Peroxidase–conjugated rabbit anti-mouse 
Ig (Dako AS, Glostrup, Denmark) was used as a second step agent. As a substrate 3-
amino-9-ethylcarbazole (AEC; Janssen, Beerse, Belgium) was used. Slides were 
counterstained with hematoxylin.  
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Flow cytometry 
All antibodies for flow cytometry were obtained from Pharmingen (San Diego, St. Louis, 
MO, USA). The following conjugated mAbs were used in duplo- or triplostaining to 
phenotype lymphocytes: fluorescein-isothiocyanate (FITC)-conjugated OX-33 (anti-rat 
CD45RA), phycoerythrin (PE)-conjugated R73 (anti-rat TCRαβ), OX39 (anti-rat CD25), 
OX-8 (anti-rat CD8α) and biotinylated OX-35 (anti-rat CD4). Single cell suspensions (2 x 
105 cells/well) in PBS with 1% BSA, 0.1% NaN3, 4% normal rat serum were centrifuged 
in a 96-well microtitre plate, resuspended and incubated with combinations of optimal 
dilutions of FITC, -PE- and biotin-conjugated mAbs (30 min, in the dark, 4°C). Cells were 
washed twice and the biotin-conjugated antibodies were stained in a second step with 
streptavidin-CyChrome (30 min, in the dark, 4°C). Samples were analyzed on a 
FACScan flow cytometer with standard FACSflow using CellQuest software (BD 
Biosciences, Franklin Lakes, NJ, USA).  
 
Ex vivo restimulation of spleen cells 
For cytokine measurements spleen cells were restimulated ex vivo with the mitogens LPS 
and ConA or with medium alone. LPS (2 µg/ml), ConA (5 µg/ml) and complete medium 
(RPMI 1640 with glutamax (Invitrogen Life Technologies, Paisley, Schotland) 
supplemented with 10% fetal bovine serum (FBS; ICN Biomedicals INC, Costa Mesa, 
CA), 2% penicillin-streptomycin (Invitrogen Lifetechnologies, Paisley, Schotland) were 
plated in a 96 well microtitre plate. Spleen cells in complete medium were added to the 
different stimuli (3.75 x 105 cells per well). Cells were incubated for 48 hours at 37°C, 5% 
CO2. After incubation supernatants were collected and stored at -70°C until cytokine 
measurement.  
 
IL-2 measurement 
The IL-2-dependent cell line CTLL-2 was kindly provided by Dr. Janssen 
(Immunotherapy, Utrecht Medical Center, Utrecht, The Netherlands). CTLL-2 cells were 
grown in Iscove’s medium supplemented with 10% FBS, 2% penicillin-streptomycin, L-
glutamin, 1% mercapto-ethanol and 20 units/ml of IL-2. For the IL-2 bioassay cells were 
washed in medium without IL-2 and plated in 96 wells plates in a concentration of 5000 
cells per well. Diluted samples and a standard curve were added to the wells and 
incubated for 24 hours at 37°C in 5% CO2. Thereafter, cells were labeled for 18 h with 0.5 
µCi/well [3H]-thymidine. Plates were harvested with a cell harvester onto filter paper and 
dried. The filter paper was placed into a bag containing scintillation fluid and [3H]-
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Thymidine incorporation was measured with a beta-plate liquid scintillation counter. The 
standard curve was used to calculate IL-2 (in units/ml) in the individual samples.  
 
TNF-α and nitric oxide measurement 
The TNF-α-sensitive murine fibroblast cell line L929 was kindly provided by Dr. 
Wulferink (PharmaAware, Utrecht University, Utrecht, The Netherlands). L929 cells were 
seeded in 96-wells flat-bottom microtitre plates (4 x 104 cells per well) in complete RPMI 
and allowed to adhere o.n. at 37°C in a 5% CO2 atmosphere. After removal of supernatant 
cells were pretreated with 2 µg/ml Actinomycin-D (Acros Organics, Geel, Belgium). 
Thereafter, diluted samples were added to the wells. A standard curve of recombinant rat 
TNF-αҏ (Biosource, Camarillo, CA, USA) was included on each plate. Plates were 
incubated for 18 h at 37°C in a 5% CO2 atmosphere. Cell viability was determined by 
measuring the decrease in mitochondrial activity using the MTT (3-4,5-dimethylthiazole-
2-yl)-2,5-diphenyl tetrazolium bromide; Sigma Chemical Co., St. Louis, MO) reduction 
assay. The standard curve was used to calculate TNF-α production (ng/ml). Nitric oxide 
(NO) production after LPS restimulation of splenocytes was measured by the Griess 
reaction that measures the accumulation of nitrite in the culture medium as described 
before (8). A standard curve of sodium nitrite was used to calculate nitrite production 
(µM). 
 
Statistical analysis 
Significant differences of treatment groups with the control group or between the HCB 
treated groups with or without CsA treatment were determined by analysis of variance 
(ANOVA) with Bonferroni post hoc test for contrasts by using SPSS software. Values 
deviating more than 2 standard deviations from group means were considered as outliers 
and not included in statistical analyses. Preceding statistical analysis, all data were 
transformed to log 10 values to homogenize variance.  
 
Results  
 
Macroscopic skin lesions 
As described previously (15), oral treatment with HCB caused skin lesions in the head and 
neck region of BN rats. Table 1 shows that rats treated with HCB alone developed skin 
lesions after 9 or 10 days of treatment, which is according to previous reports. Skin 
lesions increased in size and severity resulting in hemorrhagic lesions often with 
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exudative crusts. CsA caused a delay of the development of skin lesions with 9-11 days as 
the first lesions were visible on day 19, 20 or 21. As can be seen in Table 1 all rats 
displayed skin lesions on day 21, but rats treated with CsA had less severe lesions and the 
affected area was much smaller.  
 
Table 1: Effect of CsA on the onset, incidence, severity and lesional area of skin 
lesions induced by HCB1 
   Day 21 
Group Animal Onset Severity Relative lesional area 
HCB 1 day 10 4 2.8 
 2 day 10 4 3.9 
 3 day 9 4 2.9 
 4 day 10 4 1.7 
HCB + CsA 1 day 20 2 0.04 
 2 day 19 2 0.31 
 3 day 21 2 0.16 
 4 day 20 2 0.12 
1 Table shows the onset of the skin lesions, e.g. the day the first lesions were visible, the severity 
(see Materials and Methods for ranking) on day 21 and the relative lesional area of all rats. This 
was calculated by dividing the lesional area with the total area.  
 
Body weight gain and relative organ weights 
Neither HCB nor CsA treatment influenced the gain in body weight during the course of 
the experiment (data not shown). As shown in Figure 1, relative spleen and ALN weights 
were significantly increased in both groups treated with HCB as compared to control rats. 
CsA treatment inhibited this increase in relative spleen weight moderately but spleen 
weights were still increased when compared to the control group. In contrast, CsA 
treatment prevented the HCB-induced increase in ALN weight completely. ALN weight 
of HCB-fed rats treated with CsA was not significantly different from control rats, but 
was significantly higher than control rats treated with CsA.  
 
Total serum IgE levels and IgM levels against ssDNA 
As has been described previously, HCB caused a significant increase in total serum IgE 
levels in BN rats (15). Table 2 shows that treatment with CsA prevented this increase in 
IgE levels completely. The BN rat is a strain with high basal IgE levels and in control rats 
the total serum IgE levels were 195 ng/ml. After CsA treatment total serum IgE levels in 
both control rats and HCB-fed rats were low and in both groups only 1 out 4 rats had are 
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given in table 2. Serum levels of IgM against ssDNA are also shown in table 2. Oral 
exposure to HCB increased anti-ssDNA IgM levels with a factor of 1.7 and treatment with 
CsA suppressed this completely to control levels.  
Figure 1: Relative spleen (A) and ALN (B) weights after 21 days of exposure of female BN rats to 
control diet or HCB diet with or without CsA treatment. Data represent mean ± SE of 4 animals per 
group. The asterisks above the bars indicate significance from control group (* p<0.05; ** p<0.01), 
significance from HCB treated group is depicted with ## p<0.01. §§ indicates significance from the 
control group treated with CsA (§§ p<0.01). 
 
Histopathology 
Lung  HE stained sections of formalin-fixed lung show that the morphology of rats 
fed the control diet either treated with CsA or not appeared normal (Figure 2) except for 
some scattered microgranulomas consisting of eosinophilic granulocytes. The presence of 
these microgranulomas in the lung of untreated BN rats have been described before (16). 
Treatment with HCB caused an infiltration of eosinophilic granulocytes around small 
blood vessels, granuloma formation and also intra-alveolar accumulation of macrophages. 
These HCB-induced effects are according to those described before (15). Rats fed with 
HCB and treated with CsA still had focal accumulations of macrophages comparable to 
HCB treated rats, but the perivascular infiltrate of eosinophilic granulocytes did not occur.  
 
Spleen The most prominent alterations induced by HCB in the spleen were 
comparable with effects observed previously in rats (13,29). HCB induced hyperplasia of 
the B cell compartments (marginal zone (MZ) and follicles) and increased extramedullary 
hemopoiesis. Morphology of spleens of HCB-fed rats treated with CsA showed depleted 
T cell areas (PALS), while some but not all of the B cell compartments were hyperplastic. 
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This hyperplasia was less when compared to the hyperplasia observed in HCB-fed rats not 
treated with CsA. HCB-induced hemopoiesis was inhibited by CsA (data not shown). 
Staining of cryostat sections with the MAb ED3, which stains a subpopulation of 
macrophages, revealed an increase of the amount of ED3+ macrophages (Figure 3) 
leading to broadening of the rim these macrophages in the MZ (MZ) and scattered 
infiltrates of ED3+ in the white pulp, as described previously in Wistar rats (24). This 
infiltration of ED3+ macrophages still occurred after CsA treatment.  
 
A        B 
  
  
C        D 
  
Figure 2: Representative HE stained lung sections of female BN rats exposed to the control diet 
(A), 450 mg HCB per kg diet (B) or 450 mg HCB per kg diet plus CsA treatment (C and D). 
Feeding rats with HCB induced perivascular eosinophilic infiltrates in the lung (arrows in B). CsA 
treatment prevented this infiltration of eosinophils (C) but HCB-induced accumulations of focal 
macrophages (asterisks) did still occur (D). 
 
 
 
*
* 
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A        B 
  
 
C         
 
Figure 3:  ED3 staining of representative spleen sections from control rats (A), HCB treated rats (B) 
and HCB and CsA treated rats (C). HCB induced an increase of ED3+ macrophages leading to 
broadening of the rim of these macrophages in the marginal zone (MZ) and scattered infiltrates of 
ED3+ in the white pulp (arrows in B and C). This increase was not influenced by CsA treatment.  
 
Table 2: Total serum IgE and IgM levels against ssDNA2 
Group Total serum IgE levels  Serum IgM levels against ssDNA  
Control 195 ± 32 1.0 ± 0.1 
Control + CsA  48 0.8 ± 0.1 
HCB 727 ± 49*** 1.7 ±0.2** 
HCB + CsA  52 1.0 ± 0.1## 
2 Total IgE levels are expressed as ng/ml serum. In both groups treated with CsA only one out of four 
rats had detectable IgE levels. Only this positive value is depicted in the table. The detection limit of 
the ELISA was 40 ng/ml. Serum IgM levels against ssDNA are expressed as an ELISA index. 
Calibration curves of the reference sera were used to calculated the dilution of the test serum that would 
result in the same absorbance as that of the reference serum as calculated by linear regression. The 
ELISA index is the ratio of the test dilution used and the calculated dilution. Mean ELISA index of the 
control group has been transformed to 1 and ELISA indices of the treatment groups have been 
expressed relative to this index. Data are of 4 animals per group ± SE. Asterisks denote significance 
from the control group (**p<0.01, *** p<0.001) and from HCB group (## p<0.01). 
 
MZ 
MZ 
MZ 
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CD25 expression in the MLN 
Figure 4 shows the expression of CD25 in the MLN. HCB treatment induced a stong 
increase in CD25 expression from 5.6% in control rats to 13%, which was prevented 
completely by CsA treatment. In control rats CsA treatment decreased CD25 expression 
slightly to 3.3% (not significant).  
Figure 4: CD25 expression in MLN expressed as percentage cells staining positive. The asterisks 
above the bar indicate significance from control group (**p<0.01) and significance from the HCB 
group is indicated with ## p<0.01.  Data represent mean ± SE from 4 animals per group.  
 
Effects of CsA on thymic and peripheral T cells  
The effects of CsA on thymocyte development have been studied intensively (11,12). In 
the present study CsA treatment inhibited the development of mature single-positive 
thymocytes from their double-positive precursors, resulting in a reduction of mature 
TCRαβ single-positive CD4+ and to a lesser extent a reduction of mature TCRαβ single-
positive CD8+ thymocytes (data not shown). Table 3 shows the relative and absolute 
numbers of T and B cells and the CD4/CD8 ratio in the spleen and ALN. CsA treatment 
caused a decrease of relative and absolute T cell number in spleen and ALN in both the 
control and the HCB-treated group. The decreased CD4/CD8 ratio shows that 
predominantly CD4+ T cells were affected by CsA treatment which is in line with 
previous work (6). In both spleen and ALN absolute T cell and B cell numbers were 
increased in the HCB treated group, whereas the relative T and B cell numbers in this 
group were not changed indicating that both cell types contributed equally to the observed 
enlargement of spleen and ALN.    
 
Control Control  
+ CsA 
HCB HCB 
+ CsA 
** 
## 
0
5
10
15
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Table 3: T and B cell number and CD4/CD8 ratio in spleen and ALN3 
 T cells B cells CD4/CD8 ratio 
Spleen    
Control 336 ± 16  
(13 ± 0.5) 
 836 ± 73  
(32 ± 1.3) 
2.1 
Control + CsA 149 ± 4.9***### 
(6.6 ± 0.5***) 
 783 ± 52  
(34 ± 3) 
1.4** ## 
HCB 520 ± 31***  
(14 ± 0.2) 
1185 ± 149  
(32 ± 2.6) 
2.3 
HCB + CsA 177 ± 20*** ##  
(5.7 ± 0.3*** ##) 
1133 ± 91  
(37 ± 0.6) 
1.6* ## 
ALN    
Control 511 ± 59  
(48 ± 1.3) 
 348 ± 14  
(34 ± 2.4) 
3.5 
Control + CsA 194 ± 28##  
(35 ± 2.2) 
 228 ± 40##  
(41 ± 2.1) 
2.7 
HCB 1530 ± 512  
(43 ± 2.4) 
1413 ± 37**  
(42 ± 3.2) 
3.2 
HCB + CsA 373 ± 212#  
(36 ± 7.5) 
 271 ± 42##  
(40 ± 6.6) 
2.4* 
3Absolute (x 104 cells) and relative (%; between brackets) number of T and B cells 
and CD4/CD8 ratio in the spleen and ALN. Data represent mean ± SE of 4 animals 
per group. Asterisks denote significance from the control group (*p<0.05, **p<0.01, 
***p<0.001). Significance from HCB group: #p<0.05, ##p<0.01, ###p<0.001 
 
Cytokine and NO production by spleen cells after mitogen restimulation  
To establish the effect of CsA on T cell activation, spleen cells were restimulated with 
ConA and subsequently IL-2 levels in the supernatant were measured. Table 4 shows that 
HCB treatment alone caused a significant increase of IL-2 levels and that after CsA 
treatment IL-2 levels in both the control group and the HCB-fed group were lower than 
the untreated control group. To investigate whether CsA treatment affected macrophage 
function spleen cells were also restimulated with LPS and TNF-α and NO production 
were measured. TNF-α levels were twice as high after HCB treatment and this increase 
was not influenced by CsA treatment (Table 4). HCB also induced an increase in NO 
production and this increase was also not affected by CsA treatment.  
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Table 4: IL-2, TNF-α and NO production after restimulation of splenocytes with the 
mitogens ConA and LPS4 
Group IL-2 TNF-α NO 
Control   9.2 ± 1.6 3.2 ± 1.3   2.3 ± 1.2 
Control + CsA   3.6 ± 1.3* 3.4 ± 0.7   6.1 ± 1.4 
HCB 28 ± 8.4**  7.5 ± 1.8** 16 ± 1.7** 
HCB + CsA   4.9 ± 3.1## 7.2 ± 0.4** 19 ± 3.4** 
4IL-2 levels were measured in supernatants of ConA-stimulated spleen cells and levels of TNF-α and 
NO in supernatants of LPS-stimulated spleen cells. Data represent mean ± SE of 4 animals per group. 
Asterisks denote significant differences from the control group (* p<0.05, ** p<0.01). Significantly 
different from the HCB treated group: ## p<0.01 
 
Discussion 
 
The present study showed that CsA treatment delayed the onset of HCB-induced skin 
lesions and decreased the severity of these skin effects, but did not affect the incidence. 
CsA prevented increase in spleen weight, but not to control values. In contrast, the 
increase in ALN weight was prevented completely and infiltration of eosinophils and 
increases in serum IgE and anti-ssDNA IgM were absent or at control level, respectively, 
in HCB-fed animals treated with CsA. The T cell-specific nature of the CsA inhibitory 
effect was confirmed by the reduction of ConA-induced IL-2 production and the 
unaffected LPS-induced TNF-α and NO production by splenocytes. In line with this, 
macrophage infiltrations into lung and spleen were still present regardless of the CsA 
treatment. Together, these data show that the immunopathological effects of HCB are to a 
large extent mediated by T cells.  
 The observed upregulation of CD25, or IL-2 receptor, in the MLN supports the 
relevance of T cells in HCB-induced immunopathology. The finding that CD25 
expression in control rats and HCB-fed rats treated with CsA was not altered is in 
accordance with knowledge that CsA does not act at the level of the IL-2 receptor, but 
downregulates IL-2 mRNA (7) and production of IL-2 (see above).  
 Present observations are partly in line with studies investigating the role of T cells in 
HCB-induced immunopathology by using thymectomized, lethal irradiated, and bone 
marrow reconstituted BN rats (13). These results already suggested that thymus-
dependent T cells were not required for induction of inflammatory skin effects by HCB, 
but that T cells accelerated the occurrence of these skin lesions. In contrast to our results 
splenomegaly and eosinophilia in the lung did still occur in these T cell-depleted rats. This 
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previous study, however, was not completely conclusive since after the T cell-depleting 
procedure (thymectomy, lethal irradiation plus bone marrow reconstitution) these BN rats 
still had functional T cells left in the periphery, which could account for some T cell-
dependent processes. By using CsA we circumvented this, since CsA not only reduces the 
number of T cells, but also inhibits antigen-induced T cell activation by interfering with 
the cytokine production (7). Furthermore, we show that HCB-induced lung eosinophilia is 
not dependent on mediators derived from other cell types than T cells as was suggested 
previously (13). 
 The increase in IgM levels against ssDNA has previously been related to the ability 
of HCB to activate B1-cells, a subset of B cells present in the MZ of the spleen (25) and 
known to produce low-affinity IgM antibodies against autoantigens. This increase was 
absent in HCB-fed rats treated with CsA. Remarkably, in these rats in particular the MZ 
was still hyperplastic, although less than in rats treated only with HCB. The HCB-induced 
influx of ED3+ macrophages, which constitute an important cell population in the MZ and 
thought to be capable of activating MZ B cells (3), was not affected by CsA treatment. 
Interestingly, our data suggest that ED3+ macrophages are responsible for the expansion 
of the MZ, but that T cells are required for the augmentation of the production of ssDNA-
IgM by B-1 cells.  
 Remarkably, CsA suppressed the severity and delayed the onset of skin lesions but 
did not influence the incidence, since all rats eventually developed skin lesions. This 
might be due to HCB-induced macrophage activation, leading to the production of 
inflammatory cytokines, NO and oxidative stress which was not inhibited by CsA. CD8α 
macrophages have been observed in the dermis of HCB treated rats before (13) and these 
macrophages might become activated by uptake of the inert HCB and initiate 
inflammatory responses and lesions in the skin. Nevertheless T cells are indispensable in 
further acceleration of skin pathology.  
 Together our results indicate that T cells play a prominent role in HCB-induced 
eosinophilia and humoral responses but that macrophages do account for at least a part of 
the observed adverse immune effects.  Importantly, we show that macrophage activation 
and T cell activation by HCB are separate entities.  
 How macrophage and T cells activation leads to pathology is not completely clear as 
yet. But one can envisage that the HCB is first taken up by macrophages and that 
responses similar to those observed after silica exposure take place. Silica is an inert 
chemical that induces autoimmune-like phenomena due to chronic activation of 
macrophages, leading to the production of pro-inflammatory cytokines like TNF-α and 
reactive oxygen species which results in chronic inflammation and tissue damage (4,10). 
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Subsequently, these adjuvant signals could polyclonally activate the available T cell-pool, 
including autoreactive T cells. In addition, inflammatory cells, in particular 
polymorphonuclear cells attracted by the presence of HCB, might induce 
myeloperoxidase-dependent formation of reactive metabolites of HCB. It is known that 
pentachlorophenol, an oxidative metabolite of HCB, can be oxidized into 
tetrachlorohydroquinone (TCHQ) and TCBQ by peroxidases (22). Recently, we have 
shown by using the mouse popliteal lymph node assay that TCBQ is capable of inducing 
neoantigen specific T cell hapten (5). Once formed in vivo, these reactive intermediates 
would be able to haptenize to proteins to form neoantigens and then trigger hapten-
specific T cells as well. Since cytochrome P450 catalyzed oxidation is not involved in 
HCB-induced immunopathology (23), extrahepatic metabolism by phagocytes might be 
implicated, as has been shown before for other allergenic or autoimmunogenic chemicals 
(reviewed in ref. 27).   
 Our future research will focus on the specificity of T cells and the role of 
macrophages in HCB-induced immunopathology. Interestingly, the present data stresses 
the suitability of the HCB-Brown Norway model to separately evaluate cellular and 
molecular interactions between innate and adaptive immune phenomena in relation to 
autoimmune-like syndromes. As such it adds to already existing Brown Norway models 
using metals or pharmaceuticals (17,26). 
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Abstract 
 
Hexachlorobenzene (HCB) is a persistent environmental pollutant that causes adverse 
immune effects in man and rat. The Brown Norway (BN) rat is very susceptible to HCB-
induced immunopathology and oral exposure causes inflammatory skin and lung lesions, 
splenomegaly, lymph node (LN) enlargement and increased serum levels of IgE and anti-
ssDNA IgM. T cells play an important role, but do not account for all adverse effects 
induced by HCB. Macrophages are probably also important and the relationship between 
macrophages and T cells was further investigated. To eliminate macrophages clodronate-
liposomes were used. Furthermore, a kinetic study was performed to obtain insight in the 
early phase of the HCB-induced immune response. Also, experiments were performed to 
detect specific memory T cells. Therefore, rats were challenged with the reactive 
metabolite tetrachlorobenzoquinone (TCBQ) and additionally, an adoptive transfer study 
was performed. Our results indicate that macrophages were indeed involved in HCB-
induced skin lesions, lung eosinophilia and elevation of ssDNA-IgM. Kinetics showed that 
both skin and lung lesions occurred early after exposure. Moreover, no evidence for the 
presence of specific memory T cells was found and immune effects could not be adoptively 
transferred. Together, our results indicate that both macrophages and T cells play an 
important role in HCB-induced immune effects but that HCB exposure does not lead to 
specific T cell sensitization. Presumably, HCB exposure induces macrophage activation, 
thereby generating adjuvant signals that polyclonally stimulate T cells. Together, these 
events may lead to the observed immunopathology in BN rats. 
 
Introduction 
 
Hexachlorobenzene (HCB) is a highly persistent environmental pollutant that is produced 
as a by-product of many industrial processes. The toxic effects induced by HCB were first 
noticed after an accidental poisoning in Turkey in the 1950s. The main characteristic 
clinical sign was hepatic porphyria. Adverse immune effects, such as enlarged spleen and 
lymph nodes (LN) and arthritis were also observed (9,19). Furthermore, infants born from 
HCB-exposed mothers developed inflammatory skin and lung lesions (2).  
 The immunotoxic effects of HCB could be reproduced in rats (for reviews see refs. 
(16,31). In particular Brown Norway (BN) rats are very susceptible to HCB-induced 
immunotoxic effects and oral exposure induces inflammatory skin and lung effects, 
splenomegaly, increased LN weight, and elevated serum levels of total IgM, IgG and IgE, 
and IgM against ssDNA (17). Recently, we have shown that T cells play an important role 
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in HCB-induced skin lesions, lung eosinophilia, increase in auricular LN (ALN) cell 
number, and elevation of humoral responses. Splenomegaly appeared to be only slightly 
dependent on T cells and macrophage infiltrations in spleen and lung were T cell-
independent. The presence of macrophages in spleen and lung could be indicatory for 
their involvement in some of the HCB-induced immune effects (5).  
 The exact role of macrophages and T cells in HCB-induced immunostimulation is 
unknown. First, it is unclear if macrophages are involved in T cell activation. Mediators 
produced by activated macrophages, such as inflammatory cytokines, are able to increase 
costimulatory molecules on dendritic cells, thereby enhancing signal 2 that is necessary 
for T cell activation (13). Furthermore, pro-inflammatory cytokines can directly activate 
naive T cells (3,18). Second, the potential of HCB to sensitize BN rats after oral exposure 
and generate memory T cells is not assessed yet. Low molecular weight chemicals 
(LMWC) can become immunogenic after binding to self proteins, thereby generating 
hapten-carrier complexes (32). Previously, we have shown that the oxidative metabolite of 
HCB, tetrachlorobenzoquinone (TCBQ), can be considered as a hapten in the mouse 
popliteal lymph node assay (PLNA) (7). Alternatively, certain LMWC are known to 
interfere with antigen presentation, leading to presentation of cryptic epitopes (25). 
Importantly, sensitization of T cells can only occur when sufficient adjuvant signals are 
present, e.g. costimulatory molecules or danger signals (1,14). 
 In this study we investigated the involvement of macrophages in relation to T cell 
activation and observed immunopathology. Macrophages were eliminated with the so-
called macrophage ‘suicide’ technique using clodronate-liposomes (28). Furthermore, a 
kinetic study was performed to obtain information on the early phase of HCB-induced 
immune effects. In addition, we examined whether HCB induced specific T cell 
activation, either or not specific for TCBQ. For this purpose several experiments were 
performed, including an adoptive transfer study.  
  
Materials and methods 
 
Chemicals and reagents 
The semisynthetic diet SSP/TOX was obtained from Hope Farms (Woerden, The 
Netherlands). HCB and TCHQ were purchased from Aldrich Chemie (Bornem, Belgium) 
and TCBQ (p-chloranil; purity >98%) from Merck-Schuchardt (Hohenbrunn, Germany). 
Euthesate® was obtained from Ceva Sante Animale B.V. (Maassluis, The Netherlands). 
Myeloperoxidase (MPO), RPMI 1640 with glutamax and penicillin-streptomycin were 
purchased from Invitrogen Life Technologies (Paisley, Scotland) and fetal bovine serum 
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(FBS) from ICN Biomedicals (INC, Costa Mesa, CA). All antibodies for flow cytometry 
were obtained from Pharmingen (San Diego, St. Louis, MO, USA). The BCA protein 
assay kit was from Pierce (Rockford, Ireland). Clodronate was a kind gift of Roche 
Diagnostics GmbH (Mannheim, Germany). Alkaline-phosphatase labeled goat-anti-rat 
IgM (µ) was from Brunswich (Amsterdam, The Netherlands). Capture and detection 
antibodies for the TNF-α ELISA were obtained from R&D Systems (Oxon, UK) and 
recombinant rat TNF-α from Biosource (Camarillo, CA, USA). Streptavidine-
horseradish-peroxidase was obtained from CLB (Amsterdam). All other chemicals and 
reagents were obtained from Sigma (St. Louis, MO, USA).  
 
Rats and maintenance 
Three- to 4 week old specific pathogen-free female inbred Brown Norway 
(BN/SsNOlaHsD, termed BN) rats were purchased from Harlan (Blackthorn, UK). Rats 
were allowed to acclimatize one week before starting the experiments. All rats were 
housed at the animal facilities of the Utrecht University and were kept two by two in 
filter-topped macrolon cages on bedding of chips and wood, under standard conditions 
(50-60% relative humidity, 12-hr dark/12-hr light cycle) with food and acidified drinking 
water ad libitum. The diet consisted of the SSP/TOX diet supplemented with or without 
crystalline HCB by mixing of homogeneity (450 mg HCB/kg diet). The experiments were 
conducted according to the guidelines of the animal experiments committee of the Faculty 
of Veterinary Medicine of the Utrecht University. In all experiments body weight was 
recorded twice a week and development of skin lesions was examined daily. The severity 
of the lesional sites was rated as described before (17), irrespective of size, as 1 = minimal 
(some redness), 2 = moderate (redness), 3 = marked (dry desquamation and crusts) and 4 
= severe (exudative lesions).  
 
Dissection protocol  
Rats were sacrificed by a lethal injection of sodium pentobarbital (Euthesate®, 0.3 g/kg 
bodyweight (bwt); i.p.). Blood was drawn from the vena cava and serum was collected 
after clotting and centrifugation. Organs were collected and weighed. For morphology, 
portions of organs were fixed in phosphate-buffered 4% paraformaldehyde and lungs were 
inflated and fixed with phosphate-buffered 4% paraformaldehyde to optimize 
morphology. Formaldehyde-fixed tissues were embedded in Paraplast and sections (5 µm) 
stained with hematoxylin and eosin (HE). For cryostat sections, portions of the organs 
were snap-frozen in liquid nitrogen. To avoid bias at examination, sections were scored 
under code. Single cell suspensions from spleen and LNs were prepared for flow 
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cytometry and ex vivo restimulation with mitogens in complete medium (RPMI 1640 with 
glutamax supplemented with 10% FBS and 2% penicillin-streptomycin) and counted 
using a Coulter Counter (Coulter Electronics, Luton, UK) and then adjusted to 2.5 x 106 
cells per ml.  
 
Macrophage depletion with clodronate-liposomes  
Clodronate-liposomes were prepared as described previously (30). Rats were divided 
randomly in the following experimental groups: two control groups treated with either 
PBS (n=4) or clodronate-liposomes (n=5) and three groups exposed to the HCB diet 
treated with either PBS (n=5), clodronate-liposomes (n=6) or PBS-liposomes (n=4). Sham 
injections of PBS were included to mimic depletion treatments without affecting 
macrophages and this group will be used for to compare the effects of clodronate-
liposomes on HCB-induced pathology. PBS-liposomes were included as control groups to 
establish that liposomes themselves do not alter observed effects (30). The first injection 
with liposomes was i.v. in the tail vein and immediately after this injection rats were 
placed on the appropriate diet. Rats received 1 ml clodronate-liposomes per 100 g bwt and 
control groups received a sham injection of 1 ml PBS or PBS-liposomes per 100 g bwt. 
To maintain depletion rats were injected i.p. on days 5, 9, 13 and 17. This regimen was 
chosen based on experiments in SCID mice (8), in order to prevent repopulation of 
macrophages and deplete circulating monocytes. Blood monocytes are only depleted for a 
short period after i.v. injection of clodronate-liposomes, since macrophage depletion in 
blood, liver en spleen generates signals to the bone marrow leading to enhanced release of 
monocytes, thereby increasing the number of circulating monocytes (10). Rats were 
sacrificed on day 20. Blood, spleen, MLN and ALN were collected and spleen was 
weighed. Portions of liver and spleen were collected for morphology (formaldehyde-
fixation or snap-frozen in liquid nitrogen) and MLN and ALN were also snap-frozen in 
liquid nitrogen and used for cryostat sections. Single cell suspensions of spleen, MLN and 
ALN were used for flow cytometry and ex vivo restimulation with ConA and LPS.  
 
Time study of HCB-induced immunotoxicity  
In the kinetic study rats were exposed to HCB for 0, 4, 7, 10, 14, 18 and 21 days. All rats 
were sacrificed on the same day. Spleen and lungs were collected for morphology. 
Splenocytes were ex vivo stimulated with LPS.      
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Ex vivo restimulation of splenocytes with TCHQ and TCBQ conjugates 
Conjugates of TCHQ and TCBQ were prepared by incubation of these chemicals with 
freshly isolated hemoglobin as described previously (33). Hemoglobin was isolated from 
blood obtained from untreated BN rats. The protein concentration of the conjugates was 
determined with a BCA protein assay kit. An experiment was performed to examine the 
ability of the TCHQ- and TCBQ-conjugates to restimulate splenocytes ex vivo. Rats were 
exposed to the control diet (n=1) or the HCB diet (n=2). After 21 days rats were sacrificed 
and spleen, ALN and MLN were collected and single cell suspensions were prepared. 
TCHQ-hemoglobin, TCBQ-hemoglobin and uncoupled hemoglobin (as a control for the 
carrier) were plated in a 96 well microtitre plate in a concentration of 50 or 100 µg/ml. As 
a negative control, complete medium was included. Cells were added to the different 
stimuli (3.75 x 105 cells per well) and incubated for 72 hours at 37˚C, 5% CO2, the last 8 
hours labeled with 0.5 µCi/well [3H]-Thymidine. Plates were harvested with a cell 
harvester onto filter paper and dried. The filter paper was placed into a bag containing 
scintillation fluid and [3H]-Thymidine incorporation was measured with a beta-plate liquid 
scintillation counter.  
 
Topical application of TCBQ on the ears of HCB-exposed rats 
Rats were randomly assigned to the different experimental groups (n=2), either receiving 
control diet or the HCB diet. On day 10 rats were challenged on the ears, and rats exposed 
to HCB received from this time point on the control diet. Ear thickness was measured 
prior to TCBQ application. Rats received a topical application on the dorsum of both ears 
of 50 µl vehicle or 50 µl TCBQ (0.01, 0.1, 1 and 2%) in acetone/olive oil 4:1. In order to 
determine delayed type hypersensitivity reaction ear thickness was measured 24 and 48 
hours after challenge. Four days after challenge rats were sacrificed and ALNs were 
collected and single cells suspensions were prepared in phosphate buffered saline (PBS) 
containing 1% bovine serum albumin (PBS/1%BSA) and after washing and resuspension 
in PBS/1%BSA, cells were counted using a Coulter Counter (Coulter Electronics, Luton, 
UK) and then adjusted to 2.5 x 106 cells per ml. Phenotype analysis was performed by 
using flow cytometry.  
 
Adoptive transfer study  
The protocol for adoptive transfer was adapted from Shenton et al. (26). BN rats exposed 
to the HCB diet for 21 days were used as splenocyte donors (n=8). Spleens were collected 
from donor rats and single cell suspensions were prepared under sterile conditions. 
Erythrocytes were lysed in PBS containing 0.83% NaHCO3 and 0.83% NH4Cl. After 
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washing, cell suspensions were pooled in sterile PBS. Naive recipients (n=8) received 6 x 
108 splenocytes, which equals an entire spleen, via the tail vein and were placed on the 
diet containing HCB (n=4) or on the control diet (n=4). Control groups were untreated rats 
that received either the control (n=4) or the HCB diet (n=4). After 21 days rats were 
sacrificed. Blood, spleen and lungs were collected and used for morphology and 
splenocytes were used for ex vivo restimulation with LPS.  
 
Flow cytometry 
The following conjugated monoclonal antibodies were used in duplo- or triplostaining to 
phenotype lymphocytes: fluorescein-isothiocyanate (FITC)-conjugated OX-33 (anti-rat 
CD45RA), phycoerythrin (PE)-conjugated R73 (anti-rat TCRαβ), OX-8 (anti-rat CD8α) 
and biotinylated OX-35 (anti-rat CD4). Incubations and measurements were performed as 
described previously (5). 
 
Ex vivo restimulation of spleen or lymph node cells 
For measurement of pro-inflammatory cytokines cells were stimulated ex vivo with the 
mitogen LPS and for T cell proliferation with the mitogen ConA. LPS (2 µg/ml) and 
ConA (5 µg/ml) in complete medium were plated in a 96 well microtitre plate and cells 
(3.75 x 105 cells per well) were added. After 24 hours of incubation with LPS supernatants 
were collected for cytokine measurement. Cells were incubated with ConA for 48 hours 
and the last 8 hours cells were labeled with 0.5 µCi/well [3H]-Thymidine. Plates were 
harvested with a cell harvester onto filter paper and dried. The filter paper was placed into 
a bag containing scintillation fluid and [3H]-Thymidine incorporation was measured with 
a beta-plate liquid scintillation counter.  
 
Incubation of HCB with MPO and HPLC determinations 
To investigate if the enzyme MPO can metabolize HCB in reactive metabolites, 
incubations of HCB with commercially available MPO were performed. HCB (100 and 
200 µM) was incubated with MPO (1, 2 and 5 units) and hydrogen peroxide (100 µM) in 
phosphate buffer (100 mM KH2PO4, 100 mM K2HPO4, pH6) for 2 hours. To detect 
metabolites in the incubation mixture, extraction with ether was performed and the extract 
was analyzed by HPLC as described previously (27).  
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TNF-α ELISA 
TNF-α was measured in supernatants of cells stimulated with LPS. Procedures were 
performed according to the description of the manufacturer with some minor 
modifications. Briefly, 96-well microtitre plates were coated overnight (o.n.) at room 
temperature (RT) with 2 µg/ml monoclonal anti-rat TNF-α. They were blocked with PBS 
containing 1% BSA, 5% sucrose and 0.05% NaN3 for 2 h at RT. After washing, samples 
and standard curve were added to the plate and incubated o.n. at 4°C. Plates were washed 
and 200 ng/ml biotinylated anti-rat TNF-α in PBS containing 0.5% Tween-20, 1% BSA 
and 2% goat serum was added to the plates and incubated for 1 hour at RT. After washing 
plates were incubated with streptavidin-horesradish-peroxidase for 1 hour at RT and 
developed with tetramethylbenzidine for 15 min. The color reaction was stopped by 
adding H2SO4 and absorbance was measured at 450 nm. The standard curve of 
recombinant TNF-α was used to calculate the amount of TNF-α in the samples (pg/ml). 
 
ELISA to detect serum levels of IgM against ssDNA 
ELISA procedures to determine IgM levels against ssDNA were performed as described 
previously (5,23). To calculate IgM serum levels against ssDNA all treatment groups were 
compared to the control group. Absorbance values of serial dilutions of the control serum 
were plotted against the 2log of the dilution. The dilution of the individual test sera that 
would result in the same absorbance was calculated by linear regression and was used to 
obtain the ELISA index. This index is the ratio of the test dilution used and the calculated 
dilution of control serum at the same absorbance.  
 
Immunohistochemistry 
To visualize macrophages cryostat sections (6 µm) of spleen and LNs were stained with 
acid phosphatase. Slides were counterstained with hematoxylin. Staining sections was 
carried out as described before (7).  For determination of calcium deposits formaldehyde-
fixed sections were stained with von Kossa.   
 
Statistical analysis 
Statistically significant differences of treatment groups with the control group or between 
the HCB-exposed groups treated with PBS, clodronate-liposomes or PBS-liposomes were 
determined by analysis of variance (ANOVA) with Bonferroni post hoc test for contrasts 
by using SPSS software. Values deviating more than 2 standard deviations from group 
Chapter 5 
 91 
means were considered as outliers and not included in statistical analyses. Preceding 
statistical analysis, all data were transformed to log 10 values to homogenize variance.  
 
Results 
 
Effects of clodronate-liposomes on HCB-induced adverse immune effects 
 Body weight gain and macroscopic skin lesions  
Body weight gain was not affected by treatment with HCB, clodronate-liposomes or PBS-
liposomes. In one out of six HCB-exposed rats treated with clodronate-liposomes skin 
lesions were completely absent. In four of these six rats the initial development was not 
affected by clodronate-liposomes, but exacerbation was clearly inhibited, resulting in 
smaller and less severe lesions after 20 days of exposure. In one of the HCB-exposed rats 
clodronate-liposomes did not at all prevent onset or aggravation of skin lesions and 
lesional area and severity was similar as in HCB-exposed rats treated with PBS. Because 
of these different effects, data on skin pathology of HCB-exposed rats treated with 
clodronate-liposomes are displayed in Table 1 in three separate groups. Table 1 shows 
also that administration of PBS-liposomes had no effect on HCB-induced skin lesions.  
 
Table 1: Effects of clodronate-liposomes on the onset, relative lesional area and severity 
of skin lesions induced by HCB1 
Group No. Onset  No. Lesional 
area 
Severity 
HCB + PBS 3 
2 
8 days 
9 days 
6 2.2 ± 0.45  4 
HCB + clodronate-
liposomes 
1 
3 
2 
No lesions  
9 days 
10 days 
1 
4 
1 
0                  
0.71 ± 0.24  
3.1  
0 
3 
4 
HCB + PBS-liposomes 4 9 days 4 3.2 ± 0.67 4 
1Table shows onset of skin lesions in days of exposure (including number of rats per time-point). 
The relative lesional area (expressed relative to the total area) and the severity of skin lesions (for 
ranking see Materials and Methods) after 20 days of exposure to HCB are also shown. Lesional area 
and severity of HCB-exposed rats treated with clodronate-liposomes were divided in three groups to 
grade the differences between the rats.  
 
 Lung morphology  
Administration of clodronate-liposomes prevented HCB-induced lung pathology 
completely in one rat. Notably, this was a different rat than the rat that did not develop 
Macrophages play a critical role in hexachlorobenzene-induced adverse immune effect 
 92 
skin lesions. In the other 5 rats of that group, clodronate-liposomes inhibited the HCB-
induced perivascular eosinophilic infiltrate moderately, but could not prevent focal 
accumulations of macrophages and granuloma formation. In one of the control rats treated 
with clodronate-liposomes a few microgranulomas and scattered eosinophilic 
granulocytes were found. Lung morphology of HCB-exposed rats treated with PBS or 
PBS-liposomes was similar as described before (17). A summary of morphological 
changes in the lung is given in Table 2.  
 
Table 2: Effects of clodronate-liposomes on the incidence of histopathological effects in 
lungs of BN rats exposed to the control or HCB diet2 
 No. Accumulation 
of macrophages 
Perivascular 
infiltrate 
Granuloma 
formation 
  slight moderate slight moderate slight moderate 
Control + clod-lip.  5   1  
HCB + PBS 5 1 4  5 1 4 
HCB + clod-lip.  6 3 2 5  3 2 
HCB + PBS-lip. 4 2 2  4 2 2 
2Sections were scored under code. In control rats scattered microgranulomas were observed. The 
perivascular infiltrate consisted mainly of eosinophils. Granulomas were formed by monocytes, 
macrophages, Langhans type giant cells and eosinophilic granulocytes. 
 Spleen: organ weight, number of B and T cells and histopathology 
Treatment with clodronate-liposomes caused a nearly complete elimination of splenic 
macrophages and decreased spleen weight in both control as well as in HCB-exposed rats. 
In addition absolute numbers of B and T cells (Table 3) were drastically reduced. As a 
result tissue architecture of the spleen was disturbed (Figure 1). However, the degree of 
the effect of clodronate-liposomes differed between the different HCB-exposed rats. In 4 
out of 6 animals and the control rats treated with clodronate-liposomes a comparable 
picture was observed (Figure 1E and F), with depleted and necrotic areas, predominantly 
in the red pulp. The necrotic areas were located subcapsular and contained calcium 
deposits, as judged by Von Kossa staining (not shown). In two of the HCB-exposed rats, 
clodronate-liposomes induced less drastic derangements of the splenic architecture, with 
absence of necrotic areas (Figure 1G) and a lesser degree of macrophage depletion (Figure 
1H). HCB exposure induced comparable histopathological changes as those described 
before (5,17,23), and treatment with PBS liposomes did not alter these HCB-induced 
splenic changes (not shown).  
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Table 3: Spleen weight and number of B and T cells3 
Treatment Spleen weight B cells T cells  
Control + PBS  0.33 ± 0.13 
(0.29 ± 0.02) 
100 
(46  ± 2.3) 
 100 
(17  ± 0.97) 
Control + clodronate-lip.  0.066 ± 0.087*** 
(0.060 ± 0.008***) 
  11 ± 1.8*** ### 
(27  ± 3.9*) 
  8.9 ± 3.6* ### 
 (12  ± 3.0) 
HCB + PBS  0.70 ± 0.44*** 
(0.56 ± 0.05***) 
232 ± 16*** 
(50  ± 1.2) 
 248  ± 28* 
 (17  ± 1.5) 
HCB + clodronate-lip.  0.11 ± 0.11*** ### 
(0.082 ± 0.007*** ###) 
  30 ± 5.9***  
(43  ± 4.8*** #) 
  30  ± 4.9 *** 
(16 ± 2.8) 
HCB + PBS-liposomes  0.75 ± 0.44*** 
(0.57 ± 0.012***) 
223 ± 6.3*** 
(46 ± 1.8)  
205 ± 13** 
(15 ± 0.71) 
3Spleen weight is expressed as absolute (in g) and relative (in g/100 g bwt) weight after 20 days of 
exposure of female BN rats to control diet or HCB diet with or without treatment with liposomes. 
Number of B and T cells are expressed as absolute (expressed relative to control group in %) and 
relative (%; between brackets) numbers. Data represent mean ± SE of 4-6 animals per group. The 
asterisks above the bars indicate significance from control group (*p<0.05; **p<0.01, *** p<0.001), 
significance from HCB-exposed group treated with PBS is depicted with #p<0.05, ##p<0.01, 
###p<0.001.  
 Lymph nodes: cell number, number of macrophages, B and T cells 
Clodronate-liposomes did not result in depletion of macrophages in the ALN, as judged 
by histopathology (not shown), nor did it affect the HCB-induced increase in ALN cell 
number (Table 4) or induction of germinal center (GC) formation (not shown). The HCB-
induced increase of ALN cell number is caused by an expansion of both T and B cell 
areas. Furthermore, relative B cell numbers in the ALN increased significantly as a result 
of HCB treatment (Table 4).  
 Administration of clodronate-liposomes did not alter the number of macrophages, or 
of B and T cells in the MLN. But also HCB-exposure itself appeared not to affect cell 
number or lymphocyte subsets in these lymph nodes, and GCs were present in both 
control and HCB-exposed rats (not shown).  
 
Macrophages play a critical role in hexachlorobenzene-induced adverse immune effect 
 94 
A   
B   
C   
D   
MZ 
P 
RP 
MZ 
P 
RP 
MZ P 
RP 
MZ 
P 
RP 
Chapter 5 
 95 
 E   
F   
G   
H  
Figure 1: Representative spleen
sections from control rats (A-B),
HCB-exposed rats (C-D), control
rats treated with clodronate-
liposomes (E) and HCB-exposed
rats treated with clodronate-
liposomes (F-H). Sections are
stained with either HE (A-C-E-
G) or acid phosphatase (B-D-F-
H) to reveal macrophages (in
red). MZ: marginal zone; P:
PALS; RP: red pulp.   
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Table 4: ALN cell number and number of B and T cells4  
Treatment ALN  
cell number 
B cells T cells  
Control + PBS 17 ± 0.84 
 
  6.1 ± 0.51 
(36  ± 1.7) 
  9.4 ± 0.39 
(56 ± 1.5) 
Control + clodronate-
liposomes  
14 ± 3.4 
 
  4.9 ± 1.1  
(35 ± 0.79) 
  8.2 ± 2.0 
(57 ± 1.0) 
HCB + PBS 53 ± 5.3*** 
 
24 ± 2.9*** 
(44 ± 1.5**) 
25 ± 2.3*** 
(48 ± 1.7*) 
HCB + clodronate-liposomes  47 ± 3.5*** 
 
19 ± 1.3*** 
(42 ± 0.74*) 
23 ± 1.9*** 
(50 ± 1.1) 
HCB + PBS-liposomes 54 ± 0.85*** 
 
25 ± 0.91*** 
(47 ± 1.4***) 
25 ± 1.4*** 
(46 ± 2.3**) 
4ALN cell number and number of B and T cells that are expressed as absolute (x 106 cells) and 
relative (%; between brackets) numbers. Data represent mean ± SE of 4-6 animals per group. 
Asterisks denote significance from the control group (*p<0.05, **p<0.01, ***p<0.001).  
 TNF-α production of spleen and LN cells after incubation with LPS 
Figure 2 shows LPS-induced TNF-α production of cell suspensions from spleen, MLN 
and ALN. Treatment with clodronate-liposomes significantly prevented the HCB-induced 
increase of TNF-α production in spleen, MLN and ALN. Furthermore, splenocytes from 
control rats injected with clodronate-liposomes produced less TNF-α compared to those 
from control rats injected with PBS. Administration of PBS-liposomes did not affect 
HCB-induced elevation of TNF-α.  
Figure 2: Effect of HCB either or not combined with macrophage depletion on LPS-induced TNF-α 
production (in pg/ml) of spleen, MLN and ALN cells. Data represent mean ± SE of 4-6 animals per 
group. Significantly different from the control group: * p<0.05, ** p<0.01, *** p<0.001 and 
significantly different from the HCB+PBS group: ## p <0.01, ### p<0.001.  
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 ConA-induced proliferation of spleen and LN cells 
Table 5 shows the proliferative responses of cell suspensions from spleen, MLN and ALN 
cells after ConA incubation. In the HCB-exposed group the effect of treatment with 
clodronate-liposomes on ConA-induced proliferation of splenocytes was not clear, due to 
high variance. Two rats responded to ConA with higher proliferation (average 25215 
cpm) than the HCB-exposed group treated with PBS but lower than the PBS-treated 
control group. Splenocytes from the other 4 rats hardly responded to the mitogenic 
response (average 117 cpm), similar to control rats treated with clodronate-liposomes. 
When proliferation was compared with spleen morphology, high proliferative responses 
were observed in the 2 rats in which spleen morphology was less disturbed and 
macrophage depletion was not as pronounced (Figure 1G-H). Remarkably, HCB-exposure 
itself decreased the susceptibility of splenocytes to proliferate in response to ConA, 
resulting in decreased proliferation as compared to the PBS-treated control group.  
 Treatment with clodronate-liposomes of HCB-exposed rats resulted in a decreased 
mitogen-induced proliferation of MLN cells compared to HCB-exposed rats as well as 
compared to clodronate-liposome-treated control animals (not significant). HCB exposure 
itself did not alter ConA-induced proliferation in this organ. Treatment with clodronate-
liposomes did also prevent the HCB-induced increase in the mitogenic response of ALN 
cells, although this was again not significant (due to high variance). Mitogenic responses 
after HCB-exposure were not significantly affected by administration of PBS-liposomes 
in any of the assessed organs, although in cell cultures of MLN and ALN higher mean 
proliferation levels were measured as compared with the HCB-exposed group treated with 
PBS. 
 
Table 5: Effects of clodronate-liposomes on ConA-induced proliferation5  
Treatment Spleen MLN ALN 
Control + PBS 46592 ± 11747 10491 ± 1369    823  ± 389 
Control + clod-lip.      82  ± 9*** 16122 ± 3337  3869  ± 1619 
HCB + PBS  6754  ± 459*** 10301 ± 3762 26420 ± 10284* 
HCB + clod-lip.   8483  ± 6683***  4507  ± 944  9366  ± 2401 
HCB + PBS-lip.  6800  ± 449*** 20889 ± 5483 40619 ± 5357** 
5Table shows ConA-induced proliferation of spleen, MLN and ALN cells (expressed in 
cpm). Cells were incubated with ConA (5 µg/ml) for 48 hours and incorporation of [3H]-
Thymidine was used to determine proliferation. Each sample was measured in quadriplate 
and data represent mean ± SE of 4-6 rats per group. Asterisks denote significance from the 
control group (*p<0.05, **p<0.01, ***p<0.001).  
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 Serum levels of IgM against ssDNA 
Treatment with clodronate-liposomes prevented the HCB-induced increase of serum 
levels of ssDNA-specific IgM, and even reduced the level compared to controls (Figure 
3). In the control group treated with clodronate-liposomes the ELISA-index was slightly 
decreased. 
Figure 3: Serum IgM levels against ssDNA are expressed as an ELISA index, calculated by plotting 
absorbance values of serial dilutions of the control serum against the 2log of the dilution. The 
dilution of the individual test sera that would result in the same absorbance was calculated by linear 
regression and was used to obtain the ELISA index. This index is the ratio of the test dilution used 
and the calculated dilution of the control serum at the same absorbance. Data are of 4-6 rats per 
group ± SE. Asterisks denote significance from the control group (*p<0.05; **p<0.01) and from the 
HCB-exposed group (##p<0.01) 
 
Kinetics of HCB-induced immunotoxicity 
To get more insight in the early phase of HCB-induced immunostimulation a kinetic study 
was performed with a focus on occurrence of skin and lung pathology and activation of 
splenic macrophages, as evidenced by LPS-induced TNF-α production. The time-point at 
which the first macroscopic skin lesions were visible varied between 6 and 12 days. Most 
rats, however, displayed skin lesions after 10 days.   
 Table 6 summarizes kinetics of lung pathology, increases of spleen weight and LPS-
induced TNF-α production of splenocytes. After 4 days of exposure infiltrates of 
macrophages in the lung were observed in all four rats, 3 out of 4 rats displayed slight 
perivascular eosinophilic infiltrates and granuloma formation was seen in one rat. The 
eosinophilic infiltrate was present in all rats after 7 days of exposure, whereas granuloma 
formation was observed in 3 out of 4 rats. After continuous exposure to HCB lung effects 
became more pronounced. Spleen weight and LPS-induced TNF-α production increased 
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time-dependently from day 4 onward. However, increases in spleen weight were not 
significant until day 14 and the elevation of the TNF-α response to LPS was not 
significant until day 21 of exposure.  
 
Table 6: Kinetics of HCB-induced lung pathology and spleen effects6 
Spleen 
effects 
 HCB 
exposure 
Lung pathology 
  
 Macrophages Eosinophils Granuloma 
 + ++ ± + ++ ± + ++ 
Organ weight TNF-α  
production   
0 days        0.28±0.01 1407±105 
4 days 2 3     1 0.31±0.01 1680±80 
7 days 3  4   2 1 0.33±0.02 2302±192 
10 days 3 1 3  2 1 1 0.36±0.02 2240±201 
14 days 2  2 2  1 3 0.42±0.02*** 2617±242 
18 days    4  2 2 0.44±0.02*** 2871±425 
21 days  
 
2 
1 
1 
2 
4 
4  1 3  3 1 0.53±0.03*** 4592±954*** 
6Table shows the severity of HCB-induced lung pathology and spleen effects. Lung pathology is ranked 
by presence of foamy macrophages, perivascular eosinophilic infiltrates and granuloma. Number of rats 
investigated per time-point was 4. Relative spleen weight is expressed as g/100 g bwt) and TNF-α was 
measured in supernatants of LPS-stimulated spleen cells and is expressed in pg/ml. Data are expressed 
as mean ± SE of 4 animals per group. Asterisks denote significance from the control group (0 days), 
*** p<0.001.  
 
Involvement of memory T cells in HCB-induced immunotoxicity 
Our data suggest that macrophages are important in HCB-induced immunostimulation, 
but previous studies indicated that T cells were involved as well. This raised the question 
whether HCB treatment results in T cell sensitization. Several experiments were 
performed to investigate this.  
 To assess whether T cells derived from HCB-treated rats could recognize the 
reactive metabolite TCBQ, conjugates of both TCHQ and TCBQ coupled to hemoglobin 
were incubated with total cell suspensions of spleen, ALN and MLN from control or 
HCB-exposed rats. However, cellular proliferation in the presence of the conjugates was 
not different from proliferation in the presence of hemoglobin or the medium only. In 
additional experiments, topical application of different concentrations of TCBQ (0.01, 0.1, 
1 and 2% w/v) on the ears of control or HCB-exposed rats did not induce any ear swelling 
on the assessed time points (24 and 48 hours after application). Only application of 2% 
TCBQ caused in a moderate increase of ALN cell number, but this was similar in control 
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and HCB-exposed rats, with respective stimulation indices of 1.5 and 1.4. The challenge 
with TCBQ had no effect on relative T and B cell numbers in the ALN. Important to note, 
HCB itself already increased ALN cell numbers as compared to the control rats.  
 An adoptive transfer study was performed to assess if HCB-induced immune effects 
could be transferred to naive recipients. Transfer of splenocytes from HCB-exposed donor 
rats to recipients that were also exposed to HCB did not accelerate development, severity 
or area of skin lesions. Furthermore, adoptive transfer had no effect on other disease 
parameters (lung pathology, splenomegaly, LPS-induced TNF-α production, serum levels 
of IgM against ssDNA).  
 We also tested whether the enzyme MPO was able to metabolize HCB, but HPLC 
analyses of the incubation-mixture of HCB with the enzyme MPO could not detect any of 
the HCB metabolites. 
 
Discussion 
 
We previously demonstrated that T cells play an essential role in some of the HCB-
induced adverse immune effects. Macrophages, however, appeared to be important as well 
(5). Here we investigated the importance of macrophages in comparison to T cells in 
HCB-induced immunopathology. The present results show that macrophages are indeed 
important in HCB-induced skin lesions, lung eosinophilia and elevation of anti-ssDNA 
IgM. Data obtained in the kinetic study also suggest that macrophages are activated in 
lung and skin early after HCB exposure and that they play a role in HCB-induced clonal 
expansion of splenic B and T cells. Furthermore, no evidence was found for the induction 
of (specific) T cell sensitization and immunological memory after HCB exposure.  
 Skin lesions were not completely prevented in all HCB-exposed rats treated with 
clodronate-liposomes, but this is very likely due to incomplete macrophage depletion in 
some animals with the protocol we have used. Macrophage depletion was also not equally 
apparent in all organs, for instance macrophage infiltrations and granulomas were still 
noticed in the lung and the amount of macrophages in ALN and MLN was not diminished. 
The organ-specific depleting effect is in line with earlier findings showing that clodronate-
liposomes initially eliminate liver and spleen macrophages without depleting circulating 
monocytes. However, it has been shown that a single injection of clodronate-liposomes 
slightly reduced macrophages in some LNs, such as the MLN (29), indicating that the 
liposomes reach other organs too and repeated administration probably will only increase 
these effects. This is in accordance with our observation that clodronate-liposomes affect 
the function of macrophages before they are actually eliminated as illustrated by the 
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complete inhibition of LPS-induced TNF-α production in ALN and MLN of rats treated 
with clodronate-liposomes. An alternative explanation for the reduced macrophage 
activation in the ALN might be the relationship between ALN effects and skin lesions. 
These skin effects were less severe and as a consequence macrophage activation in ALN 
could be less pronounced. 
 Considering the observed differences in efficacy of macrophage depletion, we 
conclude that skin and lung pathology depend on macrophage activation. Together with 
the assumption that skin infiltrations of macrophages and neutrophils precede the actual 
macroscopically visible lesions kinetic data suggest that skin pathology results from an 
early non-specific inflammation. Previously, we have shown, by treating HCB-exposed 
rats with CsA, that T cells are also important in both the development of skin lesions and 
lung eosinophilia (5). But in rats treated with CsA macrophages were still apparent in the 
lung infiltrates. Combined with present work it is concluded that these T cell-dependent 
phenomena are secondary to macrophage activation. A similar conclusion can be deduced 
from data of the kinetic study. These data show that macrophage activation precedes the 
increase of spleen weight. This seems to be in accordance with our previous data, showing 
that both HCB-induced macrophage influxes in the spleen as well as splenomegaly were T 
cell-independent (5). 
 How T and B cells become activated after HCB exposure is not known, but 
cytokines, such as IL-6, produced by activated macrophages can induce polyclonal 
proliferation and activation of both T and B cells (21). Unpublished in vitro data show that 
HCB is indeed able to activate rat alveolar macrophages, thereby inducing IL-6 and TNF-
α production. After polyclonal expansion of B cells antibody-secreting cells will be 
generated. These will also include B-1 cells that produce antibodies against autoantigens, 
such as ssDNA. These splenic B-1 cells reside in the marginal zone of the spleen and 
activation of these B-1 cells seems to be under control of ED3+ macrophages (4). Both 
ED3+ macrophages as well as B-1 cells were found to be activated by HCB (23).   
 In order to elucidate the effects of macrophage depletion on T cell proliferation, cell 
suspensions were incubated with the T cell mitogen ConA, as it is well established that 
ConA-induced T cell proliferation requires interaction with macrophages (11,12). 
Regarding the severe depletion of macrophages in the spleen of these animals the 
complete absence of a mitogenic response of splenocytes is not surprising. In accordance, 
the impairment of macrophage functions (i.e. lower TNF-α production after LPS 
stimulation) in the ALN and MLN of these animals may also explain the reduced 
mitogen-induced proliferation in comparison with HCB-exposed rats treated with PBS.  
Macrophages play a critical role in hexachlorobenzene-induced adverse immune effect 
 102 
 The results of the proliferative responses observed with splenocytes from HCB-
exposed rats, however, are not that straightforward. Remarkably, proliferative responses 
in HCB-exposed animals were lower than in PBS-treated control animals and these 
responses appeared not affected by the clodronate-liposomes. The latter may be explained 
by the high variance and less efficient macrophage depletion correlated with higher 
proliferation rates. The lower responses of splenocytes of HCB-exposed animals are in 
accordance with earlier findings in Wistar rats (24) but they seem to be in contrast with 
our previous work that showed increased IL-2 production after HCB-exposure (5). 
However, increased IL-2 production does not always result in increased cellular 
proliferation, as has been shown before (20). In addition, the decreased mitogenic 
response of splenic T cells may be due to a decreased susceptibility to a mitogenic trigger 
of these T cells that have already proliferated vigorously in vivo.   
 The lack of evidence for specific T cell sensitization supports our view that after 
HCB exposure macrophage activation induced polyclonal T cell stimulation. T cells 
specific for TCBQ could not be detected. Furthermore, the fact that MPO was not able to 
metabolize HCB makes the involvement of reactive metabolites in HCB-induced immune 
effects not very likely. Especially, since previous work has shown that both cytochrome 
P450 oxidation and the mercapturic acid pathway were not involved in HCB-induced 
immune effects (15,22). In addition, susceptibility for the HCB-induced immune effects 
could not be adoptively transferred. Notably, this experiment was performed only once 
and for adoptive transfer total spleens were used instead of purified T cells. However, 
nevirapine-induced skin rash in BN rats could be adoptively transferred by splenocytes 
using the same protocol (26).  
 In conclusion, present work emphasizes the importance of macrophages as initiators 
of the HCB-induced adverse immune response. Presumably, HCB activates macrophages 
to produce pro-inflammatory mediators (i.e. IL-6, TNF-α) and reactive oxygen species. 
This is in accordance with gene expression profiles assessed with DNA microarrays (6). 
Additionally, these, pro-inflammatory mediators will provoke a cascade of events, 
attracting granulocytes and macrophages, and inducing an inflammatory response. In 
agreement with this, transcriptome profiles have shown that after HCB exposure 
upregulation of gene expression for inflammatory markers was not confided to 
immunological organs, but involved also liver and kidney, suggesting a systemic 
inflammatory response. All these events may not only cause secondary cell damage and 
hence raise additional danger signals but also induce polyclonal T and B cell activation. 
Together, this will result in the observed HCB-induced immunopathology.  
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Summary and general discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Hexachlorobenzene (HCB) is an environmental pollutant that can induce adverse immune 
effects in humans and rats (reviewed in refs. 16,26). Brown Norway rats (BN) appeared to 
be very susceptible to HCB-induced immune effects. Oral exposure causes inflammatory 
skin and lung lesions, enlarged spleen and lymph nodes (LN) and elevated humoral 
responses (17). Although the immunopathological effects induced by HCB are 
investigated comprehensively, the exact mechanisms involved are unknown. Experiments 
described in this thesis were performed to obtain more insight in the mechanisms 
underlying HCB-induced adverse immune effects, both on a cellular and molecular level. 
We tried to obtain more information on the involvement of oxidative metabolites and the 
importance of both (memory) T cells and macrophages. Furthermore, experiments focused 
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on the early phase of HCB-induced immune effects to reveal which cells are important in 
the initiation stage.  
Summary of results  
 
In chapter 2 the immunomodulatory effects of the oxidative metabolites 
tetrachlorohydroquinone (TCHQ) and tetrachlorobenzoquinone (TCBQ) were assessed. 
Therefore, these metabolites were studied in the mouse reporter antigen popliteal lymph 
node assay (RA-PLNA) with TNP-Ficoll as a RA. In this assay an isotype switch to IgG1 
indicates that the chemical injected is able to form neoantigens that can stimulate T cells. 
Both TCHQ and TCBQ induced an isotype switch to IgG1 and were thus capable of 
providing neoantigen-specific T cell help. Furthermore, this response was compound-
specific as was shown in a secondary PLNA.  
 In chapter 3 we determined gene expression profiles with DNA microarray analysis 
in BN rats. Transcriptome profiling was done in spleen, mesenteric lymph node (MLN), 
thymus, blood, liver and kidney. Data confirmed known effects of HCB such as 
stimulatory effects on the immune system and induction of enzymes involved in drug 
metabolism, porphyria and the reproductive system. New findings include the 
upregulation of genes encoding pro-inflammatory cytokines, antioxidants, acute phase 
proteins, mast cell markers, complement, chemokines, and cell adhesion molecules. In 
general, gene expression data provide evidence that HCB induces a systemic 
inflammatory response, accompanied by oxidative stress and an acute phase response. 
 Chapter 4 describes experiments performed to investigate the role of T cells in 
HCB-induced immunotoxic effects. The immunosuppressive drug Cyclosporin A (CsA) 
was used to decrease peripheral T cell numbers and inhibit T cell activation. CsA 
treatment delayed the development of HCB-induced skin lesions and prevented the 
increase in spleen weight slightly. Furthermore, increase in ALN weight, lung 
eosinophilia and humoral responses were prevented completely by in HCB-exposed rats 
treated with CsA. Macrophage infiltration was independent of T cells and macrophages 
seem also important.  
 Therefore, the relationship between macrophages and T cells was further 
investigated in Chapter 5. Co-administration of clodronate-liposomes was used to 
eliminate macrophages in HCB-exposed rats. Results indicated that macrophages played 
an important role in HCB-induced skin lesions, in particular in the aggravation of skin 
lesions. Also, HCB-induced lung eosinophilia and elevation of anti-ssDNA IgM 
antibodies were less pronounced after depletion of macrophages. To obtain information on 
events that occur in the initiation phase a kinetic study was performed. This revealed that 
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both skin and lung pathology were early inflammatory events. Furthermore, macrophage 
infiltrations in the spleen seemed to precede the increase in spleen weight. Remarkably, 
studies performed to further assess the functional role and specificity of T cells induced by 
HCB did not provide any evidence for the presence of T cells specific for TCBQ. 
Moreover, HCB-induced immune effects could not be adoptively transferred to naive 
recipients. An overview of results obtained in Chapter 4 and 5 can be found in Table 1.  
 
Table 1: Summary of T cell- and macrophage-dependent immune effects induced by HCB 
in the BN rat1 
Immune 
effects 
 CsA study (T cells) Clodronate-liposome 
study (macrophages) 
Skin 
pathology 
Initial development  
 
Severity and lesional area 
- Delayed 
 
- Decreased 
- Prevented in 1 out of 6 
rats 
- Decreased in 4 out of 6 
rats  
Lung 
pathology 
Macrophages and 
granulomas 
Eosinophilic infiltration 
- Not affected 
 
- Prevented 
- Prevented in 1 out of 6 
rats 
- Moderately prevented in 
5 out of 6 rats 
Humoral 
responses 
Increase in IgM against 
ssDNA 
Increased IgE levels 
- Prevented 
 
- Prevented 
- Prevented 
 
- Not investigated 
Spleen  
effects 
Enlargement 
Increased TNF-α production 
- Slightly  prevented 
- Prevented 
- Depleted and necrotic 
- Prevented 
ALN Enlargement 
Increased TNF-α production 
- Prevented 
- Not investigated 
- Not affected 
- Prevented 
1Results are derived from Chapter 4 (CsA study) and Chapter 5 (clodronate-liposome study)  
 
 
 Association between macrophages and T cells in  
HCB-induced immunopathology 
 
One of the main findings in this thesis is that macrophages are important in HCB-induced 
adverse immune effects (Chapter 5). But we have also demonstrated that the metabolite 
TCBQ can stimulate IgG1 responses to TNP-Ficoll in the mouse RA-PLNA, which 
indicates that TCBQ can induce non-cognate T cell help and thus form hapten-carrier 
complexes or neo-epitopes (Chapter 2; ref. 10). However, after oral exposure to HCB no 
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hapten-specific T cells could be detected in BN rats and moreover HCB-induced immune 
effects could not be transferred to naive recipients (Chapter 5). Hence, although HCB 
pathology could be partly prevented by inhibition of T cells with CsA (Chapter 4 ref. 8) 
HCB exposure does not lead to (specific) T cell sensitization and immunological memory 
(Chapter 5). Furthermore, no evidence was found for the capability of MPO to convert 
HCB into reactive intermediates (Chapter 5). In addition, previous studies have shown 
that reactive metabolites formed by cytochrome P450-catalyzed conversion of HCB (19) 
or generated in the mercapturic acid pathway (15) were not involved in the immune 
effects. Together, these data argue against involvement of reactive metabolites as 
initiators of HCB-induced immune effects.   
 Our present findings provide interesting additional information on the mechanism of 
HCB-induced immune derangements. We postulate that initially HCB activates 
macrophage in various organs, in particular the lung and skin. Notably, a previous 
toxicokinetic study showed that as soon as 3 hrs after a single oral dose of HCB peak 
concentrations of HCB were detected in the lungs (personal communication; D. 
Overstreet). This means that HCB is rapidly absorbed into the systemic circulation and 
distributed to the lung. Thus, early deposition of HCB may indeed be associated with the 
early presence of macrophages in the lungs. This accumulation of macrophages and also 
the formation of granulomas in the lung occurred independently of T cells (Chapter 4; ref. 
8).  
 Also in the spleen, macrophage infiltration and activation occurred early after 
exposure and appeared to precede the increase in spleen weight. Moreover, both HCB-
induced splenomegaly and splenic macrophage influxes were T cell-independent (Chapter 
4; ref. 8). Based on these findings we suggest that after HCB exposure T cell and B cell 
are polyclonally activated by macrophages. The polyclonal nature of the B cell response is 
also illustrated previously by the increase of total IgM, IgG and IgE and anti-ssDNA IgM 
(17,20). In addition, in this thesis we show that HCB increased gene expression of 
antibodies against the acetylcholine receptor and nerve growth factor (Chapter 3; ref. 9). 
Notably, antibodies against ssDNA are produced by B-1 cells that are presumably 
activated by MZ macrophages (3), and these B-1 cells have been found in increased 
numbers after HCB exposure (20). The absence of IgG against ssDNA in HCB treated rats 
(17) indicates that specific T cell help is not sufficiently available and hence also supports 
the idea of polyclonal T cell activation. 
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Comparison with other models of chemical-induced  
adverse immune effects 
 
Adverse immune effects induced by mercuric chloride and D-penicillamine 
In the BN rat other immunostimulating compounds have been tested extensively, such as 
D-penicillamine and mercuric chloride (HgCl2). Table 2 summarizes immune effects 
elicited by these compounds and illustrates the similarities and differences with HCB-
induced immune effects (5,7,16,22). All chemicals are capable of inducing skin lesions, 
splenomegaly, enlargement of LNs and polyclonal B (including rise in IgE levels) and T 
cell responses in BN rats. The main difference between HCB and the other chemicals is 
that the disease can be adoptively transferred to naive recipients in case of D-
penicillamine and HgCl2, but not in case of HCB. Furthermore, both D-penicillamine and 
HgCl2 generate immune complexes and induce an isotype-switch to IgG against nuclear 
antibodies. Also, pronounced strain differences with respect to adverse immune reactions 
have been observed between BN and Lewis rats in response to D-penicillamine and HgCl2 
exposure. Both HgCl2 and D-penicillamine induce autoimmunity in BN rats, but resistance 
to disease in Lewis rats. These two strains are different with respect to the polarization of 
their immune responses. After stimulation, T cells from BN rats preferentially produce 
type-2 cytokines, whereas T cells from Lewis rats predominantly secrete type-1 cytokines. 
After exposing BN rats to HgCl2 and D-penicillamine self-MHC class II-reactive Th2 cells 
expand and induce development of clinical signs. These autoreactive T cells are also 
found in Lewis rats but in these rats they produce Th1 cytokines inducing 
immunosuppression (reviewed in refs: 11,13). HCB exposure induces more or less equal 
immune manifestations in both BN and Lewis rats as well as in outbred Wistar rats. 
However, BN rats are more susceptible to the induction of skin lesions. Furthermore, 
splenomegaly is more pronounced in this strain and the increase in total serum IgG and 
IgE is confined to this strain (17).  
 Similar to HCB, some of the D-penicillamine- and HgCl2-induced adverse immune 
effects are T cell-independent. For instance oxidative stress plays a role in the early 
vasculitis induced by HgCl2 (28) and is thought to modulate mast cell function and IL-4 
production (27). Here we found that HCB also induces oxidative stress as shown by 
upregulation of genes coding for antioxidants and by the increased levels of 
hydroperoxides in the serum of HCB-exposed BN rats. However, the antioxidant N-
acetylcysteine did not affect HCB-induced immune effects in BN rats (unpublished data).  
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Table 2: Immune effects induced in BN rats after exposure to HCB, D-penicillamine and 
HgCl2 
 HCB D-penicillamine HgCl2 
Skin lesions + + + 
Splenomegaly + + + 
Increase in serum IgE + + + 
IgG antinuclear antibodies - + + 
Lymphadenopathy + + + 
Immune complexes - + + 
Polyclonal B and T cell 
activation 
+ + + 
Adoptive transfer of disease - + + 
  
 Mast cells are thought to be essential for the production of IL-4 early after exposure 
to HgCl2 (27,28). Mast cells may also be activated in HCB-induced immune effects 
because transcriptome profiles revealed upregulation of several mast cell proteins. HCB 
exposure, however, does not result in increased IL-4 gene expression in Wistar rats (25) 
nor in the Th2-prone BN rats (Chapter 3; ref. 9). However, gene expression of IL-25 is 
upregulated in the MLN of these HCB-exposed BN rats. This cytokine is produced by an 
unidentified non-T cell population and stimulates mast cells and highly polarized Th2 
cells to produce Th2 cytokines that are essential for the expansion of eosinophils and 
elevation of IgE (14).  
 Development of clinical effects after exposure to D-penicillamine can be inhibited 
by the iNOS inhibiting compound aminoguanidine, indicating the importance of nitric 
oxide (NO) (18). NO has a suppressive effect on IFN-γ production, as has been shown 
previously in the BN model for HgCl2 (24). By inhibiting NO production the cytokine 
balance will be skewed to Th1, thereby preventing the development of Th2 autoimmunity. 
However, co-administration of aminoguanidine did not affect HCB-induced immune 
effects in BN rats (data not published).  
 Importantly, the immunostimulation induced after HCB exposure seems different 
from the autoimmune effects induced by D-penicillamine and HgCl2. 
 
Autoimmune-like effects induced by silica 
Silica is a chemical that has adjuvant effects and is frequently associated with several 
autoimmune diseases, such as scleroderma and systemic lupus erythematosus (1,4). 
Mechanisms are not completely clear, but the adjuvant activity of silica most likely plays 
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an important role. In vitro data provide evidence that this adjuvant activity could lead to 
polyclonal T cell activation (23). The ability of silica to adjuvate immune responses is 
caused by a chronic activation of macrophages leading to secretion of pro-inflammatory 
mediators and cell death (6).  
 Although both HCB and silica may act by causing macrophage-induced polyclonal 
lymphocyte activation the stimulatory effects on macrophages seem to be different 
between the two substances. In the RA-PLNA, for instance, silica induces a progressive 
stimulation, leading to an ongoing increase in PLN cell number. This is probably due to 
undegradable silica deposits in the footpad that continuously attract macrophages. 
Deposits and macrophage infiltrations were also observed after injection of HCB, but in 
contrast, HCB-deposits disappeared after 3 weeks. PLN cell number was only slightly 
increased by HCB, but in time cell number restored to control values (10). An important 
difference between silica and HCB is that silica is completely resistant to degradation by 
macrophages, whereas HCB, although very inert, is probably eventually taken up by 
macrophages or due to its lipophilic nature dissolved in adipose tissue or cell membranes. 
However, in vitro data suggest that HCB (added to the cells as a suspension) activates 
macrophages similar to silica, inducing TNF-α and IL-6 production (unpublished data). 
Figure 1 shows that similar doses of HCB and silica can induce an equal increase of TNF-
α production by rat alveolar macrophages.      
Figure 1: TNF-α release (pg/ml) after exposure of rat alveolar macrophages (NR8383 cell line) for 
6 and 24 hours with HCB (1 mg/ml) and silica (0.8 mg/ml). Significantly different from the control 
group * p<0.05 and ** p<0.01.  
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General conclusions  
 
In conclusion, we propose that HCB deposition initially attracts and activates 
macrophages, thereby generating pro-inflammatory adjuvant signals that induce a 
systemic inflammatory response with influxes of neutrophils and more macrophages in 
various non-immune and immune organs. Subsequently, this leads to polyclonal activation 
of T and B cells, eosinophilia and eventually to visible clinical effects.    
 What exactly elicits the attraction of macrophages is quite speculative, but HCB 
deposition can directly induce cell damage, or elicit damage by interfering with the 
integrity of cell membranes due its lipophilic nature. Cell damage or products released by 
dying cells can activate macrophages. Figure 2 shows that if macrophages become 
activated they may release pro-inflammatory mediators, such as TNF-α, IL-1β, IL-6, 
reactive oxygen species (ROS) and chemokines. These pro-inflammatory mediators are 
known to be capable of inducing a cascade of events, including upregulation of cell 
adhesion molecules, thereby facilitating recruitment of other inflammatory cells. 
Furthermore, pro-inflammatory cytokines may also stimulate T cell responses (2).  
 Immunostimulation of autoreactive T cells by adjuvant or danger signals is 
explained by the so-called ‘bystander’ hypothesis. This hypothesis postulates that 
dysregulated macrophage activation can lead to expansion of pre-existing autoreactive T 
cells and B cells  (reviewed in ref. 21). Evidently in such a situation regulatory 
mechanisms (i.e. regulatory T cells) are not sufficient to control these pre-existing 
autoreactive T cells and B cells (12).  
 In conclusion, the HCB-induced immunopathology supports the notice that the 
etiology of immune derangements induced by xenobiotics is very complex. It also 
demonstrates that different compounds can have apparently similar adverse effects that 
are elicited by a different mode of action.  
 In general, the BN rat-model for HCB-exposure is an interesting addition to other 
existing BN rat-models, and illustrates that this strain can be very useful as a candidate for 
predictive testing of possible immunostimulatory xenobiotics.  
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Future directions 
 
A lot of additional information on HCB-induced immune effects was obtained with DNA 
microarrays. However, these were performed after 28 days of exposure, when pathology 
was already full-blown. In this stage it is very difficult to distinguish between primary and 
secondary effects. Therefore, it would be very useful to study gene expression profiles 
early after exposure. This will provide information on which events are important for the 
initiation of the immune response. DNA microanalysis combined with pathology should 
be performed in particular in the lung and skin but also in spleen, various lymph nodes 
(including lymph nodes draining the skin, lung and intestines). This knowledge on early 
mechanisms may help to clarify unsolved questions on HCB-induced effects, such as the 
order of events that take place after HCB exposure. This may elucidate that the immune 
response is initiated locally in the skin and lung. Furthermore, additional information on 
markers for cytotoxicity may be detected and this could strengthen our hypothesis that the 
immune response may be elicited by cell damage.   
 
References  
 
1. Cooper, G.S., Miller, F.W. and Germolec, D.R. (2002) Occupational exposures and 
autoimmune diseases. Int Immunopharmacol, 2, 303-13. 
2. Curtsinger, J.M., Schmidt, C.S., Mondino, A., Lins, D.C., Kedl, R.M., Jenkins, M.K. and 
Mescher, M.F. (1999) Inflammatory cytokines provide a third signal for activation of 
naive CD4+ and CD8+ T cells. J Immunol, 162, 3256-62. 
3. Damoiseaux, J.G., Dopp, E.A. and Dijkstra, C.D. (1991) Cellular binding mechanism on 
rat macrophages for sialylated glycoconjugates, inhibited by the monoclonal antibody 
ED3. J Leukoc Biol, 49, 434-41. 
4. D'Cruz, D. (2000) Autoimmune diseases associated with drugs, chemicals and environmental 
factors. Toxicol Lett, 112-113, 421-32. 
5. Donker, A.J., Venuto, R.C., Vladutiu, A.O., Brentjens, J.R. and Andres, G.A. (1984) 
Effects of prolonged administration of D-penicillamine or captopril in various strains of 
rats. Brown Norway rats treated with D-penicillamine develop autoantibodies, circulating 
immune complexes, and disseminated intravascular coagulation. Clin Immunol 
Immunopathol, 30, 142-55. 
6. Driscoll, K.E., Lindenschmidt, R.C., Maurer, J.K., Higgins, J.M. and Ridder, G. (1990) 
Pulmonary response to silica or titanium dioxide: inflammatory cells, alveolar 
macrophage-derived cytokines, and histopathology. Am J Respir Cell Mol Biol, 2, 381-90. 
7. Druet, E., Sapin, C., Gunther, E., Feingold, N. and Druet, P. (1977) Mercuric chloride-
induced anti-glomerular basement membrane antibodies in the rat: genetic control. Eur J 
Immunol, 7, 348-51. 
8. Ezendam, J., Hassing, I., Bleumink, R., Vos, J.G. and Pieters, R. (2004) 
Hexachlorobenzene-Induced Immunopathology in Brown Norway Rats Is Partly Mediated 
by T Cells. Toxicol Sci, 78, 88-95. 
9. Ezendam, J., Staedtler, F., Pennings, J., Vandebriel, R.J., Pieters, R., Harleman, J.H. 
and Vos, J.G. (2004) Toxicogenomics of subchronic hexachlorobenzene exposure in 
Chapter 6 
 115 
Brown Norway rats. Environmental Health Perspectives Toxicogenomics, 112 (7) DOI 
10.1289/txg.6861. 
10. Ezendam, J., Vissers, I., Bleumink, R., Vos, J.G. and Pieters, R. (2003) 
Immunomodulatory Effects of Tetrachlorobenzoquinone, a Reactive Metabolite of 
Hexachlorobenzene. Chem Res Toxicol, 16, 688-694. 
11. Fournie, G.J., Cautain, B., Xystrakis, E., Damoiseaux, J., Mas, M., Lagrange, D., 
Bernard, I., Subra, J.F., Pelletier, L., Druet, P. and Saoudi, A. (2001) Cellular and 
genetic factors involved in the difference between Brown Norway and Lewis rats to 
develop respectively type-2 and type-1 immune- mediated diseases. Immunol Rev, 184, 
145-60. 
12. Fournie, G.J., Mas, M., Cautain, B., Savignac, M., Subra, J.F., Pelletier, L., Saoudi, A., 
Lagrange, D., Calise, M. and Druet, P. (2001) Induction of autoimmunity through 
bystander effects. Lessons from immunological disorders induced by heavy metals. J 
Autoimmun, 16, 319-26. 
13. Fournie, G.J., Saoudi, A., Druet, P. and Pelletier, L. (2002) Th2-type immunopathological 
manifestations induced by mercury chloride or gold salts in the rat: signal transduction 
pathways, cellular mechanisms and genetic control. Autoimmunity Reviews, 1, 205-212. 
14. Ikeda, K., Nakajima, H., Suzuki, K., Kagami, S., Hirose, K., Suto, A., Saito, Y. and 
Iwamoto, I. (2003) Mast cells produce interleukin-25 upon Fc epsilon RI-mediated 
activation. Blood, 101, 3594-6. 
15. Michielsen, C., Boeren, S., Rietjens, I., van Mil, F., Vos, J. and Bloksma, N. (2000) The 
mercapturic acid biotransformation pathway of hexachlorobenzene is not involved in the 
induction of splenomegaly, or skin and lung lesions in the Brown Norway rat. Arch 
Toxicol, 74, 609-17. 
16. Michielsen, C.C., van Loveren, H. and Vos, J.G. (1999) The Role of the Immune System in 
Hexachlorobenzene-Induced Toxicity. Environ Health Perspect, 107, 783-792. 
17. Michielsen, C.P., Bloksma, N., Ultee, A., van Mil, F. and Vos, J.G. (1997) 
Hexachlorobenzene-induced immunomodulation and skin and lung lesions: a comparison 
between Brown Norway, Lewis, and Wistar rats. Toxicol Appl Pharmacol, 144, 12-26. 
18. Sayeh, E. and Uetrecht, J.P. (2001) Factors that modify penicillamine-induced 
autoimmunity in Brown Norway rats: failure of the Th1/Th2 paradigm. Toxicology, 163, 
195-211. 
19. Schielen, P., Den Besten, C., Vos, J.G., Van Bladeren, P.J., Seinen, W. and Bloksma, N. 
(1995) Immune effects of hexachlorobenzene in the rat: role of metabolism in a 13-week 
feeding study. Toxicol Appl Pharmacol, 131, 37-43. 
20. Schielen, P., Van Rodijnen, W., Pieters, R.H. and Seinen, W. (1995) Hexachlorobenzene 
treatment increases the number of splenic B-1-like cells and serum autoantibody levels in 
the rat. Immunology, 86, 568-74. 
21. Stoy, N.S. (2002) Monocyte/macrophage initiation of organ-specific autoimmunity: the 
ultimate 'bystander' hypothesis? Med Hypotheses, 58, 312-26. 
22. Tournade, H., Pelletier, L., Pasquier, R., Vial, M.C., Mandet, C. and Druet, P. (1990) D-
penicillamine-induced autoimmunity in Brown-Norway rats. Similarities with HgCl2-
induced autoimmunity. J Immunol, 144, 2985-91. 
23. Ueki, A., Yamaguchi, M., Ueki, H., Watanabe, Y., Ohsawa, G., Kinugawa, K., 
Kawakami, Y. and Hyodoh, F. (1994) Polyclonal human T-cell activation by silicate in 
vitro. Immunology, 82, 332-5. 
24. van der Meide, P.H., de Labie, M.C., Botman, C.A., Aten, J. and Weening, J.J. (1995) 
Nitric oxide suppresses IFN-gamma production in the spleen of mercuric chloride-
exposed brown Norway rats. Cell Immunol, 161, 195-206. 
25. Vandebriel, R.J., Meredith, C., Scott, M.P., Roholl, P.J. and Van Loveren, H. (1998) 
Effects of in vivo exposure to bis(tri-n-butyltin)oxide, hexachlorobenzene, and 
Summary and General Discussion 
 
 116 
benzo(a)pyrene on cytokine (receptor) mRNA levels in cultured rat splenocytes and on IL-
2 receptor protein levels. Toxicol Appl Pharmacol, 148, 126-36. 
26. Vos, J.G. (1986) Immunotoxicity of Hexachlorobenzene. In Morris, C.R. and Cabral, J.R. 
(eds.), Hexachlorobenzene: proceedings of an international symposium. IARC Scientific 
Publications, Lyon, vol. 77, pp. 347-356. 
27. Wu, Z., Turner, D.R. and Oliveira, D.B. (2001) IL-4 gene expression up-regulated by 
mercury in rat mast cells: a role of oxidant stress in IL-4 transcription. Int Immunol, 13, 
297-304. 
28. Wu, Z., Turner, D.R. and Oliveira, D.B. (2002) Antioxidants inhibit mercuric chloride-
induced early vasculitis. Int Immunol, 14, 267-73. 
 
Affiliations 
 117 
Affiliations  
 
Institute for Risk Assessment Sciences (IRAS), Immunotoxicology, P.O. Box 80.176, 
3508 TD, Utrecht University, Utrecht 
Dr. Raymond Pieters 
Rob Bleumink 
Ine Hassing 
Ischa Vissers 
Kevin Kosterman 
Henneke Spijkerboer  
 
 
National Institute for Public Health and the Environment, Laboratory for Toxicology, 
Pathology and Genetics, P.O. Box 1, 3720 BA, Bilthoven  
Prof. Dr. Jeff G. Vos 
Dr. Rob J. Vandebriel 
Dr. Jeroen Pennings 
 
Faculty of Veterinary Medicine, Department of Pathobiology, P.O. Box 80.150, 3508 TD, 
Utrecht University, Utrecht 
Prof. Dr. Jeff G. Vos 
 
Novartis Pharma AG, Biomarker Development, CH-4002, Basel, Switzerland 
Dr. Frank Staedtler  
 
Novartis Pharma AG, Preclinical Safety, CH-4002, Basel, Switzerland 
Dr. Johannes H. Harleman 
 
Faculty of Medicine, Department of Molecular Cell Biology, Free University, P.O. Box 
7057, 1007 MB  Amsterdam 
Dr. Nico van Rooijen  
Publications 
 118 
List of publications 
 
Castelijns, F.A., Ezendam, J., Latijnhouwers, M.A., Van Vlijmen-Willems, I.M., 
Zeeuwin, P.L., Gerritsen, M.J., Van de Kerkhof, P.C. and Van Erp, P.E. (1998) 
Epidermal cell kinetics by combining in situ hybridization and immunohistochemistry. 
Histochem J, 30, 869-77. 
 
Cardaba, B., Ezendam, J., Gallardo, S., del Pozo, V., Izquierdo, M., Martin, C., 
Cortegano, I., Aceituno, E., Rojo, M., Arrieta, I., Palomino, P., Posada, M. and 
Lahoz, C. (2000) DR2 antigens are associated with severity of disease in toxic oil 
syndrome (TOS). Tissue Antigens, 55, 110-7. 
 
Pieters, R., Ezendam, J., Bleumink, R., Bol, M. and Nierkens, S. (2002) Predictive 
testing for autoimmunity. Toxicol Lett, 127, 83-91. 
 
Pieters, R., Ezendam, J. and Nierkens, S. (2003) Chemical-specific properties co-
determine the type of adverse immune response. Autoimmun Rev, 2, 25-9. 
 
Ezendam, J., Vissers, I., Bleumink, R., Vos, J.G. and Pieters, R. (2003) 
Immunomodulatory Effects of Tetrachlorobenzoquinone, a Reactive Metabolite of 
Hexachlorobenzene. Chem Res Toxicol, 16, 688-694. 
 
Ezendam, J., Hassing, I., Bleumink, R., Vos, J.G. and Pieters, R. (2004) 
Hexachlorobenzene-Induced Immunopathology in Brown Norway Rats Is Partly Mediated 
by T Cells. Toxicol Sci, 78, 88-95. 
 
Ezendam, J., Staedtler, F., Pennings, J., Vandebriel, R.J., Pieters, R., Harleman, J.H. 
and Vos, J.G. (2004) Toxicogenomics of subchronic hexachlorobenzene exposure in 
Brown Norway rats. Environmental Health Perspectives Toxicogenomics, 112 (7) DOI: 
10.1289/txg.6861 
 
 
 
 
Nederlandse samenvatting 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hexachloorbenzeen 
 
Hexachloorbenzeen (HCB; C6Cl6) is een organochloorverbinding (Figuur 1) die in het 
verleden werd gebruikt als bestrijdingsmiddel tegen schimmels. Mede door de schadelijke 
effecten in zowel mens als dier is het gebruik van HCB in de jaren ’70 in de meeste 
landen verboden. Tegenwoordig komt HCB nog steeds vrij in het milieu, omdat het wordt 
gevormd als tussenproduct tijdens verschillende industriële processen. HCB is een 
chemisch erg stabiele stof, die moeilijk wordt afgebroken in het milieu, waardoor het 
accumuleert in water, bodem, en sediment. HCB kan ook teruggevonden worden in 
weefsels van onder andere vissen en vogels, maar ook in menselijk vetweefsel en 
moedermelk.  
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Figuur 1: Chemische structuur van hexachloorbenzeen 
 
 Al decennia lang wordt er onderzoek verricht naar de giftige effecten veroorzaakt 
door HCB. Aanleiding voor dit onderzoek was een vergiftiging die plaats vond in Turkije 
in de jaren ’50. Tussen de 3000 en 5000 mensen werden ziek, omdat ze brood hadden 
gegeten dat abusievelijk was gebakken van zaaigraan dat was behandeld met HCB. De 
meeste slachtoffers ontwikkelden een aandoening aan de lever (porfyrie) met als gevolg 
dat de lever vergroot was en blaarvormige huideffecten ontstonden op plekken die 
blootgesteld waren aan de zon. Andere symptomen waren schildklier en milt vergroting, 
neurologische verschijnselen en gewrichtsontstekingen. Jonge kinderen, die via de 
moedermelk waren blootgesteld aan HCB, ontwikkelden een zeer ernstige aandoening. 
Symptomen waren diarree, braken, vermagering, onsteking van de huid, lever vergroting 
en infiltraten in de longen. Meer dan 95% van deze kinderen overleefden de vergiftiging 
niet en overleden aan hart-long falen.  
 In vervolgonderzoek in proefdieren konden veel van de effecten die werden 
waargenomen in mensen, ook worden gevonden in proefdieren, zoals porfyrie, lever en 
milt vergroting en ontstekingen van de huid en longen. Uit deze studies bleek dat HCB 
ook schadelijke effecten heeft op het immuunsysteem. Dit is in overeenstemming met 
waarnemingen Turkije, maar ook in Brazilië werden effecten op het immuunsysteem 
waargenomen bij werknemers die in een fabriek werden blootgesteld aan HCB. 
 
Schadelijke effecten van HCB op het immuunsysteem  
 
HCB is een stof met een laag moleculair gewicht en van verscheidene andere chemicaliën 
met een laag moleculair gewicht, zoals bepaalde geneesmiddelen, is bekend dat ze het 
immuunsysteem kunnen verstoren. In het intermezzo is getracht uit te leggen hoe het 
immuunsysteem werkt en hoe chemische stoffen dit systeem kunnen verstoren.  
 De effecten van HCB op het immuunsysteem zijn voornamelijk bestudeerd in de rat. 
Uit eerder onderzoek is gebleken dat vooral de Brown Norway (BN) rat erg gevoelig is 
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voor immuuneffecten veroorzaakt door HCB. Deze rattenstam wordt vaker gebruikt om 
de effecten van chemische stoffen op het immuunsysteem te onderzoeken, omdat het 
immuunsysteem al iets actiever is dan in andere rattenstammen. Zo veroorzaken sommige 
geneesmiddelen autoimmuniteit alleen in BN ratten. Als BN ratten via het voedsel worden 
blootgesteld aan HCB ontwikkelen ze ontstekingsreacties in de huid en longen. Deze 
ontstekingen worden gekenmerkt door de aanwezigheid van allerlei ontstekingscellen 
zoals macrofagen en granulocyten. Daarnaast zijn de milt en lymfknopen vergroot en 
geactiveerd. In het serum zijn antistoffen verhoogd, hetgeen ook een indicatie is voor een 
stimulatie van het immuunsysteem.  
 Ondanks het onderzoek dat in het verleden is uitgevoerd is het nog steeds 
onduidelijk hoe HCB het immuunsysteem activeert. Het doel van de experimenten 
beschreven in dit proefschrift is om hier meer inzicht in te krijgen.  
 
Intermezzo 
Het immuunsysteem speelt een zeer belangrijke rol bij het herkennen en bestrijden van 
ziekteverwekkers, zoals bacteriën, virussen en parasieten. In wezen kan het 
immuunsysteem worden opgedeeld in twee categorieën: het ‘innate’ of aangeboren 
immuunsysteem en het adaptieve immuunsysteem. Het ‘innate’ immuunsysteem, is erg 
belangrijk voor de eerstelijnsafweer tegen allerlei ziekteverwekkers. De ‘innate’ 
immuuncellen herkennen patronen die aanwezig zijn op bijvoorbeeld bacteriën en worden 
hierdoor gewaarschuwd over de ‘indringers’. Vervolgens zullen ze proberen deze te 
vernietigen. ‘Innate’ immuuncellen zijn bijvoorbeeld macrofagen of granulocyten. Na 
activatie scheiden deze cellen producten uit waarmee ze de ‘indringers’ willen 
uitschakelen. Tevens produceren ze stoffen waarmee ze andere cellen waarschuwen om 
ook in actie te komen. Een voorbeeld hiervan is het uitscheiden van cytokines, waardoor 
bijvoorbeeld T cellen kunnen worden geactiveerd. T cellen horen bij het adaptieve 
immuunsysteem. De kenmerken hiervan zijn een hoge mate van specificiteit voor de 
vreemde structuur (=antigeen) en de ontwikkeling van geheugen. Na stimulatie van het 
adaptieve immuunsysteem ontstaat er een immunologisch geheugen voor het antigeen dat 
de T cellen hebben herkend. Als gevolg hiervan zal bij een tweede blootstelling dit 
antigeen veel sneller worden herkend en beter worden bestreden, hetgeen de basis is voor 
vaccinaties tegen infectieziektes.  
 Behalve ziekteverwekkers kunnen ook bepaalde chemische stoffen met een laag 
moleculair gewicht het immuunsysteem stimuleren, zoals bepaalde geneesmiddelen. Dit 
leidt meestal tot ongewenste reacties, zoals allergie of auto-immune afwijkingen. Een 
allergische reactie is gericht tegen de chemische stof zelf. Auto-immune afwijkingen 
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kunnen ontstaan als er onder invloed van de chemische stof een afweerreactie wordt 
opgewekt tegen lichaamseigen structuren. Er bestaat nog steeds veel onduidelijkheid over 
hoe chemische stoffen dit soort ongewenste reacties opwekken.  
 Het immuunsysteem onderscheidt indringers (vreemd) van het eigen lichaam (zelf) 
en reageert onder normale omstandigheden alleen maar op vreemd. Voor het herkennen 
van een antigeen worden delen hiervan gepresenteerd aan T cellen door bijvoorbeeld 
macrofagen. De T cel is zo geprogrammeerd dat hij kan onderscheiden of iets vreemd of 
zelf is. Als een T cel iets vreemds herkent zal deze geactiveerd worden. Voor complete 
activatie zijn echter ook extra activeringssignalen nodig, dit wordt co-stimulatie genoemd.  
Allerlei signalen kunnen co-stimulatoire signalen geven aan de T cel, bijvoorbeeld schade 
aan lichaamseigen structuren door infectieuze agentia of chemische stoffen. Dit worden 
gevaarsignalen genoemd. Als er geen co-stimulatie aanwezig is, zal de T cel niet 
geactiveerd worden.  
 Een chemische stof kan niet worden gepresenteerd aan een T cel. Echter, als een stof 
in staat is om in het lichaam aan een eiwit te binden zullen delen van deze nieuwe 
combinatie gepresenteerd worden aan een T cel. Deze nieuwe combinatie kan als een 
vreemd antigeen worden herkend. Als er dan ook voldoende gevaarsignalen aanwezig 
zijn, kan er een immuunreactie ontstaan. De T cellen zullen hierdoor geactiveerd worden 
en er zullen ook ‘geheugen’ cellen worden gevormd. Er bestaan ook chemische stoffen die 
zonder de hulp van T cellen een negatieve immuunreactie kunnen opwekken. Meestal 
activeren deze stoffen macrofagen, bijvoorbeeld omdat ze schade veroorzaken. Door 
activatie van macrofagen zullen allerlei producten, zoals cytokines, worden uitgescheiden 
die kunnen leiden tot activatie van andere cellen. Meestal ontstaat hierdoor een 
ontstekingsreactie. De symptomen die hierdoor worden veroorzaakt kunnen wel lijken op 
allergie of auto-immuniteit.    
 
In hoofdstuk 1 wordt een algemeen overzicht gegeven van de nadelige effecten van HCB 
op het immuunsysteem. Daarnaast wordt in dit hoofdstuk besproken op welke manieren 
chemische stoffen het immuunsysteem kunnen ontregelen. In hoofdstuk 2 is onderzocht 
of HCB of stoffen die ontstaan als HCB wordt omgezet in het lichaam (metabolieten) 
immuunstimulatie kunnen veroorzaken. Hiervoor is een muizenmodel gebruikt dat 
veelvuldig wordt toegepast om op een snelle en eenvoudige manier te onderzoeken of een 
stof het immuunsysteem stimuleert. HCB en zijn metabolieten, tetrachlorohydrochinone 
(TCHQ) en tetrachlorobenzochinone (TCBQ), werden ingespoten in de voetzool van een 
muis. Na 7 dagen werd de reactie gemeten in de lymfknoop die in de knieholte zit. Stoffen 
die immuunstimulerend zijn en T cellen kunnen activeren zullen een positieve reactie 
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veroorzaken in de lymfknoop. Dit leidt dan tot een vergroting van de lymfknoop en 
daarnaast zullen de cellen in de lymfknoop antistoffen gaan produceren. HCB zelf had 
geen effect op de lymfknoop. Dit lag ook in de lijn der verwachting, omdat HCB zelf niet 
herkend wordt door het immuunsysteem en het ook niet in staat is om te binden aan 
eiwitten. De metabolieten TCHQ en TCBQ gaven wel een positieve reactie. Uit 
voorgaand onderzoek was al gebleken dat deze stoffen aan eiwitten kunnen binden. Uit dit 
onderzoek blijkt dat ze dus ook in staat zijn om nieuwe antigenen te vormen, die in dit 
muizenmodel T cellen activeren. Het is wel belangrijk om te beseffen dat de route van 
toediening van deze snelle test niet gelijk is aan de wijze waarop mensen en ratten worden 
blootgesteld (via de voeding). In de vervolgstudies werd dan ook de BN rat gebruikt om 
de effecten van HCB verder te onderzoeken, omdat in dit model de dieren werden 
blootgesteld via het voedsel.  
 In hoofdstuk 3 werden BN ratten blootgesteld aan HCB in twee verschillende 
doseringen, een lage en een hoge dosis. Na 4 weken werden milt, thymus (zwezerik), 
mesenteriale lymfknoop, bloed, lever en nier verzameld en werd hieruit het mRNA 
(=genetisch materiaal) gehaald. Met behulp van een recent ontwikkelde techniek is 
gemeten welke genen geactiveerd werden door HCB. Deze techniek wordt genomics 
genoemd. Met behulp van zogenaamd DNA microarrays kunnen tegelijkertijd ongeveer 
8000 genen gemeten worden. Dit betekent dat er buitengewoon veel informatie kan 
worden verkregen over de effecten van een toxische stof op verschillende organen. Met 
deze nieuwe techniek konden we een aantal bekende effecten van HCB aantonen, zoals 
stimulatie van het immuunsysteem en effecten op de lever (porfyrie). Verder zijn er 
verscheidene nieuwe bevindingen gedaan, onder andere dat verscheidene cytokines die 
door macrofagen worden geproduceerd in verhoogde mate gemeten konden worden na 
blootstelling aan HCB. In het geheel genomen verschaft deze studie inzicht in het effect 
van HCB op verschillende organen en geeft informatie over welke factoren hierbij een 
belangrijke rol spelen. De algehele conclusie is dat HCB een systemische (dus in het hele 
lichaam) ontstekingsreactie veroorzaakt waarbij door macrofagen geproduceerde factoren 
een belangrijke rol spelen.  
 In hoofdstuk 4 is gekeken naar de rol van T cellen in de immuuntoxiciteit 
veroorzaakt door HCB. Ook hiervoor werden BN ratten gebruikt, die 3 weken werden 
blootgesteld aan HCB. Om T cellen te blokkeren werd Cyclosporine A (CsA) gebruikt, dit 
is een immunosuppressief (=remt het immuunsysteem) geneesmiddel dat in de kliniek 
wordt gebruikt om afstootreacties na transplantaties te voorkomen. CsA heeft als effect 
dat er minder T cellen aanwezig zijn in het lichaam en remt tevens de activatie van de nog 
aanwezige T cellen. Uit deze experimenten bleek dat T cellen belangrijk zijn voor de 
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ontwikkelen van de huideffecten en sommige longeffecten en voor de verhoogde antistof 
productie in het serum. Echter de effecten van HCB op de milt konden maar voor een deel 
worden geremd en de aantrekking van macrofagen naar zowel milt als longen werd ook 
niet beïnvloed.  
 Om het verband tussen macrofagen en T cellen verder te onderzoeken werden er in 
hoofdstuk 5 verschillende experimenten uitgevoerd. Om macrofagen te verwijderen is er 
gebruik gemaakt van clodronaat liposomen. Dit zijn vetbolletjes met hierin een giftige stof 
(clodronaat). Macrofagen ruimen deze bolletjes op, maar gaan dood door het clodronaat. 
Hiermee konden we aantonen dat ook macrofagen een belangrijke rol spelen bij het 
verergeren van de huideffecten. Daarnaast spelen macrofagen een rol bij de 
longontstekingen en bij de verhoogde gehaltes van antistoffen in het serum. Om meer 
inzicht te verkrijgen in de vroege fase van de immuunreactie werd er een experiment 
uitgevoerd waarbij is gekeken naar de effecten van HCB vroeg na blootstelling. Hieruit 
bleek dat de door HCB veroorzaakte ontstekingen in de huid en longen al vroeg na HCB 
toediening optraden en dat macrofagen al snel aanwezig waren in deze organen. Dit duidt 
erop dat deze cellen een belangrijke rol spelen bij de effecten die worden veroorzaakt door 
HCB. In dit hoofdstuk is ook nog onderzocht of er na blootstelling aan HCB een 
‘geheugen” is ontstaan voor de metabolieten van HCB. Van deze metabolieten is namelijk 
bekend dat ze kunnen worden herkend door T cellen (hoofdstuk 2). Echter, er werd geen 
bewijs gevonden voor de aanwezigheid van een ‘geheugen’ na blootstelling van BN ratten 
aan HCB.  
 In hoofdstuk 6 worden de in dit proefschrift gevonden resultaten samengevat en 
bediscussieerd. De conclusie is dat HCB nadat het is opgenomen door het lichaam 
waarschijnlijk macrofagen aantrekt, waarschijnlijk omdat HCB schade veroorzaakt aan 
het lichaamseigen structuren en er op deze manier gevaarsignalen ontstaan (zie Figuur 2, 
hoofdstuk 6). Dit zal leiden tot de productie en uitscheiding van verscheidene producten, 
zoals cytokines. Hierdoor kunnen T cellen worden geactiveerd, maar ook andere 
immuuncellen. Hierdoor zal een chronische ontstekingsreactie ontstaan in meerdere 
orgaansystemen.   
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Jaaaaaaaaa mijn boek is af!!!! Tijd om dus terug te kijken op 4 jaar werk en om iedereen 
te bedanken die direct of indirect een bijdrage heeft geleverd. Na een valse start als AIO in 
Nijmegen begon ik 4 jaar geleden aan dit project en hoopte dat dit voorspoediger zou 
verlopen. Het enthousiasme van zowel mijn promotor Sjef Vos als van mijn co-promotor 
Raymond Pieters trok me over de streep en dit was, blijkt nu, een erg goede beslissing.  
 Raymond, kleine man met zo’n groot enthousiasme! Bedankt dat je deur altijd open 
stond voor discussies over werk of het leven! Ik heb ontzettend veel van je geleerd en een 
superleuke tijd gehad op het lab, volleybalveld en in de kroeg! Dat laatste houden we er 
zeker in!  
 Sjef, je was een geweldige promotor! Je enthousiasme voor mijn onderzoek en je 
positieve feedback zorgden ervoor dat ik altijd in mezelf en dit onderzoek bleef geloven. 
Je maakte altijd tijd vrij voor werkbesprekingen, het beoordelen van coupes en het 
nakijken van mijn manuscripten.  
 Zonder de AIOs en analisten op het lab zou het allemaal een stuk minder gezellig 
zijn geweest en onmogelijk om al die secties uit te voeren. Stefan: gedurende 4 jaar was jij 
er altijd voor mij! Bedankt voor alle discussies, al je hulp en advies, alle gezellige en 
goede gesprekken op onze kamer en je luisterend oor als het weer eens tegenzat. Wat zal 
ik je gaan missen! Colin: wat zou het saai zijn geweest zonder jou! Ik zal je humor 
ontzettend gaan missen en hoop dat we hierna nog wel af en toe samen naar concerten 
gaan! Fem: gelukkig kreeg ik versterking van een vrouw met pit en een eigen mening! En 
dat is best fijn in een lab waar de vrouwonvriendelijke opmerkingen regelmatig door de 
lucht vliegen. Ik hoop dat onze eet-, praat- en filmdates ook hierna voortgezet worden. 
Marianne: bedankt voor al je hulp, je expertise en het meedenken bij praktische 
problemen. Rob: al die mooie plaatjes waren het gemopper over koude handen wel waard! 
Verder ben je briljant in het organiseren van labborrels! Ine: je hulp op het lab, met name 
bij celkweek en cytokine bioassays, was onontbeerlijk. Daarnaast heb ik ontzettend veel 
gehad aan je wijze ‘moederlijke’ adviezen.  
 Mijn studenten: Ischa, Astrid, Henneke en Kevin hebben niet alleen ontzettend veel 
werk voor me verricht maar zorgden er ook voor dat er altijd een leuke sfeer hing op het 
lab. Paulientje: eerst superstudent (helaas niet bij mij) nu AIO, dat gaat je ook wel lukken! 
Ik ben nog steeds blij dat ik jou samen met Ies nog regelmatig zie!  
 Maaik: al in je laatste AIO-jaar toen ik arriveerde maar gelukkig zien we elkaar nog 
steeds! Wat is het fijn dat ik altijd bij jou en Bas mag binnenvallen voor een AGV-tje en 
meer! Ik denk nog met veel plezier terug aan onze geweldige California trip samen met 
Henk-Jan&Hester en alle leuke etentjes die we met zijn allen hebben gehad! Als klap op 
de vuurpijl was er natuurlijk ons grote Zweden avontuur, 2000 km rijden/glibberen en kou 
en sneeuw trotseren voor een echte Zweedse bruiloft! Patrik&Åsa: thanks for all the nice 
moments we had when you were living in Utrecht, but the greatest adventure was of 
course visiting your wedding in Piteå!  
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 Lieve Leon: bijna vanaf het begin van mijn project was jij erbij en 3 jaar lang 
werkten we allebei aan onze eigen boekjes. Nu is de mijne ook af! Bedankt voor je 
relativeringsvermogen op de momenten dat ik stuiterde en alle leuke dingen die we samen 
hebben ondernomen.  
 Aangezien mijn project een samenwerking was met het RIVM en de afdeling 
Pathobiologie had ik het voordeel dat ik gebruik kon maken van de expertise in 3 
verschillende labs. Johan Garssen: bedankt voor je enthousiasme en de hulp bij de OVA- 
en TT-ELISA’s. Cor Schot: bedankt voor het mengen van het HCB-voer. Zonder Rob 
Vandebriel en Jeroen Pennings was het onmogelijk geweest om hoofdstuk 3 te schrijven. 
Rob: wat was ik blij dat jij met al je kennis mij altijd kon helpen als ik weer de weg kwijt 
was! Door je enthousiasme bleef ik zelf ook geloven dat het allemaal wel zou lukken! 
Jeroen: wat een werk heb jij verricht bij het analyseren van al die genen! Ondanks al je 
andere werkzaamheden beantwoordde je zo snel mogelijk al mijn vragen! Het 
histologisch lab van de afdeling Pathobiologie heeft prachtige coupes voor me gemaakt! 
Guy Grinwis: bedankt dat je me wegwijs hebt gemaakt op jullie afdeling en voor je 
belangstelling! Carola Michielsen: jij weet als geen ander wat voor lastig stofje HCB is! 
Ik vond het erg fijn dat ik altijd bij je terecht kon voor vragen!  
 Binnen het GDL heb ik op verschillende afdelingen gezeten en ik wil alle 
dierverzorgers bedanken. De meeste experimenten heb ik op Wit uitgevoerd en daarom 
wil ik Toon, Jan en Anja  bedanken voor hun hulp, belangstelling en de goede sfeer!  
 Dori Germolec: thanks for your kindness during my stay in North Carolina! I really 
enjoyed the 2 weeks I spend at NIEHS and at your house!  
 Frank Staedtler and Hans Harleman from Novartis: our collaboration resulted in 
chapter 3 and a really nice publication! Thanks for performing the DNA microarrays and 
the great cooperation.  
 Marty Wulferink: toen je nog in Düsseldorf werkte had ik al veel aan je vakkennis. 
Gelukkig zat je de laatste tijd iets dichter in de buurt! Bedankt voor je tijd, belangstelling, 
het meedenken en de L929 cellen! Yvonne Rietjens: bedankt voor de discussies over 
metabolisme. Jan Damoiseaux: bedankt voor de antilichamen voor flow cytometrie en al 
je tips om het protocol aan de praat te krijgen. Peter Heeringa: bedankt voor de p-ANCA 
bepaling! Gelukkig mocht ik bij TNO de IgE ELISA doen! Leon, Maaike en Elles 
bedankt voor al jullie hulp! Sandra: we zijn heel kort kamergenootjes geweest en daarna 
bleef je altijd enthousiast en vol belangstelling. Bedankt voor je hulp bij de bioassays!  
 Ook van andere IRAS-AIOs heb ik veel steun gehad de afgelopen 4 jaar en ik vind 
het heel bijzonder dat ik in deze periode zulke leuke, gezellige en lieve mensen om me 
heen had. Majorie: klein vrouwke met je grote mond en schaterlach, maar vooral je grote 
hart! Ik ken maar weinig mensen die zo oprecht zijn! Laten we vooral nog vaak tot de 
kleine uurtjes in de kroeg zitten en onder het genot van een biertje goeie gesprekken 
hebben! Martijn: bedankt voor je hulp bij computerproblemen en bij het maken van de 
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kaft! Ook met jou is het goed kroeghangen en ik hoop nog vaak te genieten van je 
briljante gin-tonics! Minne, mijn andere kamergenootje, ook met jou heb ik 4 jaar lief en 
leed gedeeld. Ik heb altijd veel bewondering gehad voor je eigen mening, je eigenzinnige 
persoonlijkheid en het feit dat je voor iedereen klaar staat. Wat was ik blij dat jij er voor 
me was in Salt Lake City! Ik zal onze dagelijkse gesprekken gaan missen! Lieke: we 
hadden een beetje een trage start, maar dat hebben we ruimschoots gecompenseerd nu. 
Brabantse gezelligheid en een gouden hart, we zullen nog vaak samen op stap gaan! 
Marjoke: ontzettend schatje en sportieveling! Wat was het gezellig om samen te volleyen, 
gelukkig ga je nu ook met me spinnen en ben ik tenminste niet de enige die met een rood 
hoofd al druppelend zit te zwoegen op die fiets! Verder alle anderen met wie het altijd 
gezellig was in de Vooghel of tijdens een avondje Katannen of Pictionairy: Bas, Jeroen 
van Meeuwen, Rocio, Nicoline, Chantal, Wouter, Frank, Tim, Jeroen de Hartog, Sofie, 
Suzanne en Rob. Aan de zijlijn van het wetenschappelijk onderzoek maar zo belangrijk 
om het instituut draaiend te houden: Ingrid, Etta, Aart, Marijke, Tejo en Joyce. 
 Karin en Edwin: wat een geweldig volleybaltoernooi hebben wij georganiseerd! Ik 
zal onze lunsjes samen met Evert erg gaan missen. Gelukkig staan jullie & Majorie mij bij 
op de avond voor mijn promotie! Hopelijk zorgen ‘de Peppers’ voor een relaxt avondje!  
 Lieve Mark: met zoveel positieve energie en een enorme glimlach op mijn gezicht 
waren die laatste loodjes opeens niet meer zo zwaar!  
 Mijn vriendinnen waren zo belangrijk voor de nodige ontspanning: Fleur (ik vind 
het fijn dat je altijd zo met me meeleeft. Bedankt voor alle lieve kaartjes!), Marjorie 
(gelukkig terug van je wereld-tournee, wat fijn dat je er bij kunt zijn!), Barbara, Esther en 
Yvette. Bedankt voor alle gezellige avonden/nachten!  
 Ik ben mijn ouders zeer dankbaar dat ze me altijd de vrijheid hebben gegeven om 
mijn eigen keuzes te maken, ook al sloeg ik een heel ander pad in dan de rest. Lieve 
mams, Henriëtte&Gerrit en Erica&Johnny: bedankt voor jullie belangstelling ook al was 
het soms moeilijk te begrijpen wat ik nu allemaal uitvoerde op mijn werk! Lieve papa, ik 
vind het ontzettend jammer dat jij er op deze dag niet bij kunt zijn.  
 Mijn twee allerliefste vriendinnen: Mabelle en Bertina, wie zou ik anders aan mijn 
zijde willen hebben op deze belangrijke dag? Lieve Tien, al vanaf de middelbare school 
vriendinnen en onze vriendschap groeit alleen maar met de jaren. Jij bent er altijd als het 
nodig is. Wat is het fijn dat je altijd met me meeleeft en even belt als je merkt dat het niet 
goed gaat! Lieve Mabellie, al dik 10 jaar vriendinnen en onze band wordt alleen maar 
sterker! Wat voel ik me altijd thuis bij jou! Je kunt zo goed luisteren en adviseren en 
daarnaast is het altijd zo grappig om met je op stap te gaan! Wanneer gaan we nu echt 
eens een keertje weer samen dansen? Ik hou zoveel van jullie allebei en jullie 
enthousiasme, eerlijkheid, puurheid en warmte! 
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Janine Ezendam werd geboren op 14 januari 1975 te Rijssen. In 1993 behaalde zij haar 
vwo diploma op College Noetsele, te Nijverdal. In datzelfde jaar begon zij aan haar studie 
Biomedische Gezondheidswetenschappen aan de Universiteit van Nijmegen. Tijdens de 
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een samenwerking van het Institute for Risk Assessment Sciences te Utrecht, het 
Rijksinstituut voor Volksgezondheid en Milieu, te Bilthoven en de afdeling Pathobiologie 
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